title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
QIAGEN  ( QGEN )  Acquires the Forensics NGS Firm Verogen,https://www.zacks.com/stock/news/2037464/qiagen-qgen-acquires-the-forensics-ngs-firm-verogen,2023-01-10 16:23:00,QIAGEN's (QGEN) acquisition of Verogen fortifies the company's position in the fast-growing field of Human ID and forensics.,BSX,0.213517,0.0,Neutral
"Illumina  ( ILMN ) , Nashville Biosciences Partner With Amgen",https://www.zacks.com/stock/news/2037439/illumina-ilmn-nashville-biosciences-partner-with-amgen,2023-01-10 15:17:00,Illumina (ILMN) is currently keeping well with its goals to strengthen its foothold in the multi-billion gene sequencing market globally.,BSX,0.245959,0.0,Neutral
"Myriad Genetics  ( MYGN )  Ailed by Mounting Costs, FX Headwind",https://www.zacks.com/stock/news/2037347/myriad-genetics-mygn-ailed-by-mounting-costs-fx-headwind,2023-01-10 14:26:00,Myriad Genetics' (MYGN) significant gross margin contraction and operating loss as a result of mounting cost pressure are concerning.,BSX,0.217834,-0.031967,Neutral
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors,https://www.globenewswire.com/news-release/2023/01/09/2585684/0/en/Nyxoah-Appoints-Mr-Daniel-Wildman-to-its-Board-of-Directors.html,2023-01-09 21:30:00,Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors,BSX,0.040969,0.079614,Neutral
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/23/01/g30341181/nyxoah-appoints-mr-daniel-wildman-to-its-board-of-directors,2023-01-09 21:30:00,"Mont-Saint-Guibert, Belgium - January 9, 2023, 10:30pm CET / 4:30pm ET - Nyxoah SA NYXH ( ""Nyxoah"" or the ""Company"" ) , a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea ( OSA ) , today announced that it has ...",BSX,0.04028,0.075528,Neutral
Abbott's  ( ABT )  New Launch to Boost Blood Donation Experience,https://www.zacks.com/stock/news/2036828/abbotts-abt-new-launch-to-boost-blood-donation-experience,2023-01-09 15:31:00,"Abbott's (ABT) mixed reality offers donors an innovative, immersive digital experience while giving blood.",BSX,0.209365,0.0,Neutral
Here's Why Investors Should Retain SmileDirectClub  ( SDC )  Now,https://www.zacks.com/stock/news/2036824/heres-why-investors-should-retain-smiledirectclub-sdc-now,2023-01-09 15:27:00,Investors are optimistic about SmileDirectClub (SDC) on continued strategic partnerships and expansion in the teledentistry space.,BSX,0.202366,0.0,Neutral
"LabCorp  ( LH )  Oncology Arm Gains Traction, Margin Pressure Stays",https://www.zacks.com/stock/news/2036735/labcorp-lh-oncology-arm-gains-traction-margin-pressure-stays,2023-01-09 14:19:00,"In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing treatments for cancer and other diseases.",BSX,0.227538,0.0,Neutral
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2036688/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings,2023-01-09 13:50:07,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,BSX,0.313218,0.327082,Somewhat-Bullish
"Top Research Reports for Caterpillar, Equinor & GSK",https://www.zacks.com/research-daily/2036221/top-research-reports-for-caterpillar-equinor-gsk,2023-01-06 20:07:00,"Today's Research Daily features new research reports on 16 major stocks, including Caterpillar Inc. (CAT), Equinor ASA (EQNR) and GSK plc (GSK).",BSX,0.118354,0.144857,Neutral
Vacuum Therapy Devices Market is expected to grow from USD 1.9 billion in 2022 to USD 2.5 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30314565/vacuum-therapy-devices-market-is-expected-to-grow-from-usd-1-9-billion-in-2022-to-usd-2-5-billion-,2023-01-06 18:00:00,"Pune India, Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the vacuum therapy devices market is operating and ...",BSX,0.024053,0.077413,Neutral
Here's Why You Should Hold on to Teleflex  ( TFX )  Stock for Now,https://www.zacks.com/stock/news/2036371/heres-why-you-should-hold-on-to-teleflex-tfx-stock-for-now,2023-01-06 17:01:00,Investors are optimistic about Teleflex (TFX) on strong preference for the UroLift system.,BSX,0.223866,0.0,Neutral
"Neogen  ( NEOG )  Q2 Earnings Top Estimates, Gross Margin Up",https://www.zacks.com/stock/news/2036207/neogen-neog-q2-earnings-top-estimates-gross-margin-up,2023-01-06 14:26:00,Growth across the Food Safety and Animal Safety segments drives Neogen's (NEOG) Q2 revenues.,BSX,0.116348,0.0,Neutral
"Alcon  ( ALC )  Gains From Innovation, Faces FX Challenges",https://www.zacks.com/stock/news/2036196/alcon-alc-gains-from-innovation-faces-fx-challenges,2023-01-06 14:10:00,"Alcon's (ALC) Surgical franchise continues to lead the market with its portfolio of advanced technology, intraocular lenses, a substantial installed base of equipment and a growing consumable base.",BSX,0.25168,-0.056751,Neutral
"AngioDynamics  ( ANGO )  Q2 Earnings, Revenues Top Estimates",https://www.zacks.com/stock/news/2036194/angiodynamics-ango-q2-earnings-revenues-top-estimates,2023-01-06 14:03:00,AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in second-quarter fiscal 2023.,BSX,0.156715,0.051709,Neutral
Here's Why You Should Retain Ecolab  ( ECL )  Stock for Now,https://www.zacks.com/stock/news/2036151/heres-why-you-should-retain-ecolab-ecl-stock-for-now,2023-01-06 13:51:00,Investors continue to be optimistic about Ecolab (ECL) owing to its strong business.,BSX,0.201523,0.0,Neutral
Surgical Monitors Market will worth USD 756.9 million by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30300549/surgical-monitors-market-will-worth-usd-756-9-million-by-2030-greyviews,2023-01-05 20:00:00,"Pune India, Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the surgical monitors market is operating and is ...",BSX,0.025679,0.092554,Neutral
Neurosurgery Surgical Power Tools Market will reach to USD 8.39 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30299639/neurosurgery-surgical-power-tools-market-will-reach-to-usd-8-39-billion-by-2030-greyviews,2023-01-05 19:00:00,"Pune India, Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",BSX,0.027603,0.024863,Neutral
"Walgreens Boots  ( WBA )  Q1 Earnings Top, Revenues View Up",https://www.zacks.com/stock/news/2035865/walgreens-boots-wba-q1-earnings-top-revenues-view-up,2023-01-05 17:00:00,"The U.S. Healthcare segment of Walgreens Boots (WBA) grows on key contract wins, continued partnership growth and a strong focus on execution.",BSX,0.081276,0.0,Neutral
Here's Why You Should Hold Cigna  ( CI )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2035807/heres-why-you-should-hold-cigna-ci-stock-in-your-portfolio,2023-01-05 16:47:00,"Cigna (CI) remains well-poised for growth on the back of the solid Evernorth and Cigna Healthcare businesses, an expanding customer base and robust cash-generating abilities.",BSX,0.328091,0.176552,Somewhat-Bullish
Here's Why You Should Retain Bio-Rad  ( BIO )  Stock for Now,https://www.zacks.com/stock/news/2035649/heres-why-you-should-retain-bio-rad-bio-stock-for-now,2023-01-05 14:11:00,"Investors are optimistic about Bio-Rad (BIO), led by robust demand in the Life Science and Clinical Diagnostics arms.",BSX,0.213988,0.0,Neutral
JenaValve Appoints Dan Dearen to Board of Directors,https://www.benzinga.com/pressreleases/23/01/g30293516/jenavalve-appoints-dan-dearen-to-board-of-directors,2023-01-05 14:00:00,"IRVINE, Calif., Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement ( TAVR ) systems, today announced that it has appointed Dan Dearen, medical device industry executive, to its Board of Directors.",BSX,0.063258,0.056015,Neutral
Tactile Medical Appoints Carmen Volkart to Board of Directors,https://www.globenewswire.com/news-release/2023/01/05/2583557/0/en/Tactile-Medical-Appoints-Carmen-Volkart-to-Board-of-Directors.html,2023-01-05 12:30:00,"MINNEAPOLIS, Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- Tactile Systems Technology, Inc. ( ""Tactile Medical"" ) ( Nasdaq: TCMD ) , a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Carmen Volkart to the Company's Board of Directors ( ...",BSX,0.095138,0.163062,Somewhat-Bullish
Tactile Medical Appoints Carmen Volkart to Board of Directors - Tactile Systems Tech  ( NASDAQ:TCMD ) ,https://www.benzinga.com/pressreleases/23/01/g30291343/tactile-medical-appoints-carmen-volkart-to-board-of-directors,2023-01-05 12:30:00,"MINNEAPOLIS, Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- Tactile Systems Technology, Inc. ( ""Tactile Medical"" ) TCMD, a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Carmen Volkart to the Company's Board of Directors ( ""Board"" ) , ...",BSX,0.092213,0.161883,Somewhat-Bullish
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APEN, HZNP, MLVF, TCFC - Apollo Endosurgery  ( NASDAQ:APEN ) , Horizon Therapeutics  ( NASDAQ:HZNP ) ",https://www.benzinga.com/pressreleases/23/01/g30290362/shareholder-investigation-halper-sadeh-llc-investigates-apen-hznp-mlvf-tcfc,2023-01-05 11:39:50,"NEW YORK, Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Apollo Endosurgery, Inc.",BSX,0.132368,0.156663,Somewhat-Bullish
Masimo's  ( MASI )  SpHb During Elective CS Favored by New Study,https://www.zacks.com/stock/news/2035324/masimos-masi-sphb-during-elective-cs-favored-by-new-study,2023-01-04 18:28:00,Masimo's (MASI) SpHb is likely to indicate clinically acceptable accuracy of Hb measurement even at low Hb levels in patients undergoing CS with antepartum hemorrhage.,BSX,0.195419,0.0,Neutral
Here's Why You Should Retain PacBio  ( PACB )  Stock for Now,https://www.zacks.com/stock/news/2035314/heres-why-you-should-retain-pacbio-pacb-stock-for-now,2023-01-04 17:34:00,PacBio's (PACB) strength in its Sequel system raises optimism about the stock.,BSX,0.214462,0.0,Neutral
PETQ vs. BSX: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2035243/petq-vs-bsx-which-stock-is-the-better-value-option,2023-01-04 16:40:13,Investors looking for stocks in the Medical - Products sector might want to consider either PetIQ ( PETQ Quick QuotePETQ - ) or Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.,BSX,0.632565,0.56361,Bullish
Walgreens  ( WBA )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2035224/walgreens-wba-to-report-q1-earnings-whats-in-the-cards,2023-01-04 16:19:00,Walgreens' (WBA) strategic executions on both the United States and the international front are likely to have contributed to the Q1 2023 top line.,BSX,0.150827,0.0,Neutral
Here's Why You Should Retain CONMED  ( CNMD )  Stock for Now,https://www.zacks.com/stock/news/2034516/heres-why-you-should-retain-conmed-cnmd-stock-for-now,2023-01-03 13:43:00,Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.,BSX,0.207571,0.0,Neutral
Will Boston Scientific  ( BSX )  Beat Q4 Earnings Estimates?,https://www.zacks.com/stock/news/2041865/will-boston-scientific-bsx-beat-q4-earnings-estimates,2023-01-20 13:42:00,"Boston Scientific (BSX) is expected to have registered strong growth in EMEA within structural heart, including TAVR, WATCHMAN, and other interventional cardiology therapies.",BSX,0.324353,0.374687,Bullish
"Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects",https://www.benzinga.com/markets/cannabis/23/01/30490764/clearmind-teams-with-yissum-university-of-jerusalem-on-2-psychedelic-r-d-projects,2023-01-19 19:57:03,Psychedelics biotech Clearmind Medicine Inc. CMND has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.,BSX,0.244109,0.202019,Somewhat-Bullish
Berg Insight says 56.8 million patients worldwide are remotely monitored,https://www.investorideas.com/news/2023/biotech/01191Patients-Remotely-Monitored.asp,2023-01-19 18:04:31,Berg Insight says 56.8 million patients worldwide are remotely ... ...,BSX,0.062434,0.040037,Neutral
Charles River  ( CRL )  to Develop RNA-based Therapy With New Pact,https://www.zacks.com/stock/news/2041418/charles-river-crl-to-develop-rna-based-therapy-with-new-pact,2023-01-19 15:19:00,Charles River's (CRL) new partnership will enable the clinical development of RNA-based anticancer gene therapy in liver cancer patients.,BSX,0.239305,0.0,Neutral
Copado Wins Top DevOps Awards for CI/CD and Automation Solutions,https://www.prnewswire.com/news-releases/copado-wins-top-devops-awards-for-cicd-and-automation-solutions-301725171.html,2023-01-19 14:30:00,Copado Wins Top DevOps Awards for CI/CD and Automation ... PR ...,BSX,0.103331,0.10055,Neutral
"The 1980s was the blueprint for the upcoming disinflation cycle and these are the stocks for it, strategists say",https://www.marketwatch.com/story/the-1980s-was-the-blueprint-for-the-upcoming-disinflation-cycle-and-these-are-the-stocks-for-it-strategists-say-11674129076,2023-01-19 12:16:00,Our call of the day from Jefferies is telling investors to start thinking about deflation and look at what happened in the good old 1980s.,BSX,0.097062,0.064191,Neutral
"A New-Era of Digital Health in Cardiac Monitoring has Begun Post Pandemic; Smart Wearables, AI-based ECG Becoming Integral Part of Ambulatory Cardiovascular Medical Practices; The Global Wearable ECG Devices Market to Witness Sales of $35 Billion by 2027 - Arizton",https://www.prnewswire.com/news-releases/a-new-era-of-digital-health-in-cardiac-monitoring-has-begun-post-pandemic-smart-wearables-ai-based-ecg-becoming-integral-part-of-ambulatory-cardiovascular-medical-practices-the-global-wearable-ecg-devices-market-to-witness-sale-301723636.html,2023-01-17 18:00:00,A New-Era of Digital Health in Cardiac Monitoring has Begun Post ... PR ...,BSX,0.087185,0.074094,Neutral
"IDEXX  ( IDXX )  Aided by Global Growth, Solid Instrument Placement",https://www.zacks.com/stock/news/2040121/idexx-idxx-aided-by-global-growth-solid-instrument-placement,2023-01-17 14:40:00,IDEXX's (IDXX) rapid assay revenue growth is supported by solid volume gains in the United States and benefits from net price increases.,BSX,0.247838,0.0,Neutral
"Nerve Repair And Regeneration Market is expected to generate a revenue of USD 14.43 Billion by 2030, Globally, at 8.37% CAGR: Verified Market Research®",https://www.prnewswire.com/news-releases/nerve-repair-and-regeneration-market-is-expected-to-generate-a-revenue-of-usd-14-43-billion-by-2030--globally-at-8-37-cagr-verified-market-research-301722342.html,2023-01-16 15:30:00,Nerve Repair And Regeneration Market is expected to generate a ... PR ...,BSX,0.039418,0.061681,Neutral
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TALO, APEN, MPB",https://www.benzinga.com/pressreleases/23/01/g30423844/shareholder-investigation-halper-sadeh-llc-investigates-talo-apen-mpb,2023-01-15 15:10:20,"NEW YORK, Jan. 15, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Talos Energy Inc.",BSX,0.137671,0.159859,Somewhat-Bullish
"Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA Medical Device Officer Joins Scientific Advisory Board",https://www.prnewswire.com/news-releases/pulnovo-medical-announces-dr-mingdong-zhang-former-fda-medical-device-officer-joins-scientific-advisory-board-301721041.html,2023-01-14 14:00:00,"Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA ... PR ...",BSX,0.129866,0.051991,Neutral
How Ireland's buoyant jobs market offers plentiful employment opportunities for varied sectors | The Financial Express,https://www.financialexpress.com/education-2/ireland-jobs-market-job-opportunities-employment-job-abroad-visa-european-union/2947655/,2023-01-14 08:15:00,How Ireland's buoyant jobs market offers plentiful employment opportunities for varied sectors The Financial Express ...,BSX,0.145145,0.047101,Neutral
Cardiac Catheters Market will worth USD 44.9 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30415717/cardiac-catheters-market-will-worth-usd-44-9-billion-by-2030-greyviews,2023-01-13 19:00:00,"Pune India, Jan. 13, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the cardiac catheter market is operating and is ...",BSX,0.02506,0.121819,Neutral
Charles River  ( CRL )  to Advance DNA Programs With New Launch,https://www.zacks.com/stock/news/2039136/charles-river-crl-to-advance-dna-programs-with-new-launch,2023-01-13 16:24:00,Charles River's (CRL) launch of the eXpDNA plasmid manufacturing platform is intended to support vaccine and advanced therapy clients through clinical trials and beyond.,BSX,0.209365,0.0,Neutral
"NuVasive  ( NUVA )  Suffers From Macro Headwinds, Price Issue",https://www.zacks.com/stock/news/2039134/nuvasive-nuva-suffers-from-macro-headwinds-price-issue,2023-01-13 16:22:00,"NuVasive (NUVA) believes that its 2022 guidance is appropriately conservative, considering macroeconomic pressures on net sales and operating profit.",BSX,0.241684,0.0,Neutral
Varicose Vein Treatment Market will worth USD 2.87 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30398074/varicose-vein-treatment-market-will-worth-usd-2-87-billion-by-2030-greyviews,2023-01-12 20:00:00,"Pune India, Jan. 12, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the varicose vein treatment market is operating ...",BSX,0.025817,-0.001901,Neutral
HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND'S INNOVESTOR LIFE SCIENCE FUND AND TESI,https://www.prnewswire.com/news-releases/hvr-cardio-closes-on-11-million-series-b-financing-with-finlands-innovestor-life-science-fund-and-tesi-301720660.html,2023-01-12 17:58:00,HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING ... PR ...,BSX,0.141726,0.053836,Neutral
"QIAGEN  ( QGEN )  Gains From Innovation, Currency Headwind Ails",https://www.zacks.com/stock/news/2038561/qiagen-qgen-gains-from-innovation-currency-headwind-ails,2023-01-12 15:34:00,The QuantiFERON franchise is a key driver behind QIAGEN's (QGEN) molecular diagnostics growth.,BSX,0.188193,0.0,Neutral
Syneos Health  ( SYNH )  to Launch Serplulimab With New Pact,https://www.zacks.com/stock/news/2038426/syneos-health-synh-to-launch-serplulimab-with-new-pact,2023-01-12 14:07:00,Syneos Health's (SYNH) new partnership will develop an advanced commercialization model to serve healthcare professionals and patients in the best possible way in today's changing environment.,BSX,0.203215,0.0,Neutral
Here's Why You Should Retain QIAGEN  ( QGEN )  Stock for Now,https://www.zacks.com/stock/news/2038399/heres-why-you-should-retain-qiagen-qgen-stock-for-now,2023-01-12 13:58:00,"Investors are optimistic about QIAGEN (QGEN), led by progress in the test menu expansion strategy.",BSX,0.185662,-0.044682,Neutral
How Doug Godshall Ignited the Spark at ShockWave,https://www.investors.com/news/management/leaders-and-success/shockwave-ceo-how-doug-godshall-ignited-the-spark/,2023-01-12 13:00:00,Shockwave CEO Doug Godshall Ignited the Spark Investor's Business Daily ...,BSX,0.088472,0.187854,Somewhat-Bullish
The Medical Bionic Implant/Artificial Organs Market Size Is Expected To Grow With The Rise In Number Of Road Accidents As Per The Business Research Company's Medical Bionic Implant/Artificial Organs Global Market Report 2023,https://www.benzinga.com/pressreleases/23/01/g30374907/the-medical-bionic-implantartificial-organs-market-size-is-expected-to-grow-with-the-rise-in-numbe,2023-01-11 16:30:00,"LONDON, Jan. 11, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the medical bionic implant/artificial organs market identifies the rise in road accidents and injuries to propel the growth of the medical bionic implant/artificial organs market going forward.",BSX,0.0362,-0.046791,Neutral
Here's Why Investors Should Buy Exact Sciences  ( EXAS )  Stock,https://www.zacks.com/stock/news/2037962/heres-why-investors-should-buy-exact-sciences-exas-stock,2023-01-11 15:53:00,Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.,BSX,0.202366,0.0,Neutral
Masimo  ( MASI )  Gets Favorable Ruling in Apple Watch Patent Suit,https://www.zacks.com/stock/news/2037839/masimo-masi-gets-favorable-ruling-in-apple-watch-patent-suit,2023-01-11 14:01:00,A U.S. Administrative Law Judge ruled that Apple watches infringe one of Masimo's (MASI) pulse oximeter patents. An import ban may follow for Apple watches.,BSX,0.188928,0.0,Neutral
Catheter Market is expected to grow from USD 49 billion in 2022 to USD 83.5 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30625942/catheter-market-is-expected-to-grow-from-usd-49-billion-in-2022-to-usd-83-5-billion-by-2030-greyvi,2023-01-30 17:00:00,"Pune India, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the catheter market is operating and is predicted ...",BSX,0.02351,0.139701,Neutral
"Global Pharmaceutical Drug Delivery Market worth $2,206.5 billion by 2026 - Exclusive Report by MarketsandMarkets™",https://www.benzinga.com/pressreleases/23/01/g30622827/global-pharmaceutical-drug-delivery-market-worth-2-206-5-billion-by-2026-exclusive-report-by-marke,2023-01-30 14:30:00,"Chicago, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report ""Pharmaceutical Drug Delivery Market Size, Growth by Route of Administration ( Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes ) , Application ( Cancer, Diabetes ) , ...",BSX,0.087503,0.021576,Neutral
"Global Traumatic Brain Injuries Assessment Market Anticipated to Generate a Revenue of $18,373.6 Million and Rise at a CAGR of 7.0% during the Estimated Period 2022-2031 [250-Pages] | Approved by Research Dive",https://www.benzinga.com/pressreleases/23/01/g30622070/global-traumatic-brain-injuries-assessment-market-anticipated-to-generate-a-revenue-of-18-373-6-mi,2023-01-30 14:01:00,"New York, USA, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research Dive, the global traumatic brain injuries assessment market is predicted to generate a revenue of $18,373.6 million and grow at a CAGR of 7.0% during the analysis period from 2022 to 2031.",BSX,0.065327,0.0,Neutral
"With 8.0% CAGR, Spinal Cord Stimulation Market Size to Surpass USD 4.12 Billion by 2027",https://www.benzinga.com/pressreleases/23/01/g30618275/with-8-0-cagr-spinal-cord-stimulation-market-size-to-surpass-usd-4-12-billion-by-2027,2023-01-30 10:39:17,"Pune, India, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- The global spinal cord stimulation market is expected to gain from increasing per capita income.",BSX,0.094576,0.045971,Neutral
"Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch",https://www.benzinga.com/news/earnings/23/01/30616031/can-market-sustain-upward-momentum-in-tech-heavy-earnings-week-apple-amazon-amd-alphabet-ford-among,2023-01-29 22:25:32,"With a full week of earnings behind us, it's time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed. Some of the big tech names that fell short are Intel Corp. INTC and Texas Instruments, Inc.",BSX,0.054114,0.157789,Somewhat-Bullish
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LMST, LBC, APEN, TIG",https://www.benzinga.com/pressreleases/23/01/g30615596/shareholder-investigation-halper-sadeh-llc-investigates-lmst-lbc-apen-tig,2023-01-29 13:52:55,"NEW YORK, Jan. 29, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Limestone Bancorp, Inc.",BSX,0.133841,0.157538,Somewhat-Bullish
Structural Heart Devices Market will grow to USD 31.7 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30608665/structural-heart-devices-market-will-grow-to-usd-31-7-billion-by-2030-greyviews,2023-01-27 20:00:00,"Pune India, Jan. 27, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the structural heart devices market is operating ...",BSX,0.024077,0.147672,Neutral
Boston Scientific  ( NYSE:BSX )  Stock Rating Upgraded by StockNews.com,https://www.etfdailynews.com/2023/01/27/boston-scientific-nysebsx-stock-rating-upgraded-by-stocknews-com/,2023-01-27 00:33:45,Boston Scientific ( NYSE:BSX ) Stock Rating Upgraded by StockNews ... ETF Daily News ...,BSX,0.755086,0.437365,Bullish
At a CAGR of 9.7% The Defibrillator Market Predicted to Gain US$18.2 billion by 2026 - Exclusive Report by MarketsandMarkets™,https://www.benzinga.com/pressreleases/23/01/g30597087/at-a-cagr-of-9-7-the-defibrillator-market-predicted-to-gain-us-18-2-billion-by-2026-exclusive-repo,2023-01-27 00:30:00,"Chicago, Jan. 26, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report ""Defibrillator Market by Product Type ( Implantable Cardioverter Defibrillator and External Defibrillator ) , Patient Type ( Adult, Pediatric ) , End Users, and Region ( North America, Europe, APAC, Latin ...",BSX,0.035189,0.040608,Neutral
Earnings Preview: SurModics  ( SRDX )  Q1 Earnings Expected to Decline,https://www.zacks.com/stock/news/2044845/earnings-preview-surmodics-srdx-q1-earnings-expected-to-decline,2023-01-26 15:01:02,SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,BSX,0.175539,0.024046,Neutral
Boston Scientific  ( BSX )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release,https://www.zacks.com/stock/news/2044107/boston-scientific-bsx-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release,2023-01-25 15:00:51,Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,BSX,0.296463,0.244703,Somewhat-Bullish
The Worldwide Endoscopic Ultrasound Industry is Projected to Reach $2.1 Billion by 2031,https://www.prnewswire.com/news-releases/the-worldwide-endoscopic-ultrasound-industry-is-projected-to-reach-2-1-billion-by-2031--301729776.html,2023-01-25 12:50:00,The Worldwide Endoscopic Ultrasound Industry is Projected to ... PR ...,BSX,0.03631,0.0,Neutral
Prosthetic Heart Valve Market will value USD 26.2 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30530546/prosthetic-heart-valve-market-will-value-usd-26-2-billion-by-2030-greyviews,2023-01-23 19:00:00,"Pune India, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the prosthetic heart valve market is operating and ...",BSX,0.023885,0.240815,Somewhat-Bullish
"Global guidewires market: Driving factors, industry challenges, segmentation, key vendor analysis, leading countries, and market size and forecast 2023-2027 - Technavio",https://www.prnewswire.com/news-releases/global-guidewires-market-driving-factors-industry-challenges-segmentation-key-vendor-analysis-leading-countries-and-market-size-and-forecast-2023-2027---technavio-301726690.html,2023-01-23 17:30:00,"Global guidewires market: Driving factors, industry challenges ... PR ...",BSX,0.035983,-0.038843,Neutral
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2042737/heres-why-you-should-retain-boston-scientific-bsx-now,2023-01-23 15:48:00,Investors are optimistic about Boston Scientific (BSX) on recent acquisitions and robust performance of the WATCHMAN device.,BSX,0.333685,0.332984,Somewhat-Bullish
Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors,https://www.globenewswire.com/news-release/2023/01/23/2593139/0/en/Aerovate-Therapeutics-Appoints-Donald-Santel-To-Its-Board-of-Directors.html,2023-01-23 13:00:00,"WALTHAM, Mass., Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- Aerovate Therapeutics, Inc. ( Nasdaq: AVTE ) , a clinical-stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the appointment of Donald ...",BSX,0.041755,0.016421,Neutral
Nerve Repair and Regeneration Market Report Will Reach to USD 19.16 Billion by 2030 at a CAGR of 12.2% : GreyViews,https://www.benzinga.com/pressreleases/23/02/g30820533/nerve-repair-and-regeneration-market-report-will-reach-to-usd-19-16-billion-by-2030-at-a-cagr-of-1,2023-02-08 19:00:00,"Pune India, Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Nerve Repair and Regeneration Market Size by Product Type ( Biomaterials and Neurostimulation & Neuromodulation Devices ) , By Application ( Stem Cell Therapy, Neurorrhaphy, Neurostimulation, Nerve Grafting, Neuromodulation Surgeries, and Others ) ...",BSX,0.03443,0.106678,Neutral
"Global Percutaneous Aortic Valve Implantation Market Anticipated to Garner $13,454.6 Million, Growing with 13.9% CAGR in the 2021-2028 Timeframe [160-Pages] | Announced by Research Dive",https://www.benzinga.com/pressreleases/23/02/g30810319/global-percutaneous-aortic-valve-implantation-market-anticipated-to-garner-13-454-6-million-growin,2023-02-08 14:01:00,"New York, USA, Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Research Dive has published a new report on the global percutaneous aortic valve implantation market. According to the report, the global market is projected to surpass $13,454.6 million and grow with a CAGR of 13.9% in the estimated period, ...",BSX,0.058188,0.0,Neutral
"Global Bronchial Thermoplasty Catheter Market Anticipated to Generate a Revenue of $5,416.8 Million and Rise at a CAGR of 4.99% during the Analysis Period 2022-2031 [200-Pages] | Details by Research Dive",https://www.benzinga.com/pressreleases/23/02/g30763377/global-bronchial-thermoplasty-catheter-market-anticipated-to-generate-a-revenue-of-5-416-8-million,2023-02-07 14:02:00,"New York, USA, Feb. 07, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research Dive, the global bronchial thermoplasty catheter market is anticipated to garner a revenue of $5,416.8 million and grow at a CAGR of 4.99% over the estimated period from 2022 to 2031.",BSX,0.159569,0.180718,Somewhat-Bullish
"Global mHealth and Home Monitoring Market Analysis Report 2023: Focus on Cardiac Rhythm, Sleep Therapy, Telehealth, ECG Monitoring, Glucose Monitoring, and Medication Compliance - Forecast to 2027",https://www.prnewswire.com/news-releases/global-mhealth-and-home-monitoring-market-analysis-report-2023-focus-on-cardiac-rhythm-sleep-therapy-telehealth-ecg-monitoring-glucose-monitoring-and-medication-compliance---forecast-to-2027-301739198.html,2023-02-06 10:40:00,Global mHealth and Home Monitoring Market Analysis Report 2023 ... PR ...,BSX,0.053749,0.093977,Neutral
"Boston Scientific  ( NYSE:BSX )  Lifted to ""Buy"" at StockNews.com",https://www.etfdailynews.com/2023/02/04/boston-scientific-nysebsx-lifted-to-buy-at-stocknews-com/,2023-02-04 07:10:43,"Boston Scientific ( NYSE:BSX - Get Rating ) was upgraded by analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a report released on Thursday. BSX has been the subject of several other research reports.",BSX,0.746902,0.430103,Bullish
Boston Scientific  ( NYSE:BSX )  Rating Increased to Buy at StockNews.com,https://www.defenseworld.net/2023/02/04/boston-scientific-nysebsx-rating-increased-to-buy-at-stocknews-com.html,2023-02-04 07:10:41,Boston Scientific ( NYSE:BSX ) Rating Increased to Buy at StockNews ... Defense World ...,BSX,0.744196,0.457259,Bullish
"Healthcare education solutions market recorded 8.25% growth between 2021 and 2022; Insights on top countries such as the UK, among others - Technavio",https://www.prnewswire.com/news-releases/healthcare-education-solutions-market-recorded-8-25-growth-between-2021-and-2022-insights-on-top-countries-such-as-the-uk-among-others--technavio-301736018.html,2023-02-04 01:00:00,Healthcare education solutions market recorded 8.25% growth ... PR ...,BSX,0.04497,-0.018743,Neutral
"SHAREHOLDER ALERT: Morris Kandinov Investigating ALBO, APEN, ATCX and PAYA Mergers and Acquisitions; Shareholders are Encouraged to Contact the Firm",https://www.benzinga.com/pressreleases/23/02/g30697503/shareholder-alert-morris-kandinov-investigating-albo-apen-atcx-and-paya-mergers-and-acquisitions-s,2023-02-02 21:20:48,"SAN DIEGO, Feb. 02, 2023 ( GLOBE NEWSWIRE ) -- National law firm Morris Kandinov is investigating Albireo Pharma, Inc., Apollo Endosurgery, Inc., Atlas Technical Consultants, and Paya Holdings Inc. If you are a current owner of shares, contact leo@moka.law. Is Albireo Pharma, Inc.",BSX,0.068112,0.066925,Neutral
"Phlow Corp. Announces Formation of Business Advisory Board, New Board of Directors Appointment and Corporate President as Company Accelerates Towards Next Stage of Growth",https://www.benzinga.com/pressreleases/23/02/g30693737/phlow-corp-announces-formation-of-business-advisory-board-new-board-of-directors-appointment-and-c,2023-02-02 17:58:39,"Richmond, Virginia, Feb. 02, 2023 ( GLOBE NEWSWIRE ) -- Phlow Corp., a U.S.-based public benefit corporation leveraging advanced manufacturing processes to re-imagine the domestic production of pharmaceutical products critical to U.S. healthcare, announced today the formation of the Phlow ...",BSX,0.042048,0.230649,Somewhat-Bullish
"Balloon Catheter Market Size to Surpass USD 6.70 Billion by 2030, Size, Share, Emerging Trends, Business Strategies, Competitive Landscape and Regional Overview",https://www.prnewswire.com/news-releases/balloon-catheter-market-size-to-surpass-usd-6-70-billion-by-2030--size-share-emerging-trends-business-strategies-competitive-landscape-and-regional-overview-301737330.html,2023-02-02 17:30:00,Balloon Catheter Market Size to Surpass USD 6.70 Billion by 2030 ... PR ...,BSX,0.018215,0.065984,Neutral
"Pharma Behemoth Skids On Mixed Earnings, But Boosts Outlook",https://www.investors.com/news/technology/lly-stock-eli-lilly-earnings-q4-2022/,2023-02-02 13:58:00,"LLY Stock Dives On Mixed Earnings, But Boosts Profit Outlook ... Investor's Business Daily ...",BSX,0.250386,0.589625,Bullish
"Boston Scientific  ( BSX )  Q4 Earnings Miss, Operating Margin Up",https://www.zacks.com/stock/news/2047817/boston-scientific-bsx-q4-earnings-miss-operating-margin-up,2023-02-01 16:44:00,Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in the fourth quarter of 2022.,BSX,0.352432,0.095151,Neutral
"Transradial Access Devices Market Size is projected to reach USD 4.9 Billion by 2031, growing at a CAGR of 8.3%: Straits Research",https://www.benzinga.com/pressreleases/23/02/g30670322/transradial-access-devices-market-size-is-projected-to-reach-usd-4-9-billion-by-2031-growing-at-a-,2023-02-01 15:45:00,"New York, United States, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- Transradial access is preferred for coronary angiography and percutaneous coronary intervention due to a lower risk of bleeding and vascular complications, higher patient satisfaction, and decreased mortality.",BSX,0.030216,0.0,Neutral
Why Boston Scientific  ( BSX )  Shares Are Trading Higher Today,https://www.benzinga.com/news/earnings/23/02/30668737/why-boston-scientific-shares-are-trading-higher-today,2023-02-01 15:44:35,"Boston Scientific Corp BSX generated Q4 revenues of $3.24 billion, in line with the Wall Street estimate. Sales increased 3.7% Y/Y on a reported basis, 8.7% on an operational basis, and 7.1% on an organic basis. The company achieved an adjusted EPS of $0.45, missing the consensus of $0.47.",BSX,0.895116,0.391378,Bullish
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today,https://www.benzinga.com/news/earnings/23/02/30668192/1000-invested-in-boston-scientific-10-years-ago-would-be-worth-this-much-today,2023-02-01 14:34:17,"Boston Scientific BSX has outperformed the market over the past 10 years by 9.38% on an annualized basis producing an average annual return of 19.75%. Currently, Boston Scientific has a market capitalization of $66.25 billion.",BSX,0.980595,0.386944,Bullish
A Bullish Outlook Helped This Medical Giant To Surge,https://www.investors.com/news/technology/tmo-stock-bsx-stock-q4-2022-earnings/,2023-02-01 14:28:00,TMO Pops On Its Bullish Outlook As BSX Stock Rises On In-Line ... Investor's Business Daily ...,BSX,0.72844,0.062716,Neutral
Boston Scientific  ( BSX )  Lags Q4 Earnings Estimates,https://www.zacks.com/stock/news/2047498/boston-scientific-bsx-lags-q4-earnings-estimates,2023-02-01 12:55:05,"Boston Scientific (BSX) delivered earnings and revenue surprises of -4.26% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",BSX,0.398148,0.155401,Somewhat-Bullish
US Stocks On Track For Nervous Start As Traders Go Fed Watching: AMD Earnings Calm Investors,https://www.benzinga.com/news/earnings/23/02/30662721/us-stocks-on-track-for-nervous-start-as-traders-go-fed-watching-amd-earnings-calm-investors,2023-02-01 11:56:12,"Futures trading point to a negative start by Wall Street stocks on Wednesday as traders exercise restraint ahead of the Fed decision due in the afternoon. Stocks closed notably higher on Tuesday, capping off a strong January, as positive reactions to earnings from companies, including General ...",BSX,0.087663,0.0,Neutral
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022,https://www.prnewswire.com/news-releases/boston-scientific-announces-results-for-fourth-quarter-and-full-year-2022-301735494.html,2023-02-01 11:30:00,BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH ... PR ...,BSX,0.100789,0.103644,Neutral
Morning Bid: A quart and two halves,https://www.reuters.com/markets/us/global-markets-view-usa-2023-02-01/,2023-02-01 11:04:01,"A look at the day ahead in U.S. and global markets from Mike Dolan. After a heady January brew, investors now see triples all round.",BSX,0.053509,0.0,Neutral
U.S. stock futures shift lower as investors brace for Fed policy decision,https://www.marketwatch.com/story/u-s-stock-futures-shift-lower-as-investors-brace-for-fed-policy-decision-11675248565,2023-02-01 10:49:00,"A new month of trading is set to kick off with losses, as markets wait to hear from the Federal Reserve, whose two-day policy meeting wraps up Wednesday.",BSX,0.129168,0.0,Neutral
"Medical Device Stocks' Earnings on Feb 1: BSX, TMO & More",https://www.zacks.com/stock/news/2046933/medical-device-stocks-earnings-on-feb-1-bsx-tmo-more,2023-01-31 14:04:00,"Medical device companies' results are likely to reflect a sequential decline. Let's see how BSX, TMO, HOLX and ALGN fare this time.",BSX,0.230235,0.30682,Somewhat-Bullish
"Boston Scientific  ( BSX )  Gains From New Buyouts, Cost Woes Stay",https://www.zacks.com/stock/news/2055461/boston-scientific-bsx-gains-from-new-buyouts-cost-woes-stay,2023-02-16 15:50:00,"Boston Scientific's (BSX) EMEA business grows above market, supported by the company's ongoing investments in emerging markets.",BSX,0.458708,0.218177,Somewhat-Bullish
Remote Patient Monitoring Devices Market Exhibits 18.9% CAGR to Reach USD 101.02 Billion by 2028,https://www.benzinga.com/pressreleases/23/02/g30893457/remote-patient-monitoring-devices-market-exhibits-18-9-cagr-to-reach-usd-101-02-billion-by-2028,2023-02-14 10:41:10,"Pune, India, Feb. 14, 2023 ( GLOBE NEWSWIRE ) -- The global remote patient monitoring devices market size was valued at USD 25.32 billion in 2020. The market is projected to grow from USD 30.05 billion in 2021 to USD 101.02 billion by 2028, exhibiting a CAGR of 18.9% during the forecast period.",BSX,0.042346,-0.03395,Neutral
Supply-chain mapping startup Altana staffs up,https://www.axios.com/2023/02/13/altana-supply-chain-mapping-startup-staffs-up,2023-02-13 11:00:21,"After raising more than $115 million, New York startup Altana has made several key executive hires designed to advance its mission: mapping the world's supply chains. Why it matters: Companies are paying a lot more attention to supply chains in a world disrupted by global pandemics, wars and ...",BSX,0.095899,0.180372,Somewhat-Bullish
Egg Medical Names Gavin Philipps as Global Chief Commercial Officer,https://www.prnewswire.com/news-releases/egg-medical-names-gavin-philipps-as-global-chief-commercial-officer-301744386.html,2023-02-10 20:27:00,Egg Medical Names Gavin Philipps as Global Chief Commercial ... PR ...,BSX,0.129516,0.041281,Neutral
X-Ray Systems Devices And Equipment Global Market Report 2023,https://www.prnewswire.com/news-releases/x-ray-systems-devices-and-equipment-global-market-report-2023-301743323.html,2023-02-10 17:00:00,"NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Major players in the X-ray devices and equipment market are Siemens Healthcare, Carestream Health, Philips Healthcare, Hitachi Medical, GE Healthcare, Shimadzu, Fujifilm Holdings, Toshiba Medical Systems Corporation, and Canon.",BSX,0.029545,0.035762,Neutral
"Gynecological Devices Market [2023-2030], Industry Size, Share, Revenue, Key Players, CAGR, Demand and Sales Forecast",https://www.benzinga.com/pressreleases/23/02/g30850694/gynecological-devices-market-2023-2030-industry-size-share-revenue-key-players-cagr-demand-and-sal,2023-02-10 09:22:03,"Pune, India, Feb. 10, 2023 ( GLOBE NEWSWIRE ) -- As per Fortune Business Insights, the gynecological devices market is poised for growth in the coming years, driven by the increasing incidence of gynecological conditions and the growth of healthcare infrastructure.",BSX,0.052455,0.0,Neutral
"Artificial organs market size to grow at a CAGR of 9.14% by 2027; Growth opportunities led by Abbott Laboratories, Asahi Kasei Corp among others - Technavio",https://www.prnewswire.com/news-releases/artificial-organs-market-size-to-grow-at-a-cagr-of-9-14-by-2027-growth-opportunities-led-by-abbott-laboratories-asahi-kasei-corp-among-others---technavio-301755252.html,2023-02-25 04:00:00,Artificial organs market size to grow at a CAGR of 9.14% by 2027 ... PR ...,BSX,0.041251,0.11255,Neutral
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises,https://www.zacks.com/stock/news/2058680/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises,2023-02-24 13:50:04,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,BSX,0.328236,0.30223,Somewhat-Bullish
StockNews.com Downgrades Boston Scientific  ( NYSE:BSX )  to Hold,https://reporter.am/2023/02/24/stocknews-com-downgrades-boston-scientific-nysebsx-to-hold.html,2023-02-24 09:00:41,"Boston Scientific ( NYSE:BSX - Get Rating ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued to clients and investors on Wednesday. Several other analysts have also recently weighed in on the stock.",BSX,0.726067,0.379044,Bullish
Boston Scientific  ( NYSE:BSX )  Downgraded to Hold at StockNews.com,https://www.defenseworld.net/2023/02/23/boston-scientific-nysebsx-downgraded-to-hold-at-stocknews-com.html,2023-02-23 10:36:43,StockNews.com downgraded shares of Boston Scientific ( NYSE:BSX - Get Rating ) from a buy rating to a hold rating in a research note published on Wednesday. BSX has been the topic of several other reports.,BSX,0.826505,0.491423,Bullish
"Energy-based non-invasive medical aesthetic treatment system market size is set to grow at a CAGR of 11.11% by 2027, Growth led by Bausch Health Co Inc., Boston Scientific Corp., among others - Technavio",https://www.prnewswire.com/news-releases/energy-based-non-invasive-medical-aesthetic-treatment-system-market-size-is-set-to-grow-at-a-cagr-of-11-11-by-2027--growth-led-by-bausch-health-co-inc-boston-scientific-corp-among-others--technavio-301749692.html,2023-02-21 02:30:00,Energy-based non-invasive medical aesthetic treatment system ... PR ...,BSX,0.033468,0.068782,Neutral
The Worldwide Bionic Devices Industry is Expected to Reach $8.68 Billion by 2027,https://www.benzinga.com/pressreleases/23/02/g30975100/the-worldwide-bionic-devices-industry-is-expected-to-reach-8-68-billion-by-2027,2023-02-20 09:53:37,"Dublin, Feb. 20, 2023 ( GLOBE NEWSWIRE ) -- The ""Bionic Devices Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis"" report has been added to ResearchAndMarkets.com's offering.Global Bionic Devices Market will grow and reach US$ 8.68 ...",BSX,0.06515,0.112395,Neutral
Looking Into Boston Scientific's Recent Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/03/31301730/looking-into-boston-scientifics-recent-short-interest,2023-03-10 19:15:46,"Boston Scientific's BSX short percent of float has risen 30.88% since its last report. The company recently reported that it has 12.69 million shares sold short, which is 0.89% of all regular shares that are available for trading.",BSX,0.221819,0.155473,Somewhat-Bullish
"8.8% CAGR for Active Implantable Medical Devices Market Revenue to Cross $54.52 Billion, Globally, by 2028 - Exclusive Research Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/03/g31276527/8-8-cagr-for-active-implantable-medical-devices-market-revenue-to-cross-54-52-billion-globally-by-,2023-03-09 13:50:38,"New York, March 09, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Active Implantable Medical Devices Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Implantable Cardioverter Defibrillators ( Transvenous Implantable ...",BSX,0.028221,0.227011,Somewhat-Bullish
"Women's Health Devices Market Size Expected to Hit USD 62.61 Billion by 2028, exhibiting 8.4% CAGR",https://www.benzinga.com/pressreleases/23/03/g31262045/womens-health-devices-market-size-expected-to-hit-usd-62-61-billion-by-2028-exhibiting-8-4-cagr,2023-03-08 17:14:50,"Pune, India, March 08, 2023 ( GLOBE NEWSWIRE ) -- The global Women's Health Devices Market size was valued at USD 34.23 billion in 2020. The market is projected to grow from USD 35.63 billion in 2021 to USD 62.61 billion in 2028, exhibiting a CAGR of 8.4% during the forecast period.",BSX,0.035397,0.0,Neutral
Abbott's  ( ABT )  MitraClip Device Shows Favorable Outcome,https://www.zacks.com/stock/news/2062470/abbotts-abt-mitraclip-device-shows-favorable-outcome,2023-03-07 13:03:00,Abbott's (ABT) landmark COAPT trial demonstrated that MitraClip is safe and effective and can reduce the hospitalization rate.,BSX,0.156123,0.215925,Somewhat-Bullish
Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial,https://www.newswire.ca/news-releases/medtronic-pulseselect-pfa-system-demonstrates-impressive-results-in-landmark-pulsed-af-global-ide-trial-863523514.html,2023-03-06 14:30:00,Medtronic PulseSelect PFA System demonstrates impressive results ... Canada ...,BSX,0.024749,0.078513,Neutral
Investing Action Plan: Feeling March Momentum,https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-from-powell-to-payrolls-a-busy-week/,2023-03-03 23:23:00,"Stock Market Investing Action Plan: From Powell To Payrolls, A Busy ... Investor's Business Daily ...",BSX,0.059785,0.079999,Neutral
Boston Scientific  ( BSX )  Down 1.7% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2061636/boston-scientific-bsx-down-17-since-last-earnings-report-can-it-rebound,2023-03-03 16:30:46,Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,BSX,0.292922,0.1084,Neutral
Will Boston Scientific Stock See Higher Levels?,https://www.forbes.com/sites/greatspeculations/2023/03/03/will-boston-scientific-stock-see-higher-levels/,2023-03-03 13:00:19,"Boston Scientific stock (NYSE: BSX) has seen a fall of 3% in a month, compared with -5% returns for the broader S&P500 index.",BSX,0.797383,0.246303,Somewhat-Bullish
"Intravenous Infusion Pumps Market to reach USD 9.11 Bn in 2029, Technological Advancements and Regional Analysis",https://www.benzinga.com/pressreleases/23/03/g31189946/intravenous-infusion-pumps-market-to-reach-usd-9-11-bn-in-2029-technological-advancements-and-regi,2023-03-03 11:50:00,"Pune, March 03, 2023 ( GLOBE NEWSWIRE ) -- A global Engineering Equipment business-consulting firm, Maximize Market research, has published a market intelligence and competitive landscape report on the ""Intravenous Infusion Pumps Market"".",BSX,0.032164,-0.113392,Neutral
StockNews.com has upgraded Boston Scientific  ( NYSE:BSX )  to Buy.,https://beststocks.com/stocknews-com-has-upgraded-boston-scientific-nyse/,2023-03-03 09:22:56,"The analysts at StockNews.com raised their recommendation for Boston Scientific ( NYSE: BSX ) , shifting it from ""hold"" to ""buy"" in a research note that was disseminated to investors on Thursday. Those involved in equity research have provided some recent commentary on the stock.",BSX,0.698332,0.362693,Bullish
Boston Scientific  ( NYSE:BSX )  Upgraded by StockNews.com to Buy,https://www.defenseworld.net/2023/03/02/boston-scientific-nysebsx-upgraded-by-stocknews-com-to-buy.html,2023-03-02 08:42:46,"Boston Scientific ( NYSE:BSX - Get Rating ) was upgraded by analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued to investors on Thursday. A number of other equities research analysts have also recently commented on the stock.",BSX,0.81804,0.461454,Bullish
"Boston Scientific  ( NYSE:BSX )  Upgraded to ""Buy"" at StockNews.com",https://www.etfdailynews.com/2023/03/02/boston-scientific-nysebsx-upgraded-to-buy-at-stocknews-com/,2023-03-02 08:42:44,"Boston Scientific ( NYSE:BSX - Get Rating ) was upgraded by research analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a report released on Thursday. Several other equities analysts have also weighed in on the company.",BSX,0.778784,0.461202,Bullish
Salesforce  ( CRM )  Q4 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/03/01/salesforce-crm-q4-2023-earnings-call-transcript/,2023-03-02 02:30:24,"CRM earnings call for the period ending December 31, 2022.",BSX,0.017746,0.111761,Neutral
Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer,https://www.globenewswire.com/news-release/2023/03/21/2631824/0/en/Minerva-Surgical-Announces-the-Appointment-of-Kaile-Zagger-as-Chief-Commercial-Officer.html,2023-03-21 20:05:00,"SANTA CLARA, Calif., March 21, 2023 ( GLOBE NEWSWIRE ) -- Minerva Surgical, Inc. ( Nasdaq: UTRS ) ( Minerva Surgical ) , a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, announced today the appointment of Kaile Zagger as its new Chief ...",BSX,0.056143,0.167947,Somewhat-Bullish
Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer - Minerva Surgical  ( NASDAQ:UTRS ) ,https://www.benzinga.com/pressreleases/23/03/g31446380/minerva-surgical-announces-the-appointment-of-kaile-zagger-as-chief-commercial-officer,2023-03-21 20:05:00,"SANTA CLARA, Calif., March 21, 2023 ( GLOBE NEWSWIRE ) -- Minerva Surgical, Inc. UTRS ( Minerva Surgical ) , a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, announced today the appointment of Kaile Zagger as its new Chief Commercial Officer.",BSX,0.055109,0.167885,Somewhat-Bullish
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2067900/heres-why-you-should-retain-boston-scientific-bsx-now,2023-03-20 13:07:00,"Investors are optimistic about Boston Scientific (BSX), led by impressive value-added acquisitions.",BSX,0.238133,0.17863,Somewhat-Bullish
"Cardiac Sutures Market Size to Cross USD 2.3 Bn by 2031 with CAGR of 6.8%, Exclusive Research by TMR",https://www.benzinga.com/pressreleases/23/03/g31397546/cardiac-sutures-market-size-to-cross-usd-2-3-bn-by-2031-with-cagr-of-6-8-exclusive-research-by-tmr,2023-03-17 13:30:00,"Wilmington, Delaware, United States, March 17, 2023 ( GLOBE NEWSWIRE ) -- According to Transparency Market Research, ""The global cardiac sutures market size was valued at US$ 1.3 Bn in 2022, and the global industry is anticipated to exceed US$ 2.3 Bn by 2031.",BSX,0.03853,0.0,Neutral
Angiography Devices Market Size to Cross USD 22 Bn by 2031 Due to the Rise in Prevalence of Cardiovascular Diseases | TMR Study,https://www.benzinga.com/pressreleases/23/03/g31375788/angiography-devices-market-size-to-cross-usd-22-bn-by-2031-due-to-the-rise-in-prevalence-of-cardio,2023-03-16 10:30:00,"Wilmington, Delaware, United States, March 16, 2023 ( GLOBE NEWSWIRE ) -- According to the latest study by Transparency Market Research, ""The global angiography devices market was valued at US$ 12.4 Bn in 2022 and is estimated to grow at a CAGR of 6.7% for the forecast period between 2023 and ...",BSX,0.038906,-0.011758,Neutral
Boston Scientific  ( NYSE:BSX )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/03/16/boston-scientific-nysebsx-research-coverage-started-at-stocknews-com.html,2023-03-16 06:48:50,Boston Scientific ( NYSE:BSX ) Research Coverage Started at ... Defense World ...,BSX,0.69448,0.37513,Bullish
Size of Disposable Endoscope Market Worth $3Bn by 2028 at 16.9% CAGR - Exclusive Research by The Insight Partners,https://www.benzinga.com/pressreleases/23/03/g31361567/size-of-disposable-endoscope-market-worth-3bn-by-2028-at-16-9-cagr-exclusive-research-by-the-insig,2023-03-15 13:55:18,"New York, March 15, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Disposable Endoscope Market Size, Share, Growth, Segments and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Application ( Urologic Endoscopy, GI Endoscopy, Bronchoscopy, Arthroscopy, ...",BSX,0.076358,0.113769,Neutral
"Field Medical, Inc. Appoints Industry Veterans Mark Wisniewski and Marlou Janssen to Board of Directors",https://www.prnewswire.com/news-releases/field-medical-inc-appoints-industry-veterans-mark-wisniewski-and-marlou-janssen-to-board-of-directors-301772493.html,2023-03-15 12:00:00,"Field Medical, Inc. Appoints Industry Veterans Mark Wisniewski and ... PR ...",BSX,0.126784,0.094619,Neutral
"Field Medical, Inc. Appoints Industry Veterans Mark Wisniewski and Marlou Janssen to Board of Directors",https://www.prnewswire.com/news-releases/field-medical-inc-appoints-industry-veterans-mark-wisniewski-and-marlou-janssen-to-board-of-directors-301772546.html,2023-03-15 12:00:00,"Field Medical, Inc. Appoints Industry Veterans Mark Wisniewski and ... PR ...",BSX,0.126784,0.094619,Neutral
Paul Pharris Joins Egg Medical,https://www.prnewswire.com/news-releases/paul-pharris-joins-egg-medical-301772051.html,2023-03-14 19:08:00,"ARDEN HILLS, Minn., March 14, 2023 /PRNewswire/ -- Egg Medical, Inc., a medical technology company committed to reducing scatter radiation exposure during interventional angiographic procedures, is excited to announce that Paul Pharris will be joining the Company as the Chief Revenue Officer and ...",BSX,0.22421,0.032006,Neutral
Hemodynamic Flow Alteration Devices Market to Hit USD 1.5 Bn by 2031 | Exclusive Report by TMR,https://www.benzinga.com/pressreleases/23/03/g31603535/hemodynamic-flow-alteration-devices-market-to-hit-usd-1-5-bn-by-2031-exclusive-report-by-tmr,2023-03-31 07:35:46,"Wilmington, Delaware, United States, March 31, 2023 ( GLOBE NEWSWIRE ) -- The expert team of analysts at TMR has conducted thorough market research and curated hemodynamic flow alteration devices market report.",BSX,0.039033,0.0,Neutral
Chronic Total Occlusion Devices Market to Reach USD 2.9 Bn by 2031 | TMR Study,https://www.benzinga.com/pressreleases/23/03/g31601775/chronic-total-occlusion-devices-market-to-reach-usd-2-9-bn-by-2031-tmr-study,2023-03-31 01:30:00,"Wilmington, Delaware, United States, March 31, 2023 ( GLOBE NEWSWIRE ) -- According to a market report by TMR, the global chronic total occlusion devices industry was valued at USD 1.7 Bn in 2022 to reach USD 2.9 Bn by 2031. It is expected to expand at a CAGR of 6.1% during the forecast period ...",BSX,0.04111,0.0,Neutral
VREX or BSX: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2071975/vrex-or-bsx-which-is-the-better-value-stock-right-now,2023-03-29 15:40:13,VREX vs. BSX: Which Stock Is the Better Value Option?,BSX,0.664882,0.633548,Bullish
Scivita Medical enters into Strategic Agreement with Boston Scientific in China,https://www.prnewswire.com/news-releases/scivita-medical-enters-into-strategic-agreement-with-boston-scientific-in-china-301784636.html,2023-03-29 13:18:00,Scivita Medical enters into Strategic Agreement with Boston ... PR ...,BSX,0.337197,0.275146,Somewhat-Bullish
Endoluminal Suturing Devices Market Expected to Flourish in Coming Years says Brandessence Market Research,https://www.prnewswire.com/news-releases/endoluminal-suturing-devices-market-expected-to-flourish-in-coming-years-says-brandessence-market-research-301783203.html,2023-03-28 10:26:00,Endoluminal Suturing Devices Market Expected to Flourish in ... PR ...,BSX,0.032736,0.111732,Neutral
"Orthopedic soft tissue repair devices market size to grow by USD 5,633.11 million from 2022 to 2027; The rising geriatric population across the globe will drive growth - Technavio",https://www.prnewswire.com/news-releases/orthopedic-soft-tissue-repair-devices-market-size-to-grow-by-usd-5-633-11-million-from-2022-to-2027-the-rising-geriatric-population-across-the-globe-will-drive-growth---technavio-301779859.html,2023-03-25 00:00:00,Orthopedic soft tissue repair devices market size to grow by USD ... PR ...,BSX,0.047988,0.026993,Neutral
Cutting Angioplasty Balloons Market to Hit USD 360.0 Mn by 2031 | Transparency Market Research,https://www.benzinga.com/pressreleases/23/03/g31489132/cutting-angioplasty-balloons-market-to-hit-usd-360-0-mn-by-2031-transparency-market-research,2023-03-24 11:35:38,"Wilmington, Delaware, United States, March 24, 2023 ( GLOBE NEWSWIRE ) -- According to recent study by Transparency Market Research, the global cutting angioplasty balloons market is projected to expand at a CAGR of 6.4% from 2023 to 2031 and surpass value of USD 360.0 Mn by 2031.",BSX,0.03704,-0.198422,Somewhat-Bearish
Atrial Fibrillation Surgery Devices Market to Hit USD 7.0 Bn by 2031 | Transparency Market Research,https://www.benzinga.com/pressreleases/23/03/g31474905/atrial-fibrillation-surgery-devices-market-to-hit-usd-7-0-bn-by-2031-transparency-market-research,2023-03-23 13:30:00,"Wilmington, Delaware, United States, March 23, 2023 ( GLOBE NEWSWIRE ) -- According to Transparency Market Research, The global atrial fibrillation surgical devices market size was worth USD 2.1 Bn in 2022 and is estimated to exceed USD 7.0 Bn by 2031.",BSX,0.040622,0.0,Neutral
Benign Prostatic Hyperplasia Treatment Market is Expected to Reach $14.1 billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/03/g31456711/benign-prostatic-hyperplasia-treatment-market-is-expected-to-reach-14-1-billion-marketsandmarkets,2023-03-22 13:30:00,"Chicago, March 22, 2023 ( GLOBE NEWSWIRE ) -- In the near future, the Benign Prostatic Hyperplasia ( BPH ) treatment industry is likely to see further developments and advancements in treatment options.",BSX,0.03878,0.017192,Neutral
"Here's one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.",https://www.marketwatch.com/story/heres-one-for-the-battered-bulls-the-second-largest-sector-in-the-s-p-500-is-stirring-to-life-says-this-strategist-5e179744,2023-03-22 10:52:00,"Everyone is watching the banks, but what about healthcare. It's breaking out, says this strategist.",BSX,0.077593,0.170485,Somewhat-Bullish
"Life Science Outsourcing, Inc. Welcomes Yiorgos Polizos as Vice President of Sales & Marketing",https://www.prnewswire.com/news-releases/life-science-outsourcing-inc-welcomes-yiorgos-polizos-as-vice-president-of-sales--marketing-301791358.html,2023-04-06 14:00:00,"Life Science Outsourcing, Inc. Welcomes Yiorgos Polizos as Vice ... PR ...",BSX,0.084722,0.186137,Somewhat-Bullish
Pain Management Devices Market to Grow at a CAGR of 6.4% by 2028 | Exclusive Research by TMR,https://www.benzinga.com/pressreleases/23/04/g31697743/pain-management-devices-market-to-grow-at-a-cagr-of-6-4-by-2028-exclusive-research-by-tmr,2023-04-06 13:30:00,"Wilmington, Delaware, United States, April 06, 2023 ( GLOBE NEWSWIRE ) -- The pain management devices market was valued at USD 4.1 Bn in 2020 and is projected to reach USD 7.1 Bn by 2028 with CAGR of 6.4% from 2021 to 2028.",BSX,0.037681,-0.141344,Neutral
Boston Scientific  ( BSX )  Hits 52-Week High: What's Driving It?,https://www.zacks.com/stock/news/2075403/boston-scientific-bsx-hits-52-week-high-whats-driving-it,2023-04-06 13:05:00,Boston Scientific (BSX) outperforms the industry and the S&P 500 due to several new acquisitions and the long-term growth prospects of the WATCHMAN device.,BSX,0.431554,0.357838,Bullish
Urology Devices Market to Reach USD 64 Bn by 2031 Owing to the Rise in the Number of Urology Disorders | TMR Study,https://www.benzinga.com/pressreleases/23/04/g31685689/urology-devices-market-to-reach-usd-64-bn-by-2031-owing-to-the-rise-in-the-number-of-urology-disor,2023-04-05 18:30:00,"Wilmington, Delaware, United States, April 06, 2023 ( GLOBE NEWSWIRE ) -- The global urology devices market is estimated to flourish at a CAGR of 5.6% from 2022 to 2031. According to Transparency Market Research, sales of urology devices are slated to total USD 64 billion by the end of the ...",BSX,0.076115,0.18525,Somewhat-Bullish
UroDev Medical Appoints Dean Briesemeister as CEO,https://www.prnewswire.com/news-releases/urodev-medical-appoints-dean-briesemeister-as-ceo-301790739.html,2023-04-05 13:30:00,"MINNEAPOLIS, April 5, 2023 /PRNewswire/ -- UroDev Medical, a medical device company working to improve the quality of life for people who suffer from neurogenic bladder and chronic urinary retention, has appointed medical device executive Dean Briesemeister as chief executive officer.",BSX,0.101582,0.073438,Neutral
BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies,https://www.globenewswire.com/news-release/2023/04/04/2640452/0/en/BioCardia-Announces-Issuance-of-Two-Patents-Related-to-Technology-That-Guides-Interventional-Therapies.html,2023-04-04 11:00:00,"SUNNYVALE, Calif., April 04, 2023 ( GLOBE NEWSWIRE ) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of two patent grants related to enabling technologies for ...",BSX,0.044386,0.141853,Neutral
BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies - BioCardia  ( NASDAQ:BCDA ) ,https://www.benzinga.com/pressreleases/23/04/g31650840/biocardia-announces-issuance-of-two-patents-related-to-technology-that-guides-interventional-thera,2023-04-04 11:00:00,"SUNNYVALE, Calif., April 04, 2023 ( GLOBE NEWSWIRE ) -- BioCardia®, Inc. BCDA, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of two patent grants related to enabling technologies for delivery of its ...",BSX,0.042571,0.141275,Neutral
Hemostasis Valves Market Revenue to Cross USD 245.6 Mn by 2031 with CAGR of 4.8% | Transparency Market Research,https://www.benzinga.com/pressreleases/23/04/g31642182/hemostasis-valves-market-revenue-to-cross-usd-245-6-mn-by-2031-with-cagr-of-4-8-transparency-marke,2023-04-03 19:30:00,"Wilmington, Delaware, United States, April 04, 2023 ( GLOBE NEWSWIRE ) -- According to TMR estimates, the global hemostasis valves industry would be worth USD 161.3 Bn worldwide in 2022. The market is predicted to reach USD 245.6 Bn by 2031, rising at a rapidly increasing CAGR of 4.8% from 2023 ...",BSX,0.043738,0.0,Neutral
"NVIDIA, Boston Scientific And This Technology Stock Insiders Are Selling - Boston Scientific  ( NYSE:BSX ) , Five9  ( NASDAQ:FIVN ) ",https://www.benzinga.com/news/23/04/31632752/nvidia-boston-scientific-and-this-technology-stock-insiders-are-selling,2023-04-03 13:03:19,"The Nasdaq Composite closed higher by over 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced.",BSX,0.506613,-0.093259,Neutral
Engine Sputtering: Tesla's Disappointing Quarter Weighs On Market As Recession Fears Grow - Tesla  ( NASDAQ:TSLA ) ,https://www.benzinga.com/markets/23/04/31921533/engine-sputtering-teslas-disappointing-quarter-weighs-on-market-as-recession-fears-grow,2023-04-20 17:53:49,"( Thursday market open ) Disappointing earnings from Tesla TSLA set the tone this morning, helping send major indexes lower overnight. Overall, the hot start to earnings season cooled over the last few days, though there have been some positive highlights.",BSX,0.039977,0.080338,Neutral
"Gearing Up For Tesla: EV Maker To Report Later Today After More Price Cuts As Bank Earnings Wrap Up - Tesla  ( NASDAQ:TSLA ) , Morgan Stanley  ( NYSE:MS ) ",https://www.benzinga.com/markets/23/04/31897308/gearing-up-for-tesla-ev-maker-to-report-later-today-after-more-price-cuts-as-bank-earnings-wrap-up,2023-04-19 17:09:21,"( Wednesday market open ) Another day began with another major bank surpassing Wall Street's earnings estimates. Today's results came from Morgan Stanley MS, the last of the ""big banks"" to report. Still, stocks declined in overnight futures trading after barely moving on Tuesday amid the ...",BSX,0.039878,0.101862,Neutral
Here's Why You Should Buy Boston Scientific  ( BSX )  Stock,https://www.zacks.com/stock/news/2081423/heres-why-you-should-buy-boston-scientific-bsx-stock,2023-04-19 14:26:00,Investors are optimistic about Boston Scientific (BSX) owing to impressive growth in MedSurg market share.,BSX,0.345674,0.446074,Bullish
Internet of Things  ( IoT )  in Healthcare Market to be Worth $312.7 Billion by 2030 - Exclusive Report by Meticulous Research®,https://www.benzinga.com/pressreleases/23/04/g31887285/internet-of-things-iot-in-healthcare-market-to-be-worth-312-7-billion-by-2030-exclusive-report-by-,2023-04-19 11:46:14,"Redding, California, April 19, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'IoT in Healthcare Market by Component ( Monitoring Devices ( Glucose, Cardiac, Respiratory, Blood Pressure ) , Pacemaker, Ventilator, Infusion Pump}, Software ) , Application ( ...",BSX,0.020722,0.037308,Neutral
Agios Appoints Jeffrey Capello to Board of Directors,https://www.globenewswire.com/news-release/2023/04/19/2649857/31990/en/Agios-Appoints-Jeffrey-Capello-to-Board-of-Directors.html,2023-04-19 11:00:00,- Board Member Paul Clancy Will Step Down at the End of His Term ...,BSX,0.036532,0.044678,Neutral
Agios Appoints Jeffrey Capello to Board of Directors - Agios Pharmaceuticals  ( NASDAQ:AGIO ) ,https://www.benzinga.com/pressreleases/23/04/g31886205/agios-appoints-jeffrey-capello-to-board-of-directors,2023-04-19 11:00:00,"- Board Member Paul Clancy Will Step Down at the End of His Term - CAMBRIDGE, Mass., April 19, 2023 ( GLOBE NEWSWIRE ) -- Agios Pharmaceuticals, Inc. AGIO, a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced that Jeffrey Capello has been appointed ...",BSX,0.035502,0.044479,Neutral
What's in Store for Boston Scientific  ( BSX )  in Q1 Earnings?,https://www.zacks.com/stock/news/2080593/whats-in-store-for-boston-scientific-bsx-in-q1-earnings,2023-04-18 16:26:00,"Boston Scientific (BSX) is expected to have registered strong growth in EMEA within structural heart, including TAVR, WATCHMAN, and other interventional cardiology therapies in the first quarter.",BSX,0.365085,0.463035,Bullish
Surgical Sutures Market to be Worth $4.42 Billion by 2030 - Exclusive Report by Meticulous Research®,https://www.benzinga.com/pressreleases/23/04/g31833643/surgical-sutures-market-to-be-worth-4-42-billion-by-2030-exclusive-report-by-meticulous-research,2023-04-17 15:00:00,"Redding, California, April 17, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Surgical Sutures Market by Type [Absorbable {Polyglactin, Polydioxanone, Poliglecaprone, Collagen} Nonabsorbable {Polypropylene, Nylon, Silk}] Structure [Monofilament, Multifilament] ...",BSX,0.024724,0.007192,Neutral
"The Zacks Analyst Blog Highlights Eli Lilly, Thermo Fisher Scientific, Lockheed Martin, Boston Scientific and Canadian Pacific Railway",https://www.zacks.com/stock/news/2079667/the-zacks-analyst-blog-highlights-eli-lilly-thermo-fisher-scientific-lockheed-martin-boston-scientific-and-canadian-pacific-railway,2023-04-17 12:53:00,"Eli Lilly, Thermo Fisher Scientific, Lockheed Martin, Boston Scientific and Canadian Pacific Railway are part of the Zacks top Analyst Blog.",BSX,0.682689,0.0,Neutral
"Top Analyst Reports for Eli Lilly, Thermo Fisher Scientific & Lockheed Martin",https://www.zacks.com/research-daily/2078975/top-analyst-reports-for-eli-lilly-thermo-fisher-scientific-lockheed-martin,2023-04-14 20:29:00,"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Thermo Fisher Scientific Inc. (TMO) and Lockheed Martin Corporation (LMT).",BSX,0.121959,0.07298,Neutral
Minimally Invasive Surgery Market to Hit USD 324.9 Bn by 2031 | Transparency Market Research,https://www.benzinga.com/pressreleases/23/04/g31797251/minimally-invasive-surgery-market-to-hit-usd-324-9-bn-by-2031-transparency-market-research,2023-04-13 20:30:00,"Wilmington, Delaware, United States, April 14, 2023 ( GLOBE NEWSWIRE ) -- The global minimally invasive surgery market stood at USD 231.1 Bn in 2021 and is estimated to surpass USD 324.9 Bn by 2031, expanding at a CAGR of 3.2% during the forecast period between 2022 and 2031.",BSX,0.035502,-0.096439,Neutral
Conquering Venous Diseases: Global Treatment Market Set to Reach USD10 Billion by 2030,https://www.benzinga.com/pressreleases/23/04/g31781195/conquering-venous-diseases-global-treatment-market-set-to-reach-usd10-billion-by-2030,2023-04-13 03:00:00,"Houston, Texas, April 13, 2023 ( GLOBE NEWSWIRE ) -- Market Overview A series of diseases in which there is an issue with blood flow in the veins in the legs are collectively referred to as a venous disease, sometimes known as venous insufficiency.",BSX,0.027011,0.067157,Neutral
Medical-device makers gain amid return to normalcy,https://www.foxbusiness.com/healthcare/medical-device-makers-gain-amid-return-normalcy,2023-04-12 16:30:00,"Medical-device makers' stocks are basking in the good times. That is a marked shift from the turbulence of recent years, when device makers contended with inflationary pressures and a drop in medical procedures as hospitals faced staffing shortages and many patients deferred surgery during the ...",BSX,0.214462,0.180331,Somewhat-Bullish
Market Rally Volatile And Tight Amid Big Earnings Moves,https://www.investors.com/news/market-rally-wobbles-amid-big-earnings-moves-from-microsoft-meta-crocs-cloudflare/,2023-04-28 16:36:00,Market Rally Wobbles Amid Big Earnings Moves From Microsoft ... Investor's Business Daily ...,BSX,0.054773,-0.11609,Neutral
Is Boston Scientific  ( BSX )  Stock Outpacing Its Medical Peers This Year?,https://www.zacks.com/stock/news/2086853/is-boston-scientific-bsx-stock-outpacing-its-medical-peers-this-year,2023-04-28 13:40:13,Here is how Boston Scientific (BSX) and Cardinal Health (CAH) have performed compared to their sector so far this year.,BSX,0.771935,0.386728,Bullish
This Week in Health News: 10 Stories You Need to See,https://www.prnewswire.com/news-releases/this-week-in-health-news-10-stories-you-need-to-see-301810265.html,2023-04-28 11:32:00,"A roundup of the week's most newsworthy health industry press releases from PR Newswire, including parents' dissatisfaction with pediatric mental health benefits. NEW YORK, April 28, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with ...",BSX,0.03319,0.098422,Neutral
"If You Invested $1000 In This Stock 15 Years Ago, You Would Have $3,800 Today - Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/news/earnings/23/04/32062881/if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-3-800-today,2023-04-27 21:00:28,"Boston Scientific BSX has outperformed the market over the past 15 years by 2.06% on an annualized basis producing an average annual return of 9.45%. Currently, Boston Scientific has a market capitalization of $74.78 billion.",BSX,0.980595,0.386944,Bullish
"Tenet Healthcare's  ( THC )  Q1 Earnings Beat, Shares Up 3.9%",https://www.zacks.com/stock/news/2086323/tenet-healthcares-thc-q1-earnings-beat-shares-up-39,2023-04-27 15:43:00,"Tenet Healthcare's (THC) first-quarter 2023 results gain on increased patient volumes. Management presently expects adjusted EPS within $4.92-$6.09 in 2023, up from the prior view of $4.68-$5.85.",BSX,0.059341,0.061992,Neutral
"Meta Platforms To Rally Around 67%? Here Are 10 Other Analyst Forecasts For Thursday - ASGN  ( NYSE:ASGN ) , Activision Blizzard  ( NASDAQ:ATVI ) ",https://www.benzinga.com/news/23/04/32045754/meta-platforms-to-rally-around-67-here-are-10-other-analyst-forecasts-for-thursday,2023-04-27 13:00:29,"Morgan Stanley cut the price target for Old Dominion Freight Line, Inc. ODFL from $339 to $334. Morgan Stanley analyst Ravi Shanker maintained an Equal-Weight rating. Old Dominion shares fell 0.2% to $305.00 in pre-market trading. RBC Capital cut the price target for PagerDuty, Inc.",BSX,0.285526,0.159976,Somewhat-Bullish
AbbVie Plunges As Humira Biosimilars Take A 25% Cut,https://www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q1-2023/,2023-04-27 12:46:00,AbbVie Stock Crumbles As Humira Biosimilars Take A 25% Cut ... Investor's Business Daily ...,BSX,0.159569,-0.485408,Bearish
Indexes Off Session Lows As Q1 Earnings Hold Center Court. Transportation Sector Just Got More Bad News,https://www.investors.com/market-trend/stock-market-today/q1-earnings-stocks-fade-as-traders-place-bets-on-microsoft-jumps-but-solar-stocks-melt/,2023-04-26 16:15:00,Stocks Firm As Traders Place Bets On Q1 Earnings. Microsoft Jumps ... Investor's Business Daily ...,BSX,0.093289,0.150552,Somewhat-Bullish
"Boston Scientific  ( BSX )  Q1 Earnings Beat, 2023 View Raised",https://www.zacks.com/stock/news/2085157/boston-scientific-bsx-q1-earnings-beat-2023-view-raised,2023-04-26 14:50:00,Reported and organic revenues at each of Boston Scientific's (BSX) core business segments and geographies increase in the reported quarter.,BSX,0.356865,0.402577,Bullish
"Boston Scientific Clocks Strong Q1 Earnings As Elective Surgeries Recover, Boosts FY23 Outlook - Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/news/earnings/23/04/32009790/boston-scientific-clocks-strong-q1-earnings-as-elective-surgeries-recover-boosts-fy23-outlook,2023-04-26 13:39:57,"Boston Scientific Corp BSX generated Q1 revenues of $3.39 billion, beating the Wall Street estimate of $3.16 billion and the management growth estimate of 3%-5%. Sales increased 12% Y/Y on a reported basis, 14.9% on an operational basis, and 14% on an organic basis.",BSX,0.83383,0.073445,Neutral
Medtech Giant Nears Profit-Taking Zone On First-Quarter Beat,https://www.investors.com/news/technology/bsx-stock-boston-scientific-earnings-q1-2023/,2023-04-26 12:52:00,BSX Stock Nears Profit-Taking Zone After Beating First-Quarter Views Investor's Business Daily ...,BSX,0.896455,0.455953,Bullish
Boston Scientific lifts annual profit forecast on heart devices strength,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-lifts-annual-profit-forecast-heart-devices-strength-2023-04-26/,2023-04-26 12:23:00,"April 26 ( Reuters ) - Boston Scientific Corp ( BSX.N ) raised its full-year profit forecast on Wednesday, after strong sales in its cardiovascular devices unit helped the company beat first-quarter estimates.",BSX,0.555911,0.484933,Bullish
Boston Scientific  ( BSX )  Q1 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2084727/boston-scientific-bsx-q1-earnings-and-revenues-surpass-estimates,2023-04-26 11:45:12,"Boston Scientific (BSX) delivered earnings and revenue surprises of 9.30% and 7.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",BSX,0.399204,0.276951,Somewhat-Bullish
"Nasdaq Futures Surge On Microsoft, Alphabet Earnings Cheer - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/04/32006199/nasdaq-futures-surge-on-microsoft-alphabet-earnings-cheer-analyst-tells-why-investors-might-not-sel,2023-04-26 11:02:11,"Stocks could rebound from Tuesday's steep sell-off, as earnings from Alphabet, Inc. GOOGL GOOG and Microsoft Corp. MSFT gave investors a reason to cheer. Traders could also draw clues from the durable goods orders report and more earnings news flow.",BSX,0.11123,0.0,Neutral
Boston Scientific Announces Results for First Quarter 2023,https://www.prnewswire.com/news-releases/boston-scientific-announces-results-for-first-quarter-2023-301807626.html,2023-04-26 10:30:00,"MARLBOROUGH, Mass., April 26, 2023 /PRNewswire/ -- ( NYSE: BSX ) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational1 basis and 14.0 percent on an organic2 basis, all compared to the prior year period.",BSX,0.229459,0.185828,Somewhat-Bullish
"Nasdaq futures rally over 1% after upbeat Microsoft, Alphabet results",https://www.reuters.com/markets/us/nasdaq-futures-rally-over-1-after-upbeat-microsoft-alphabet-results-2023-04-26/,2023-04-26 10:16:31,April 26 ( Reuters ) - Nasdaq futures rallied more than 1% on Wednesday after upbeat results from Microsoft and Alphabet dwarfed worries about the impact of rising interest rates on the U.S. economy.,BSX,0.07157,0.0,Neutral
"Risk-Off Rerun: Banking Concerns, Nerves Ahead of Microsoft, Alphabet Earnings Bring Pressure - First Republic Bank  ( NYSE:FRC ) , General Electric  ( NYSE:GE ) ",https://www.benzinga.com/markets/23/04/31993957/risk-off-rerun-banking-concerns-nerves-ahead-of-microsoft-alphabet-earnings-bring-pressure,2023-04-25 16:25:43,( Tuesday market open ) The rubber hits the road for info tech earnings starting later today when Microsoft MSFT and Alphabet GOOGL open their quarterly books.,BSX,0.037416,0.079618,Neutral
Philips'  ( PHG )  Q1 Earnings Jump Y/Y on Strong Top-Line Growth,https://www.zacks.com/stock/news/2084448/philips-phg-q1-earnings-jump-yy-on-strong-top-line-growth,2023-04-25 15:17:00,Philips' (PHG) first-quarter results benefit from robust performances by the Diagnosis & Treatment and the Connected Care businesses.,BSX,0.19117,0.144941,Neutral
"MedTech Stocks' Q1 Earnings on Apr 25: BSX, TMO and More",https://www.zacks.com/stock/news/2084329/medtech-stocks-q1-earnings-on-apr-25-bsx-tmo-and-more,2023-04-25 15:09:00,"MedTech companies' results are likely to reflect a sequential decline. Let's see how BSX, TMO, EW and ALGN fare this time.",BSX,0.181819,0.281494,Somewhat-Bullish
New Product Launches To Aid Boston Scientific's Q1,https://www.forbes.com/sites/greatspeculations/2023/04/25/new-product-launches-to-aid-boston-scientifics-q1/,2023-04-25 13:00:00,A rise in elective surgeries performed and market share gains for some of its products will likely aid the company's top-line growth.,BSX,0.732005,0.261175,Somewhat-Bullish
Endoscopy Devices Market Will Attain USD 42.8 Bn Valuation by 2028 with CAGR of 3.8%: Exclusive Study by TMR,https://www.benzinga.com/pressreleases/23/04/g31969942/endoscopy-devices-market-will-attain-usd-42-8-bn-valuation-by-2028-with-cagr-of-3-8-exclusive-stud,2023-04-24 20:30:00,"Wilmington, Delaware, United States, April 25, 2023 ( GLOBE NEWSWIRE ) -- According to Transparency Market Research, the global endoscopy devices market size stood at USD 31.8 Bn in 2020, and is projected to surpass value of USD 42.8 Bn by 2028.",BSX,0.039033,0.0,Neutral
"Setting the Bar: After Shares Rallied in Q1, Big-Tech Companies Ready to Share Results This Week",https://www.benzinga.com/markets/23/04/31961561/setting-the-bar-after-shares-rallied-in-q1-big-tech-companies-ready-to-share-results-this-week,2023-04-24 15:51:49,"( Monday market open ) Earnings season is nearly 20% complete, but this week is when company reports could start having a more dramatic impact on major indexes. That's because ""mega-cap"" companies like Microsoft ( MSFT ) , Alphabet ( GOOGL ) , Amazon ( AMZN ) , and Meta ( META ) are among the ...",BSX,0.04161,0.080752,Neutral
Futures: Four Titans Lead Earnings Wave; What To Do Now,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-microsoft-meta-google-lead-earnings-wave/,2023-04-23 14:06:00,Futures: Four Titans Lead Earnings Wave. What To Do Now Investor's Business Daily ...,BSX,0.096412,0.103155,Neutral
"Investing Action Plan: Microsoft, Amazon, Boeing, Alphabet Earnings",https://www.investors.com/research/investing-action-plan/stock-trading-action-plan-inflation-gauges-and-microsoft-amazon-boeing-alphabet-earnings/,2023-04-21 22:24:00,"Stock Trading Action Plan: Inflation Gauges And Microsoft, Amazon ... Investor's Business Daily ...",BSX,0.037652,0.12756,Neutral
Stocks Quiet Ahead Of Earnings Flood; What To Do Now,https://www.investors.com/market-trend/stock-market-today/market-rally-awaits-earnings-flood-microsoft-meta-amazon-google/,2023-04-21 20:58:00,"Market Rally Awaits Earnings Wave Led By Microsoft, Meta, Amazon ... Investor's Business Daily ...",BSX,0.09989,0.101983,Neutral
Why Shockwave Medical Stock Blasted More Than 10% Higher on Friday,https://www.fool.com/investing/2023/04/21/why-shockwave-medical-stock-blasted-more-than-10-h/,2023-04-21 20:45:00,The compay might soon be swallowed by a larger rival.,BSX,0.651499,0.405499,Bullish
Earnings Round One Ends With Banks A Clear Winner But Uncertain Results Overall As Market Sags,https://www.benzinga.com/news/earnings/23/04/31939743/earnings-round-one-ends-with-banks-a-clear-winner-but-uncertain-results-overall-as-market-sags,2023-04-21 16:59:11,( Friday market open ) Bulls and bears touch gloves and go to their separate corners at the end of the week before the bell rings to signal another heavy bout of earnings and economic data starting Monday.,BSX,0.038314,0.07988,Neutral
Boston Scientific weighing deal to buy Shockwave Medical - Bloomberg News,https://www.reuters.com/markets/deals/boston-scientific-weighing-deal-buy-shockwave-medical-bloomberg-news-2023-04-21/,2023-04-21 16:05:49,Boston Scientific weighing deal to buy Shockwave Medical ... ...,BSX,0.846873,0.143626,Neutral
Shockwave Soars As Boston Sci Reportedly Mulls A Takeover,https://www.investors.com/news/technology/swav-stock-soars-as-boston-scientific-reportedly-mulls-a-shockwave-takeover/,2023-04-21 16:01:00,"Boston Scientific ( BSX ) is considering a takeover of Shockwave Medical ( SWAV ) , according to a report Friday that sent SWAV stock soaring. Shockwave uses an electrical impulse to ""crack"" hardened calcium in the arteries. The process, called intravascular lithotripsy, is gaining steam as an ...",BSX,0.70749,0.518276,Bullish
Boston Scientific  ( BSX )  Just Overtook the 20-Day Moving Average,https://www.zacks.com/stock/news/2092315/boston-scientific-bsx-just-overtook-the-20-day-moving-average,2023-05-09 13:35:04,Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?,BSX,0.702434,0.67207,Bullish
Deep Brain Stimulation  ( DBS )  Devices Market for Parkinson's Disease to Reach USD 1.2 Bn by 2028 with CAGR of 5.1% - TMR Study,https://www.benzinga.com/pressreleases/23/05/g32282122/deep-brain-stimulation-dbs-devices-market-for-parkinsons-disease-to-reach-usd-1-2-bn-by-2028-with-,2023-05-09 10:30:00,"Wilmington, Delaware, United States, May 09, 2023 ( GLOBE NEWSWIRE ) -- The global deep brain stimulation devices market for Parkinson's disease was valued at USD 0.85 Bn in 2020 and is anticipated to exceed USD 1.2 Bn by 2028 at a CAGR of 5.1% between 2021 and 2028.",BSX,0.04912,0.132049,Neutral
Shockwave Medical  ( SWAV )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/08/shockwave-medical-swav-q1-2023-earnings-call-trans/,2023-05-09 03:30:37,"SWAV earnings call for the period ending March 31, 2023.",BSX,0.00495,0.064299,Neutral
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/earnings/23/05/32269581/100-invested-in-this-stock-15-years-ago-would-be-worth-400-today,2023-05-08 17:00:35,"Boston Scientific BSX has outperformed the market over the past 15 years by 2.41% on an annualized basis producing an average annual return of 9.85%. Currently, Boston Scientific has a market capitalization of $76.52 billion.",BSX,0.980595,0.386944,Bullish
Shockwave Skids As Boston Sci Deal Reportedly Falls Apart,https://www.investors.com/news/technology/swav-stock-tumbles-as-boston-scientific-takeover-talk-reportedly-breaks-down/,2023-05-08 16:18:00,SWAV Stock Tumbles As Boston Scientific Takeover Talk Reportedly ... Investor's Business Daily ...,BSX,0.468029,-0.107873,Neutral
Stock Market Indexes Pause Ahead Of Inflation Numbers. Buffett's Berkshire Not Interested Full Ownership Of OXY.,https://www.investors.com/market-trend/stock-market-today/stock-market-indexes-pause-ahead-of-inflation-numbers-buffetts-berkshires-not-interested-in-full-ownership-of-oxy/,2023-05-08 14:59:00,Stock Market Off Lows Ahead Of Inflation Report. Analyst Warns ... Investor's Business Daily ...,BSX,0.118064,-0.084353,Neutral
"Zacks Industry Outlook Highlights Stryker, Boston Scientific, Zimmer Biomet and Insulet",https://www.zacks.com/stock/news/2091489/zacks-industry-outlook-highlights-stryker-boston-scientific-zimmer-biomet-and-insulet,2023-05-08 12:36:00,"Stryker, Boston Scientific, Zimmer Biomet and Insulet are part of the Zacks Industry Outlook article.",BSX,0.125569,0.156708,Somewhat-Bullish
Heart valve repair and replacement devices market size to grow by USD 3.01 billion from 2021 to 2026; Innovations in heart valve repair and replacement devices to improve market growth - Technavio,https://www.prnewswire.com/news-releases/heart-valve-repair-and-replacement-devices-market-size-to-grow-by-usd-3-01-billion-from-2021-to-2026-innovations-in-heart-valve-repair-and-replacement-devices-to-improve-market-growth---technavio-301816248.html,2023-05-05 20:15:00,Heart valve repair and replacement devices market size to grow by ... PR ...,BSX,0.032871,0.0,Neutral
"Urinary Catheters Market Value to expand at a 4.5% CAGR from 2021 to 2028, reaching USD 5.1 billion: TMR Report",https://www.benzinga.com/pressreleases/23/05/g32246046/urinary-catheters-market-value-to-expand-at-a-4-5-cagr-from-2021-to-2028-reaching-usd-5-1-billion-,2023-05-05 18:30:00,"Wilmington, Delaware, United States, May 06, 2023 ( GLOBE NEWSWIRE ) -- The global urinary catheters market was estimated at a market value of USD 3.1 billion in 2020. During the forecast years of 2021 to 2028, the market is expected to grow at a rate of 4.5% CAGR and finally reach USD 5.1 ...",BSX,0.046095,0.185271,Somewhat-Bullish
ABNB Stock In Holding Pattern Ahead Of Q1 Results; Warren Buffett Favorite Occidental Petroleum Set To Report,https://www.investors.com/research/earnings-preview/abnb-stock-holding-pattern-q1-results-warren-buffett-favorite-occidental-petroleum-oxy-earnings/,2023-05-05 14:43:00,ABNB Stock In Holding Pattern Ahead Of Q1 Results. Warren Buffett ... Investor's Business Daily ...,BSX,0.065506,0.043037,Neutral
4 Medical Products Stocks to Capitalize on the Industry's Recovery,https://www.zacks.com/commentary/2090763/4-medical-products-stocks-to-capitalize-on-the-industrys-recovery,2023-05-05 13:59:00,"Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, BSX, ZBH and PODD are well-poised to gain from the favorable factors.",BSX,0.107688,0.127811,Neutral
Copado Brings Generative AI to Its DevOps Platform to Improve Software Development for Enterprise SaaS,https://www.prnewswire.com/news-releases/copado-brings-generative-ai-to-its-devops-platform-to-improve-software-development-for-enterprise-saas-301815686.html,2023-05-04 13:30:00,Copado Brings Generative AI to Its DevOps Platform to Improve ... PR ...,BSX,0.077094,0.094482,Neutral
"Back to the Futuristic: 3 Game-Changing Wearable Technologies Coming Soon, Explored by IDTechEx",https://www.benzinga.com/pressreleases/23/05/n32205483/back-to-the-futuristic-3-game-changing-wearable-technologies-coming-soon-explored-by-idtechex,2023-05-04 06:56:00,"BOSTON, May 4, 2023 /PRNewswire/ -- Consumer technology available today is impressive but still not as cool as promised by many classic sci-fi movies. Dreams of hoverboards and holograms have been replaced by stagnating smartphone designs and doom-scrolling. Yet things look set to change.",BSX,0.038345,0.07587,Neutral
"Remote Patient Monitoring Market Set to Grow at 26.7% CAGR, Reaching USD 53.6 Billion in 2022, Driven by Rising Prevalence of Chronic Diseases and Technological Advances.",https://markets.businessinsider.com/news/stocks/remote-patient-monitoring-market-set-to-grow-at-26-7-cagr-reaching-usd-53-6-billion-in-2022-driven-by-rising-prevalence-of-chronic-diseases-and-technological-advances-1032286872,2023-05-03 14:26:00,"Remote Patient Monitoring ( RPM ) Devices Market, By Product Type ( Stationary Devices, Wearable Devices, and Others ) , By End-use, and By Region Forecast to 2032 The Remote Patient Monitoring ( RPM ) market has witnessed significant growth in recent years, with a size of USD 53.6 billion in ...",BSX,0.033515,0.251995,Somewhat-Bullish
Here's Why You Should Retain National Vision  ( EYE )  Stock Now,https://www.zacks.com/stock/news/2087896/heres-why-you-should-retain-national-vision-eye-stock-now,2023-05-02 12:02:00,National Vision's (EYE) share price is likely to grow following the company's efforts to expand remote capabilities and investments in doctor recruiting and retention efforts.,BSX,0.195287,0.065098,Neutral
Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies,https://www.prnewswire.com/news-releases/data-at-heart-rhythm-2023-highlight-key-boston-scientific-therapies-301830233.html,2023-05-20 18:54:00,"Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the FARAPULSE™ Pulsed Field Ablation System* Results from global trial of the POLARx™ Cryoablation System* meet safety and effectiveness endpoints",BSX,0.098557,0.194304,Somewhat-Bullish
We're starting a new position in one of the Big 3 global medical imaging and diagnostics companies,https://www.cnbc.com/2023/05/17/were-starting-a-new-position-in-a-medical-imaging-and-diagnostics-leader.html,2023-05-17 17:30:53,This company operates in an $84 billion total addressable market that the company sees growing to around $100 billion by 2024.,BSX,0.073209,0.110168,Neutral
Looking Into Boston Scientific's Recent Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/05/32446269/looking-into-boston-scientifics-recent-short-interest,2023-05-17 14:15:28,"Boston Scientific's BSX short percent of float has risen 22.73% since its last report. The company recently reported that it has 15.44 million shares sold short, which is 1.08% of all regular shares that are available for trading.",BSX,0.221819,0.155473,Somewhat-Bullish
Shockwave Appoints Kevin Ballinger to Board of Directors,https://www.globenewswire.com/news-release/2023/05/17/2670960/0/en/Shockwave-Appoints-Kevin-Ballinger-to-Board-of-Directors.html,2023-05-17 12:00:00,"SANTA CLARA, Calif., May 17, 2023 ( GLOBE NEWSWIRE ) -- Shockwave Medical, Inc. ( Nasdaq: SWAV ) , a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Kevin Ballinger has joined its Board of ...",BSX,0.243701,0.018265,Neutral
HCA Healthcare  ( HCA )  Gains 29% in a Year: More Upside Left?,https://www.zacks.com/stock/news/2096015/hca-healthcare-hca-gains-29-in-a-year-more-upside-left,2023-05-16 19:29:00,"HCA Healthcare (HCA) is well-poised for growth on the back of higher revenues, a diversified treatment network and sound operating cash flows.",BSX,0.224903,0.093117,Neutral
Are Medical Stocks Lagging Boston Scientific  ( BSX )  This Year?,https://www.zacks.com/stock/news/2095247/are-medical-stocks-lagging-boston-scientific-bsx-this-year,2023-05-15 13:40:11,Here is how Boston Scientific (BSX) and Aravive (ARAV) have performed compared to their sector so far this year.,BSX,0.7414,0.38849,Bullish
Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635 ( c )  ( 4 )  - Standard BioTools  ( NASDAQ:LAB ) ,https://www.benzinga.com/pressreleases/23/05/g32389250/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grant,2023-05-15 11:30:14,"Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period SOUTH SAN FRANCISCO, Calif., May 15, 2023 ( GLOBE NEWSWIRE ) -- Standard BioTools Inc.",BSX,0.03916,-0.024901,Neutral
Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635 ( c )  ( 4 ) ,https://www.globenewswire.com/news-release/2023/05/15/2668646/0/en/Standard-BioTools-Appoints-Jeffrey-Black-as-Chief-Financial-Officer-and-Announces-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html,2023-05-15 11:30:00,Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience ...,BSX,0.039811,-0.024964,Neutral
"Defibrillator Market to Reach New Heights, Predicted to Surpass USD 16.3 Bn by 2031 Due to Rising Incidence of Cardiac Disease - Global Analysis by Transparency Market Research",https://www.benzinga.com/pressreleases/23/05/g32360142/defibrillator-market-to-reach-new-heights-predicted-to-surpass-usd-16-3-bn-by-2031-due-to-rising-i,2023-05-12 10:30:00,"Wilmington, Delaware, United States, May 12, 2023 ( GLOBE NEWSWIRE ) -- The global defibrillators market was valued at USD 7.2 Bn in 2021 and is projected to reach USD 16.3 Bn by 2031 growing at a CAGR of 8.9%.",BSX,0.038969,0.09178,Neutral
Catalent  ( CTLT )  Expands Its Facility Capabilities in Shiga,https://www.zacks.com/stock/news/2101477/catalent-ctlt-expands-its-facility-capabilities-in-shiga,2023-05-30 15:29:00,Catalent's (CTLT) latest capability expansion is expected to boost its business in the global clinical trials space in its Clinical Supply Services network.,BSX,0.251032,0.046166,Neutral
Coronary Stents Market to Witness Phenomenal Gains by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/coronary-stents-market-to-witness-phenomenal-gains-by-2029--brandessence-market-research-301836605.html,2023-05-29 14:45:00,Coronary Stents Market to Witness Phenomenal Gains by 2029 ... PR ...,BSX,0.020615,0.039405,Neutral
Mithra Appoints Experienced Life Sciences Executive Christian Homsy* as Chairman,https://www.globenewswire.com/news-release/2023/05/29/2677537/0/en/Mithra-Appoints-Experienced-Life-Sciences-Executive-Christian-Homsy-as-Chairman.html,2023-05-29 05:30:00,"Liege, Belgium, 29 May 2023 - 7:30 CEST - Mithra ( Euronext Brussels: MITRA ) , a company dedicated to Women's Health, today announces the appointment of leading life sciences executive Dr.Christian Homsy as Chairman of the Board of Directors.",BSX,0.051551,0.024793,Neutral
These Growth Stocks Seem Stalled. That May Be A Good Thing.,https://www.investors.com/stock-lists/ibd-50/growth-stocks-these-ibd-50-members-seem-stalled-that-may-be-a-good-thing/,2023-05-26 19:08:00,"Seven growth stocks on the elite IBD 50 show a similar pattern often seen before a stock hits new highs. These constructive patterns started forming following the companies' latest earnings reports. Tight price action, meaning little movement after an advance, can be a bullish sign.",BSX,0.134968,0.070196,Neutral
Why Is Boston Scientific  ( BSX )  Down 0.9% Since Last Earnings Report?,https://www.zacks.com/stock/news/2100381/why-is-boston-scientific-bsx-down-09-since-last-earnings-report,2023-05-26 15:31:39,Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,BSX,0.321673,0.1924,Somewhat-Bullish
Veeva Systems  ( VEEV )  Offerings Adopted by Minaris Regenerative,https://www.zacks.com/stock/news/2100475/veeva-systems-veev-offerings-adopted-by-minaris-regenerative,2023-05-26 15:20:00,Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid the CDMO to modernize its operations and streamline its quality processes globally.,BSX,0.210274,0.040086,Neutral
"Medtronic  ( MDT )  Q4 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2099925/medtronic-mdt-q4-earnings-beat-estimates-margins-down,2023-05-25 18:29:00,"Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.",BSX,0.176825,0.032145,Neutral
Mithra's General Meeting Of Shareholders Approves the Renewal of its Board of Directors,https://www.globenewswire.com/news-release/2023/05/25/2676537/0/en/Mithra-s-General-Meeting-Of-Shareholders-Approves-the-Renewal-of-its-Board-of-Directors.html,2023-05-25 16:39:00,"Mithra's General Meeting Of Shareholders Approves the Renewal of its Board of Directors Liege, Belgium, 25 MAY 2023 - 5:45 CEST - Mithra ( Euronext Brussels: MITRA ) , a company dedicated to Women's Health, today announces that at its Annual General Meeting, held today the appointment/renewal of ...",BSX,0.030838,0.057554,Neutral
Mithra's General Meeting Of Shareholders Approves the Renewal of its Board of Directors,https://www.globenewswire.com/news-release/2023/05/25/2676451/0/en/Mithra-s-General-Meeting-Of-Shareholders-Approves-the-Renewal-of-its-Board-of-Directors.html,2023-05-25 15:45:00,"Liege, Belgium, 25 MAY 2023 - 5:45 CEST - Mithra ( Euronext Brussels: MITRA ) , a company dedicated to Women's Health, today announces that at its Annual General Meeting, held today all agenda items put to vote were approved, including the appointment of Directors for a two-year mandate.",BSX,0.029399,0.057122,Neutral
Regulatory Hurdles Force Boston Scientific to Opt for Minority Stake in M.I. Tech - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/large-cap/23/05/32574504/regulatory-hurdles-force-boston-scientific-to-opt-for-minority-stake-in-m-i-tech,2023-05-25 14:21:30,"Boston Scientific Corporation BSX is terminating its $230 million plan to buy a majority stake in M.I. Tech, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.",BSX,0.79415,0.354427,Bullish
Masimo's  ( MASI )  Platform Expansion to Boost Patient Monitoring,https://www.zacks.com/stock/news/2099731/masimos-masi-platform-expansion-to-boost-patient-monitoring,2023-05-25 14:17:00,Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.,BSX,0.237551,0.04412,Neutral
"Boston Scientific  ( BSX )  Gains From Acquisitions, New Launches",https://www.zacks.com/stock/news/2099237/boston-scientific-bsx-gains-from-acquisitions-new-launches,2023-05-24 16:38:00,Boston Scientific (BSX) remains excited about 2023 performance and expects to continue to outpace its peers within the EMEA market.,BSX,0.426824,0.303608,Somewhat-Bullish
BSX: 4 Hypergrowth Stocks That Could Soar,https://stocknews.com/news/bsx-cah-cdtx-geos-4-hypergrowth-stocks-that-could-soar/,2023-05-24 16:01:46,"Coupled with warnings around the debt ceiling growing louder, the Fed's persistent efforts to curb the stubbornly high inflation and the banking system jitters have aggravated concerns of an economic slump. The resultant market volatilities are anticipated to linger for a while.",BSX,0.179195,0.210933,Somewhat-Bullish
Accuray  ( ARAY )  Hits 52-Week High: What's Aiding the Stock?,https://www.zacks.com/stock/news/2099116/accuray-aray-hits-52-week-high-whats-aiding-the-stock,2023-05-24 14:42:00,Investors are optimistic about Accuray's (ARAY) solid product portfolio.,BSX,0.231884,0.043315,Neutral
Veeva Systems'  ( VEEV )  New Tie-Up to Improve Clinical Trials,https://www.zacks.com/stock/news/2099093/veeva-systems-veev-new-tie-up-to-improve-clinical-trials,2023-05-24 14:14:00,Veeva Systems' (VEEV) latest collaboration is expected to advance the patient experience in clinical trials.,BSX,0.22595,0.042388,Neutral
"Bare-metal Stents Market to Achieve Remarkable Growth, Projected at 5.2% CAGR, and Surpassing USD 4.8 Billion by 2031 - TMR Study",https://www.benzinga.com/pressreleases/23/05/g32545814/bare-metal-stents-market-to-achieve-remarkable-growth-projected-at-5-2-cagr-and-surpassing-usd-4-8,2023-05-24 08:30:00,"Wilmington, Delaware, United States, May 24, 2023 ( GLOBE NEWSWIRE ) -- The global bare metal stents market is projected to flourish at a CAGR of 5.2% from 2023 to 2031. As per the report published by TMR, the global cancer immunotherapy market is expected to exceed a value of USD 4.8 billion by ...",BSX,0.084423,0.120949,Neutral
Avantor's  ( AVTR )  New Tie-Up to Improve Lab Inventory Management,https://www.zacks.com/stock/news/2098649/avantors-avtr-new-tie-up-to-improve-lab-inventory-management,2023-05-23 16:17:00,Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.,BSX,0.22861,0.042826,Neutral
3 Reasons to Add Merit Medical  ( MMSI )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2098586/3-reasons-to-add-merit-medical-mmsi-stock-to-your-portfolio,2023-05-23 15:04:00,Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.,BSX,0.208017,0.039711,Neutral
3 Reasons to Hold Inspire Medical  ( INSP )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2098052/3-reasons-to-hold-inspire-medical-insp-stock-in-your-portfolio,2023-05-22 15:10:00,Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.,BSX,0.213988,0.04064,Neutral
BD's  ( BDX )  Latest Product Launch to Boost Research Outcome,https://www.zacks.com/stock/news/2098046/bds-bdx-latest-product-launch-to-boost-research-outcome,2023-05-22 15:00:00,BD's (BDX) latest cell sorting technology is expected to speed up the process of cell sorting and allow researchers to answer complex biological questions.,BSX,0.202366,0.03891,Neutral
Sports Medicine Market to Grow Exponentially by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/sports-medicine-market-to-grow-exponentially-by-2029--brandessence-market-research-301830920.html,2023-05-22 14:42:00,Sports Medicine Market to Grow Exponentially by 2029 ... PR ...,BSX,0.019978,0.084606,Neutral
"Global Interventional Pulmonology Market Anticipated to Garner $6,903.70 Million, Growing at a 6.7% CAGR in the 2022-2031 Timeframe [250-Pages] | Ratified by Research Dive",https://www.benzinga.com/pressreleases/23/05/g32507564/global-interventional-pulmonology-market-anticipated-to-garner-6-903-70-million-growing-at-a-6-7-c,2023-05-22 13:05:00,"New York, USA, May 22, 2023 ( GLOBE NEWSWIRE ) -- Research Dive has published a new report on the global interventional pulmonology market. According to the report, the global market is projected to surpass $6,903.70 million and grow at a CAGR of 6.7% in the estimated period, 2022-2031.",BSX,0.058759,0.0,Neutral
Catalent  ( CTLT )  Launches Expanded OneBio Suite to Aid Customers,https://www.zacks.com/stock/news/2106532/catalent-ctlt-launches-expanded-onebio-suite-to-aid-customers,2023-06-09 15:53:00,Catalent's (CTLT) expansion of its OneBio Suite across multiple biologic therapies is expected to aid customers in leveraging its end-to-end capabilities in these areas.,BSX,0.238133,0.044248,Neutral
What's Next For Boston Scientific Stock After Outperforming During The 2022 Inflation Shock?,https://www.forbes.com/sites/greatspeculations/2023/06/09/whats-next-for-boston-scientific-stock-after-outperforming-during-the-2022-inflation-shock/,2023-06-09 13:00:46,The notable rise in Boston Scientific's revenues in the recent past has also contributed to the stock's outperformance.,BSX,0.600035,0.032242,Neutral
"Intravascular Ultrasound [IVUS] Devices Market to Grow at a 5.9% CAGR from 2023 to 2031, reaching USD 1240 million: TMR Report",https://www.benzinga.com/pressreleases/23/06/g32794302/intravascular-ultrasound-ivus-devices-market-to-grow-at-a-5-9-cagr-from-2023-to-2031-reaching-usd-,2023-06-09 12:30:00,"Wilmington, Delaware, United States, June 09, 2023 ( GLOBE NEWSWIRE ) -- The global intravascular ultrasound [IVUS] devices market is anticipated to grow at a 5.9% CAGR from 2023 to 2031. A market valuation of US$ 1,240 million is expected by end of the forecast period.",BSX,0.038655,0.0,Neutral
"Neurostimulation Devices Market to Experience Robust 12.0% CAGR, Highlights TMR Study",https://www.benzinga.com/pressreleases/23/06/g32785965/neurostimulation-devices-market-to-experience-robust-12-0-cagr-highlights-tmr-study,2023-06-08 19:30:00,"Wilmington, Delaware, United States, June 09, 2023 ( GLOBE NEWSWIRE ) -- The global neurostimulation devices market size was worth at US$ 119.7 Bn in 2022. Expanding at a CAGR of 12.0% between 2023 and 2031, the global industry is likely to be valued at US$ 331.5 Bn by 2031.",BSX,0.043579,0.0,Neutral
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/earnings/23/06/32781824/heres-how-much-1000-invested-in-boston-scientific-10-years-ago-would-be-worth-today,2023-06-08 15:30:47,"Boston Scientific BSX has outperformed the market over the past 10 years by 8.17% on an annualized basis producing an average annual return of 18.38%. Currently, Boston Scientific has a market capitalization of $73.23 billion.",BSX,0.980595,0.386944,Bullish
Inari Medical  ( NARI )  Launches New Catheters to Address VTE,https://www.zacks.com/stock/news/2105829/inari-medical-nari-launches-new-catheters-to-address-vte,2023-06-08 15:13:00,Inari Medical's (NARI) latest launches are expected to serve a wider patient pool by improving treatment options.,BSX,0.20537,0.039356,Neutral
3 Reasons to Retain Intuitive Surgical  ( ISRG )  Stock for Now,https://www.zacks.com/stock/news/2105355/3-reasons-to-retain-intuitive-surgical-isrg-stock-for-now,2023-06-07 18:44:00,Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.,BSX,0.212115,0.04036,Neutral
Masimo's  ( MASI )  New FDA Approval to Boost Patient Monitoring,https://www.zacks.com/stock/news/2105320/masimos-masi-new-fda-approval-to-boost-patient-monitoring,2023-06-07 16:36:00,Masimo's (MASI) Radius VSM is expected to equip any hospital bed with comprehensive monitoring and offer more personalized care without additional bedside equipment.,BSX,0.202366,0.038872,Neutral
Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer,https://www.globenewswire.com/news-release/2023/06/07/2683759/0/en/Orchestra-BioMed-Appoints-Bill-Little-as-Executive-Vice-President-of-Corporate-Development-and-Strategy-and-Andrew-Taylor-as-Chief-Financial-Officer.html,2023-06-07 12:30:00,"Bill Little, previously Chief Operating Officer ( COO ) of Neovasc, Inc. through its acquisition by Shockwave Medical in April 2023, will lead efforts to forge further strategic collaborations in newly created Executive Vice President ( EVP ) of Corporate Development and Strategy role ...",BSX,0.024572,0.045154,Neutral
"Hospital Supplies Market  ( Type, Geography )  - Reach $101 Billion by 2027 at 11.9% CAGR Dominated by North America  ( 12.1% CAGR )  | The Insight Partners",https://www.benzinga.com/pressreleases/23/06/g32754706/hospital-supplies-market-type-geography-reach-101-billion-by-2027-at-11-9-cagr-dominated-by-north-,2023-06-07 11:13:19,"Pune, India, June 07, 2023 ( GLOBE NEWSWIRE ) -- The Insight Partners published latest research study on ""Hospital Supplies Market Size Report, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Geography"", the global hospital ...",BSX,0.02275,0.069413,Neutral
"Varicose Veins Treatment Market on an Upward Trajectory, Estimated to Surpass USD 2.4 Bn by 2031: TMR Study Highlights Growth Factors",https://www.benzinga.com/pressreleases/23/06/g32743939/varicose-veins-treatment-market-on-an-upward-trajectory-estimated-to-surpass-usd-2-4-bn-by-2031-tm,2023-06-06 17:30:00,"Wilmington, Delaware, United States, June 06, 2023 ( GLOBE NEWSWIRE ) -- The global varicose veins treatment market is projected to expand at a CAGR of 4.8% from 2022 to 2031 and is anticipated to surpass US$ 2.4 Bn by 2031.",BSX,0.035608,0.0,Neutral
"HealthEquity  ( HQY )  Surpasses Q1 Earnings Estimates, FY24 View Up",https://www.zacks.com/stock/news/2104586/healthequity-hqy-surpasses-q1-earnings-estimates-fy24-view-up,2023-06-06 14:58:00,"HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the first quarter of fiscal 2024.",BSX,0.166169,-0.006929,Neutral
Here's Why You Should Hold Integer Holdings  ( ITGR )  Stock for Now,https://www.zacks.com/stock/news/2104585/heres-why-you-should-hold-integer-holdings-itgr-stock-for-now,2023-06-06 14:56:00,Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and a solid foothold in the broader MedTech space.,BSX,0.203643,0.039099,Neutral
iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments,https://www.globenewswire.com/news-release/2023/06/06/2682907/0/en/iRhythm-Technologies-Further-Strengthens-its-Board-of-Directors-with-Two-New-Independent-Director-Appointments.html,2023-06-06 13:00:00,"SAN FRANCISCO, June 06, 2023 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the appointment of Mojdeh Poul and Brian Yoor as directors to its ...",BSX,0.049939,0.120215,Neutral
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer - Motus GI Hldgs  ( NASDAQ:MOTS ) ,https://www.benzinga.com/pressreleases/23/06/g32726079/motus-gi-announces-appointment-of-ravit-ram-as-chief-financial-officer,2023-06-05 20:42:43,"Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers, including seeking key FDA approvals and pursuit of strategic partnerships to accelerate commercialization FORT LAUDERDALE, Fla., June 05, 2023 ( GLOBE NEWSWIRE ) -- Motus GI ...",BSX,0.068698,0.095313,Neutral
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer,https://www.globenewswire.com/news-release/2023/06/05/2682394/0/en/Motus-GI-Announces-Appointment-of-Ravit-Ram-as-Chief-Financial-Officer.html,2023-06-05 20:42:00,"FORT LAUDERDALE, Fla., June 05, 2023 ( GLOBE NEWSWIRE ) -- Motus GI Holdings, Inc. ( NASDAQ: MOTS ) ( ""Motus GI"" or the ""Company"" ) , a medical technology company focused on improving endoscopic outcomes and experiences, today announced the promotion of its current Vice President of Global ...",BSX,0.051441,0.094481,Neutral
Nuwellis Announces the Appointment of Mike McCormick to its Board of Directors,https://www.globenewswire.com/news-release/2023/06/05/2682379/26106/en/Nuwellis-Announces-the-Appointment-of-Mike-McCormick-to-its-Board-of-Directors.html,2023-06-05 20:15:00,"MINNEAPOLIS, June 05, 2023 ( GLOBE NEWSWIRE ) -- Nuwellis, Inc. ( Nasdaq: NUWE ) , a medical technology company focused on transforming the lives of patients suffering from fluid overload, today announced that Mike McCormick has been appointed to the company's Board of Directors.",BSX,0.12645,0.068323,Neutral
Nuwellis Announces the Appointment of Mike McCormick to its Board of Directors - Nuwellis  ( NASDAQ:NUWE ) ,https://www.benzinga.com/pressreleases/23/06/g32725001/nuwellis-announces-the-appointment-of-mike-mccormick-to-its-board-of-directors,2023-06-05 20:15:00,"MINNEAPOLIS, June 05, 2023 ( GLOBE NEWSWIRE ) -- Nuwellis, Inc. NUWE, a medical technology company focused on transforming the lives of patients suffering from fluid overload, today announced that Mike McCormick has been appointed to the company's Board of Directors.",BSX,0.121959,0.067175,Neutral
Hologic  ( HOLX )  Stock Up 5.6% YTD: Will the Rally Continue?,https://www.zacks.com/stock/news/2104045/hologic-holx-stock-up-56-ytd-will-the-rally-continue,2023-06-05 18:12:00,"The higher capital equipment revenues, procedural volumes return and an acceleration from the new business lines poise Hologic (HOLX) for future growth.",BSX,0.200273,0.038562,Neutral
Here's Why You Should Hold on to Align Technology  ( ALGN )  Now,https://www.zacks.com/stock/news/2104002/heres-why-you-should-hold-on-to-align-technology-algn-now,2023-06-05 15:45:00,Investors are optimistic about Align Technology (ALGN) owing to expanding work-flow options of its leading iTero scanners.,BSX,0.190793,0.035635,Neutral
Here's Why You Should Retain AMN Healthcare  ( AMN )  Stock for Now,https://www.zacks.com/stock/news/2103929/heres-why-you-should-retain-amn-healthcare-amn-stock-for-now,2023-06-05 15:36:00,Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.,BSX,0.200273,0.0386,Neutral
Copado and nCino Partner to Provide Proven DevOps Tools for Financial Institutions,https://www.prnewswire.com/news-releases/copado-and-ncino-partner-to-provide-proven-devops-tools-for-financial-institutions-301841525.html,2023-06-05 13:30:00,Copado and nCino Partner to Provide Proven DevOps Tools for ... PR ...,BSX,0.051774,0.092763,Neutral
Here's Why You Should Retain PacBio  ( PACB )  Stock for Now,https://www.zacks.com/stock/news/2103412/heres-why-you-should-retain-pacbio-pacb-stock-for-now,2023-06-02 16:08:00,PacBio's (PACB) product development activities raise optimism about the stock.,BSX,0.206685,0.039551,Neutral
Illumina's Board of Directors elects two experienced Independent Directors to Board,https://www.prnewswire.com/news-releases/illuminas-board-of-directors-elects-two-experienced-independent-directors-to-board-301841153.html,2023-06-02 11:30:00,Illumina's Board of Directors elects two experienced Independent ... PR ...,BSX,0.046363,0.034351,Neutral
"Veeva Systems  ( VEEV )  Beats on Q1 Earnings, Ups FY24 Outlook",https://www.zacks.com/stock/news/2102610/veeva-systems-veev-beats-on-q1-earnings-ups-fy24-outlook,2023-06-01 14:59:00,Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performances by both segments.,BSX,0.167032,-0.006957,Neutral
Here's Why You Should Retain DaVita  ( DVA )  Stock for Now,https://www.zacks.com/stock/news/2102601/heres-why-you-should-retain-davita-dva-stock-for-now,2023-06-01 14:46:00,Investors remain optimistic about DaVita (DVA) due to the strength of its DaVita Kidney Care.,BSX,0.217834,0.041214,Neutral
Is Augmedix  ( AUGX )  Outperforming Other Medical Stocks This Year?,https://www.zacks.com/stock/news/2101912/is-augmedix-augx-outperforming-other-medical-stocks-this-year,2023-05-31 13:40:10,"Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.",BSX,0.404563,0.277615,Somewhat-Bullish
Charted: Boston's highest-paid CEOs,https://www.axios.com/local/boston/2023/05/31/highest-paid-ceos-massachusetts,2023-05-31 08:30:50,Charted: Boston's ...,BSX,0.116914,0.06817,Neutral
Humana  ( HUM )  Sees Insurance Costs at Upper Limit of Guidance,https://www.zacks.com/stock/news/2110195/humana-hum-sees-insurance-costs-at-upper-limit-of-guidance,2023-06-19 15:58:00,"Despite the rising demand for elective procedures, Humana (HUM) sticks to its earnings guidance.",BSX,0.268786,0.115396,Neutral
"Global Foreign Body Removal Market Forecast 2023-2032 - Market Size, Drivers, Trends, And Competitors As Per The Business Research Company's Foreign Body Removal Global Market Report 2023",https://www.benzinga.com/pressreleases/23/06/g32913425/global-foreign-body-removal-market-forecast-2023-2032-market-size-drivers-trends-and-competitors-a,2023-06-19 15:35:00,"LONDON, June 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's foreign body removal Market Report 2023, the market will grow from$1.8 billion in 2022 to $1.9 billion in 2023, with a compound annual growth rate ( CAGR ) of more than 5%.",BSX,0.062926,0.080025,Neutral
3 Reasons to Retain Nevro  ( NVRO )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2110107/3-reasons-to-retain-nevro-nvro-stock-in-your-portfolio,2023-06-19 14:27:00,Investors continue to be optimistic about Nevro (NVRO) due to its R&D edge.,BSX,0.205807,0.039421,Neutral
IDEXX  ( IDXX )  Stock Up 18.4% YTD: Will the Rally Continue?,https://www.zacks.com/stock/news/2110139/idexx-idxx-stock-up-184-ytd-will-the-rally-continue,2023-06-19 14:24:00,The continued solid demand for veterinary services and benefits from strong execution poise IDEXX (IDXX) well for future growth.,BSX,0.220308,0.043407,Neutral
"Hologic  ( HOLX )  Gains From Core Businesses' Growth, Innovation",https://www.zacks.com/stock/news/2109972/hologic-holx-gains-from-core-businesses-growth-innovation,2023-06-19 12:57:00,Hologic's (HOLX) GYN Surgical business grows organically as the company registers procedural volumes return and acceleration from new business lines.,BSX,0.218325,0.041352,Neutral
Surmodics'  ( SRDX )  Receipt of New FDA Nod to Boost Patient Care,https://www.zacks.com/stock/news/2109506/surmodics-srdx-receipt-of-new-fda-nod-to-boost-patient-care,2023-06-16 15:20:00,Surmodics' (SRDX) receipt of FDA's clearance is expected to expand the treatment range of the Pounce platform and serve a wider patient pool.,BSX,0.207127,0.039579,Neutral
Is Augmedix  ( AUGX )  Stock Outpacing Its Medical Peers This Year?,https://www.zacks.com/stock/news/2109400/is-augmedix-augx-stock-outpacing-its-medical-peers-this-year,2023-06-16 13:40:09,"Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.",BSX,0.393462,0.326353,Somewhat-Bullish
IDEXX  ( IDXX )  Launches First Veterinary Diagnostic Test,https://www.zacks.com/stock/news/2109407/idexx-idxx-launches-first-veterinary-diagnostic-test,2023-06-16 12:42:00,"IDEXX's (IDXX) Cystatin B Test can help veterinary professionals to spot kidney damage before it affects kidney function, which may result in better patient outcomes.",BSX,0.173958,0.036302,Neutral
"Unispace: ""Returning for Good"" Global Survey - Do employers understand what workers need from the workplace?",https://www.prnewswire.com/apac/news-releases/unispace-returning-for-good-global-survey---do-employers-understand-what-workers-need-from-the-workplace-301852856.html,2023-06-16 06:56:00,"• 94% of employees hot-desking would be happier to come to the office more frequently if they had an assigned space • 2 in 5 employees in are in the office four or more days per week, below the global average of 50% - but only 26% are happy with that frequency • 76% of businesses in expanded ...",BSX,0.04076,0.218252,Somewhat-Bullish
Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase  ( nNOS )  Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem,https://www.globenewswire.com/news-release/2023/06/15/2689366/0/en/Beyond-Air-Licenses-Commercial-Rights-to-Selective-Neuronal-Nitric-Oxide-Synthase-nNOS-Inhibitors-for-the-Treatment-of-Autism-Spectrum-Disorder-from-Hebrew-University-of-Jerusalem.html,2023-06-15 20:05:00,"Hebrew University's preclinical results recently published in Advanced Science show a reversal of the molecular, synaptic and behavioral autism spectrum disorder ( ASD ) phenotypes ...",BSX,0.017716,0.105684,Neutral
Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase  ( nNOS )  Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem - Beyond Air  ( NASDAQ:XAIR ) ,https://www.benzinga.com/pressreleases/23/06/g32882839/beyond-air-licenses-commercial-rights-to-selective-neuronal-nitric-oxide-synthase-nnos-inhibitors-,2023-06-15 20:05:00,"Hebrew University's preclinical results recently published in Advanced Science show a reversal of the molecular, synaptic and behavioral autism spectrum disorder ( ASD ) phenotypes Plan to initiate a first-in-human clinical trial of nNOS for treatment of ASD in 2025",BSX,0.017471,0.10551,Neutral
3 Reasons to Hold Patterson Companies  ( PDCO )  Stock for Now,https://www.zacks.com/stock/news/2108950/3-reasons-to-hold-patterson-companies-pdco-stock-for-now,2023-06-15 15:31:00,Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.,BSX,0.22335,0.042039,Neutral
"Meet 19 executives guiding eBay's online marketplace toward AI, ads, and authentication",https://www.businessinsider.com/ebay-growth-executives-ai-ads-authentication-2023-6,2023-06-15 15:14:00,"eBay Power Players Driving Its Next Phase With AI, Ads, Authentication - Business Insider ...",BSX,0.030524,0.084442,Neutral
BD's  ( BDX )  Latest Product to Automate Clinical Flow Cytometry,https://www.zacks.com/stock/news/2108928/bds-bdx-latest-product-to-automate-clinical-flow-cytometry,2023-06-15 15:08:00,The latest worldwide commercial availability of BD's (BDX) product is expected to lead to increased automation in clinical lab workflow.,BSX,0.206245,0.039486,Neutral
Neogen  ( NEOG )  Introduces Improved Genomic Test for Cats,https://www.zacks.com/stock/news/2108877/neogen-neog-introduces-improved-genomic-test-for-cats,2023-06-15 13:58:00,Neogen's (NEOG) My CatScan 2.0 offers insightful genetic information that enables preventive cat care by tackling curable conditions.,BSX,0.209365,0.045166,Neutral
Here's Why You Should Invest in Hologic  ( HOLX )  Stock Now,https://www.zacks.com/stock/news/2108776/heres-why-you-should-invest-in-hologic-holx-stock-now,2023-06-15 12:13:00,Investors are optimistic about Hologic (HOLX) on continued strength in GYN Surgical and Breast Health businesses.,BSX,0.186378,0.04728,Neutral
Market Resilient; Big Warning Fuels This Group,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-resilient-after-fed-surprise-tesla-ends-record-run/,2023-06-15 10:19:00,Dow Jones Futures Fall: Market Rally Resilient After Fed Surprise ... Investor's Business Daily ...,BSX,0.108761,0.088149,Neutral
Market Resilient; Big Warning Fuels This Group,https://www.investors.com/market-trend/stock-market-today/market-rally-resilient-after-fed-surprise-tesla-ends-record-run-big-warning-fuels-this-group/,2023-06-15 02:27:00,Market Rally Resilient After Fed Surprise. Tesla Ends Record Run ... Investor's Business Daily ...,BSX,0.113169,0.089467,Neutral
"Unispace: Employees in Hong Kong reluctant to return to the office, with firms missing privacy office setting",https://www.prnewswire.com/apac/news-releases/unispace-employees-in-hong-kong-reluctant-to-return-to-the-office-with-firms-missing-privacy-office-setting-301850484.html,2023-06-15 02:00:00,"• Employers failing to spot burnout with 64% of workers impacted • Among 59% of hot desking employees, 95% prefer their own assigned desk to increase their sense of belongings • 63% of workers currently in the workplace four or more days a week, compared to 50% worldwide and 40% in • 64% of ...",BSX,0.050148,0.221328,Somewhat-Bullish
Health Insurance Stocks Tumble Over Spike In Surgeries Delayed By Pandemic,https://www.forbes.com/sites/katherinehamilton/2023/06/14/health-insurance-stocks-tumble-over-spike-in-surgeries-delayed-by-pandemic/,2023-06-14 17:32:57,UnitedHealth's stock fell 7% Wednesday after saying an uptick in surgeries could squeeze revenues.,BSX,0.107495,-0.04004,Neutral
Centene  ( CNC )  Divests Apixio to Boost Its Core Business,https://www.zacks.com/stock/news/2108394/centene-cnc-divests-apixio-to-boost-its-core-business,2023-06-14 16:37:00,Centene (CNC) completes the sale of Apixio to New Mountain Capital in a bid to dispose of non-core assets and grow its core Managed Care business.,BSX,0.245339,0.209974,Somewhat-Bullish
QIAGEN's  ( QGEN )  QCI Is Used by Danish National Genome Center,https://www.zacks.com/stock/news/2108405/qiagens-qgen-qci-is-used-by-danish-national-genome-center,2023-06-14 15:48:00,"QIAGEN's (QGEN) QCI Interpret offers evidence-based variant interpretation and reporting, and upholds the highest standards for data security and privacy. It also provides testing sites flexibility.",BSX,0.185306,0.028857,Neutral
Here's Why You Should Retain Illumina  ( ILMN )  Stock for Now,https://www.zacks.com/stock/news/2108381/heres-why-you-should-retain-illumina-ilmn-stock-for-now,2023-06-14 15:22:00,Investors are optimistic about Illumina (ILMN) on solid long-term growth potential in the oncology space.,BSX,0.179121,0.035512,Neutral
"Dow Giant's Bad News Hits Insurers, But Sparks This Breakout",https://www.investors.com/news/unitedhealth-bad-news-hits-unh-stock-insurers-but-sparks-surgery-partners-breakout/,2023-06-14 13:03:00,"UnitedHealth's Bad News Hits UNH Stock, Insurers, But Surgery ... Investor's Business Daily ...",BSX,0.166743,0.115274,Neutral
Stock market today: Wall Street drifts ahead of Fed decision on rates,https://apnews.com/article/stock-market-interest-inflation-rates-fed-2d27a2a8fcac13358e21cd9c98f50db0,2023-06-14 05:25:02,Stock market today: Asian stocks mixed after US inflation cools The Associated Press ...,BSX,0.068112,0.085232,Neutral
Stock market today: Wall Street swings to mixed close as Fed hints of rate hikes to come,https://apnews.com/article/stock-market-interest-inflation-rates-fed-2d27a2a8fcac13358e21cd9c98f50db0,2023-06-14 05:25:02,Stock market today: Asian stocks mixed after US inflation cools The Associated Press ...,BSX,0.042122,0.082841,Neutral
CVS Heath  ( CVS )  MinuteClinic Earns 6th Health Care Approval,https://www.zacks.com/stock/news/2107822/cvs-heath-cvs-minuteclinic-earns-6th-health-care-approval,2023-06-13 17:59:00,"CVS Heath's (CVS) MinuteClinic has an in-clinic Net Promotor Score of more than 81, putting it in the top customer rankings.",BSX,0.17813,0.03537,Neutral
"LSI USA Emerging Medtech Summit Returns to Dana Point March 18, 2024",https://www.prnewswire.com/news-releases/lsi-usa-emerging-medtech-summit-returns-to-dana-point-march-18-2024-301849891.html,2023-06-13 17:57:00,"HUNTINGTON BEACH, Calif., June 13, 2023 /PRNewswire/ -- LSI, the company behind LSI Emerging Medtech Summits, the partnering events for global leaders building breakthrough healthcare businesses, today announced it will host its next USA Emerging Medtech Summit, LSI USA '24, on March 18 through ...",BSX,0.074001,0.053388,Neutral
How This IBD Stock Of The Day Is 'Cracking' The Breakout Code,https://www.investors.com/research/ibd-stock-of-the-day/swav-stock-eyes-another-breakout-and-big-growth-on-a-bevy-of-good-news/,2023-06-13 17:12:00,"SWAV Stock Eyes Another Breakout, And 40% Growth, On A Bevy ... Investor's Business Daily ...",BSX,0.133841,-0.103576,Neutral
Here's Why You Should Retain BD  ( BDX )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2107670/heres-why-you-should-retain-bd-bdx-stock-in-your-portfolio,2023-06-13 14:27:00,Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.,BSX,0.208017,0.03975,Neutral
"Catalent  ( CTLT )  Tops Q3 Earnings Estimates, Cuts FY23 View",https://www.zacks.com/stock/news/2107090/catalent-ctlt-tops-q3-earnings-estimates-cuts-fy23-view,2023-06-12 14:43:00,"Catalent (CTLT) records lower revenues in both segments in third-quarter fiscal 2023, resulting in overall soft performance.",BSX,0.190417,-0.007645,Neutral
Cardiac Implantable Electronic Devices Market Surpasses USD 16.1 Bn by 2031 Owing to Surge in Adoption of Implantable Loop Recorder: Transparency Market Research,https://www.benzinga.com/pressreleases/23/06/g32817249/cardiac-implantable-electronic-devices-market-surpasses-usd-16-1-bn-by-2031-owing-to-surge-in-adop,2023-06-12 14:30:00,"Wilmington, Delaware, United States, June 12, 2023 ( GLOBE NEWSWIRE ) -- The global cardiac implantable electronic devices market was valued at USD 10.8 Bn in 2021 and is projected to reach more than USD 16.1 Bn by 2031.",BSX,0.041394,0.155744,Somewhat-Bullish
Teleflex's  ( TFX )  Arrow EZ-IO Needle Receives FDA Approval,https://www.zacks.com/stock/news/2107098/teleflexs-tfx-arrow-ez-io-needle-receives-fda-approval,2023-06-12 13:52:00,Teleflex's (TFX) Arrow EZ-IO Needle is the first and only intraosseous (IO) needle for MR Conditional labelling.,BSX,0.197413,0.038177,Neutral
"Artificial Organ Market Overview 2023-2027: Market Size, Key Trends, And Top Segments As Per The Business Research Company's Artificial Organ Global Market Report 2023",https://www.benzinga.com/pressreleases/23/06/g33062157/artificial-organ-market-overview-2023-2027-market-size-key-trends-and-top-segments-as-per-the-busi,2023-06-29 15:30:00,"LONDON, June 29, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's report on the artificial organ market forecasts the global artificial organ market size is expected to grow from $20.3 billion in 2022 to $22.2 billion in 2023 at a compound annual growth rate ( CAGR ) of more than 9%.",BSX,0.053035,0.275868,Somewhat-Bullish
Walgreens  ( WBA )  to Advance Diabetes Care at FFL Conference,https://www.zacks.com/stock/news/2114837/walgreens-wba-to-advance-diabetes-care-at-ffl-conference,2023-06-29 13:30:00,Walgreens (WBA) will sponsor Children with Diabetes' FFL event to make a difference in the lives of the 122 million individuals afflicted by diabetes and pre-diabetes.,BSX,0.213517,0.04057,Neutral
Three Reasons to Add Surmodics  ( SRDX )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2114312/three-reasons-to-add-surmodics-srdx-stock-to-your-portfolio,2023-06-28 15:31:00,Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.,BSX,0.208914,0.039845,Neutral
Amedisys  ( AMED )  to Advance Value-Based Care With Optum Merger,https://www.zacks.com/stock/news/2114256/amedisys-amed-to-advance-value-based-care-with-optum-merger,2023-06-28 13:21:00,"Amedisys' (AMED) combination with Optum brings together two organizations committed to offering patients and their families compassionate, value-based comprehensive care.",BSX,0.197413,0.038177,Neutral
Here's Why You Should Retain CVS Health  ( CVS )  Stock for Now,https://www.zacks.com/stock/news/2113789/heres-why-you-should-retain-cvs-health-cvs-stock-for-now,2023-06-27 16:34:00,"Investors are optimistic about CVS Health (CVS) backed by the acquisition of Oak Street Health, which broadens its value-based primary care platform.",BSX,0.183546,0.036149,Neutral
McKesson's  ( MCK )  Latest Launch to Give Access to OTC Products,https://www.zacks.com/stock/news/2113766/mckessons-mck-latest-launch-to-give-access-to-otc-products,2023-06-27 15:22:00,McKesson's (MCK) latest launch is expected to meet the evolving needs and growing demand for quality OTC private-label health and wellness products.,BSX,0.261818,0.047757,Neutral
Three Reasons to Add Masimo  ( MASI )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2113659/three-reasons-to-add-masimo-masi-stock-to-your-portfolio,2023-06-27 14:25:00,Masimo's (MASI) solid product suite raises optimism about the stock.,BSX,0.218817,0.041322,Neutral
Boston Scientific Elects Dr. Jessica L. Mega and Susan E. Morano to Board of Directors,https://www.prnewswire.com/news-releases/boston-scientific-elects-dr-jessica-l-mega-and-susan-e-morano-to-board-of-directors-301864104.html,2023-06-27 10:30:00,"MARLBOROUGH, Mass., June 27, 2023 /PRNewswire/ -- Boston Scientific Corporation ( NYSE: BSX ) announced today the election of Dr. Jessica L. Mega and Susan E. Morano to its board of directors, each effective immediately.",BSX,0.453099,0.573727,Bullish
Here's Why Investors Should Retain Abbott  ( ABT )  Stock Now,https://www.zacks.com/stock/news/2113211/heres-why-investors-should-retain-abbott-abt-stock-now,2023-06-26 16:30:00,Investors are optimistic about Abbott (ABT) on continued growth in Diabetes business and upbeat guidance.,BSX,0.200273,0.0386,Neutral
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/earnings/23/06/33007673/heres-how-much-1000-invested-in-boston-scientific-10-years-ago-would-be-worth-today,2023-06-26 15:00:45,"Boston Scientific BSX has outperformed the market over the past 10 years by 8.95% on an annualized basis producing an average annual return of 19.33%. Currently, Boston Scientific has a market capitalization of $77.20 billion.",BSX,0.980595,0.386944,Bullish
Inspire Medical  ( INSP )  Hits 52-Week High: What's Aiding It?,https://www.zacks.com/stock/news/2113103/inspire-medical-insp-hits-52-week-high-whats-aiding-it,2023-06-26 14:50:00,Investors are optimistic about Inspire Medical's (INSP) global presence.,BSX,0.208017,0.03975,Neutral
Masimo's  ( MASI )  W1 to Boost Virtual Care in Preoperative Patients,https://www.zacks.com/stock/news/2113098/masimos-masi-w1-to-boost-virtual-care-in-preoperative-patients,2023-06-26 14:44:00,Masimo's (MASI) W1 advanced health-tracking watch is expected to provide better insights into pre-operative patients' heart rate variability data and improve pre-habilitation.,BSX,0.240489,0.044558,Neutral
"Ultrasound Equipment Market 2023-2027; Segmentation by product type, end-user and geography; CAGR accelerating at 5.24% by 2027- Technavio",https://www.prnewswire.com/news-releases/ultrasound-equipment-market-2023-2027-segmentation-by-product-type-end-user-and-geography-cagr-accelerating-at-5-24-by-2027--technavio-301858395.html,2023-06-23 23:00:00,"Ultrasound Equipment Market 2023-2027. Segmentation by product type, end-user and geography. CAGR accelerating ... PR ...",BSX,0.034984,0.105939,Neutral
Abbott  ( ABT )  FreeStyle Libre 2 Gets Reimbursement in France,https://www.zacks.com/stock/news/2112562/abbott-abt-freestyle-libre-2-gets-reimbursement-in-france,2023-06-23 16:28:00,Abbott's (ABT) FreeStyle Libre increased reimbursement makes it possible for more people in France with diabetes to use the recent CGM technology.,BSX,0.190793,0.037204,Neutral
Reasons to Retain QuidelOrtho  ( QDEL )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2112525/reasons-to-retain-quidelortho-qdel-stock-in-your-portfolio,2023-06-23 16:13:00,Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its product innovation aiding growth.,BSX,0.209365,0.03995,Neutral
Boston Scientific's  ( BSX )  New Launches Aid Amid Cost Pressure,https://www.zacks.com/stock/news/2112440/boston-scientifics-bsx-new-launches-aid-amid-cost-pressure,2023-06-23 14:52:00,Boston Scientific (BSX) remains excited about the rest of 2023 and expects to continue to outpace its peers within the EMEA market.,BSX,0.40375,0.260633,Somewhat-Bullish
Here's How Much a $1000 Investment in Boston Scientific Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2112245/heres-how-much-a-1000-investment-in-boston-scientific-made-10-years-ago-would-be-worth-today,2023-06-23 12:30:06,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",BSX,0.534445,0.386195,Bullish
The Orthopedic Device Market size is to grow by USD 12.11 billion from 2022 to 2027; new product launches coupled with R&D activities are the major trend - Technavio,https://www.prnewswire.com/news-releases/the-orthopedic-device-market-size-is-to-grow-by-usd-12-11-billion-from-2022-to-2027-new-product-launches-coupled-with-rd-activities-are-the-major-trend---technavio-301858321.html,2023-06-23 09:15:00,The Orthopedic Device Market size is to grow by USD 12.11 billion from 2022 to 2027. new product launches coupled ... PR ...,BSX,0.027667,0.07358,Neutral
"The Zacks Analyst Blog Highlights Pfizer, Philip Morris, American Tower, Boston Scientific and Northrop Grumman",https://www.zacks.com/stock/news/2112158/the-zacks-analyst-blog-highlights-pfizer-philip-morris-american-tower-boston-scientific-and-northrop-grumman,2023-06-23 09:00:00,"Pfizer, Philip Morris, American Tower, Boston Scientific and Northrop Grumman are included in this Analyst Blog.",BSX,0.699089,0.0,Neutral
"Top Stock Reports for Pfizer, Philip Morris & American Tower",https://www.zacks.com/research-daily/2111844/top-stock-reports-for-pfizer-philip-morris-american-tower,2023-06-22 18:03:00,"Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Philip Morris International Inc. (PM) and American Tower Corporation (AMT).",BSX,0.11983,0.104147,Neutral
Quest Diagnostics'  ( DGX )  New Buyout Expands Cancer Portfolio,https://www.zacks.com/stock/news/2111989/quest-diagnostics-dgx-new-buyout-expands-cancer-portfolio,2023-06-22 16:35:00,Quest Diagnostics (DGX) will use MRD technology to create new blood-based clinical lab services for solid tumour cancers that will be available starting in 2024.,BSX,0.195814,0.03798,Neutral
Masimo's  ( MASI )  Launch to Serve the Personalized Hearables Market,https://www.zacks.com/stock/news/2111973/masimos-masi-launch-to-serve-the-personalized-hearables-market,2023-06-22 15:33:00,Masimo's (MASI) new product offerings are expected to enable it to expand its footprint in the personalized hearables market.,BSX,0.203215,0.038998,Neutral
Here's Why Buying Brookdale  ( BKD )  Stock is a Prudent Move Now,https://www.zacks.com/stock/news/2111837/heres-why-buying-brookdale-bkd-stock-is-a-prudent-move-now,2023-06-22 14:23:00,"For the second quarter, Brookdale (BKD) expects RevPAR growth to be in the range of 11.5-12%.",BSX,0.184834,0.081509,Neutral
Here's Why Hold Strategy is Apt for The Joint  ( JYNT )  Stock Now,https://www.zacks.com/stock/news/2111817/heres-why-hold-strategy-is-apt-for-the-joint-jynt-stock-now,2023-06-22 14:05:00,The Joint (JYNT) is expected to keep growing due to rising patient visits and new clinic openings.,BSX,0.183895,0.079752,Neutral
"Benign Prostatic Hyperplasia Treatment Market to Grow at a 5.6% CAGR from 2023 to 2031, reaching US$ 11.9 billion: TMR Report",https://www.benzinga.com/pressreleases/23/06/g32964677/benign-prostatic-hyperplasia-treatment-market-to-grow-at-a-5-6-cagr-from-2023-to-2031-reaching-us-,2023-06-22 12:30:00,"Wilmington, Delaware, United States, June 22, 2023 ( GLOBE NEWSWIRE ) -- The global benign prostatic hyperplasia treatment market is anticipated to grow at a 5.6% CAGR from 2023 to 2031. A market valuation of US$ 11.9 billion is expected by the end of the forecast period.",BSX,0.036643,0.0,Neutral
Continence Care Market to Exceed $25 Billion by 2031 with Over 5% CAGR: According to a TMR study,https://www.benzinga.com/pressreleases/23/06/g32962170/continence-care-market-to-exceed-25-billion-by-2031-with-over-5-cagr-according-to-a-tmr-study,2023-06-22 10:30:00,"Wilmington, Delaware, United States, June 22, 2023 ( GLOBE NEWSWIRE ) -- The global market for continence care was estimated to have reached a market valuation of around US$ 14 billion in 2020. The market is likely to garner a steady 5.7% CAGR from 2021 to 2031 and by 2031, the market is likely ...",BSX,0.039224,-0.063581,Neutral
QIAGEN's  ( QGEN )  ForenSeq MainstAY Workflow Gets FBI Nod,https://www.zacks.com/stock/news/2111418/qiagens-qgen-forenseq-mainstay-workflow-gets-fbi-nod,2023-06-21 16:50:00,QIAGEN's (QGEN) ForenSeq MainstAY workflow is a cost-effective substitute for analyzing short tandem repeats with capillary electrophoresis and facilitates volume casework for sexual assault cases.,BSX,0.201105,0.038723,Neutral
Cardinal Health  ( CAH )  Hits 52-Week High: What's Aiding It?,https://www.zacks.com/stock/news/2111341/cardinal-health-cah-hits-52-week-high-whats-aiding-it,2023-06-21 15:35:00,Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.,BSX,0.207571,0.039683,Neutral
Avanos'  ( AVNS )  Latest Buyout to Boost Its RF Product Offering,https://www.zacks.com/stock/news/2111282/avanos-avns-latest-buyout-to-boost-its-rf-product-offering,2023-06-21 15:10:00,Avanos' (AVNS) latest acquisition is expected to strengthen its foothold with a comprehensive suite of RF offerings.,BSX,0.232996,0.043482,Neutral
The Joint  ( JYNT )  Buys Wisconsin Regional Developer Zone Rights,https://www.zacks.com/stock/news/2111147/the-joint-jynt-buys-wisconsin-regional-developer-zone-rights,2023-06-21 12:27:00,"The Joint (JYNT) expects the Wisconsin region to hold a total of 53 clinics, of which 21 are currently operating.",BSX,0.262052,0.097724,Neutral
Align's  ( ALGN )  Invisalign Sales Grow Globally Amid Margin Woe,https://www.zacks.com/stock/news/2110683/aligns-algn-invisalign-sales-grow-globally-amid-margin-woe,2023-06-20 15:44:00,Align (ALGN) is confident about a largely untapped market opportunity for digital orthodontics and restorative dentistry.,BSX,0.213517,0.042349,Neutral
3 Reasons to Add HealthEquity  ( HQY )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2110761/3-reasons-to-add-healthequity-hqy-stock-in-your-portfolio,2023-06-20 15:43:00,Investors continue to be optimistic about HealthEquity's (HQY) strength in HSA.,BSX,0.213517,0.04053,Neutral
PacBio's  ( PACB )  New Tie-Up to Boost Rare Disease Research,https://www.zacks.com/stock/news/2110759/pacbios-pacb-new-tie-up-to-boost-rare-disease-research,2023-06-20 15:41:00,PacBio's (PACB) latest collaboration is expected to highlight the feasibility and cost-effectiveness of using its HiFi sequencing technology.,BSX,0.223866,0.042116,Neutral
Orthofix  ( OFIX )  Advances in ALIF Procedure With New Launch,https://www.zacks.com/stock/news/2110678/orthofix-ofix-advances-in-alif-procedure-with-new-launch,2023-06-20 15:39:00,"Orthofix (OFIX) WaveForm A interbody features a wave-like design, providing a balance of strength, porosity and stability, along with a large implant graft aperture for bone graft material.",BSX,0.187463,0.038329,Neutral
Quest Diagnostics  ( DGX )  Partners to Offer New Testing Service,https://www.zacks.com/stock/news/2110739/quest-diagnostics-dgx-partners-to-offer-new-testing-service,2023-06-20 15:22:00,Quest Diagnostics' (DGX) latest test indicates how different genes and their variants affect how a person reacts to drugs.,BSX,0.217834,0.043021,Neutral
Here's Why You Should Buy Boston Scientific  ( BSX )  Stock,https://www.zacks.com/stock/news/2110733/heres-why-you-should-buy-boston-scientific-bsx-stock,2023-06-20 15:19:00,"Investors are optimistic about Boston Scientific's (BSX) strong improvement in organic sales, indicating a solid rebound in the legacy business.",BSX,0.367412,0.402096,Bullish
3 Reasons to Retain PacBio  ( PACB )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2118221/3-reasons-to-retain-pacbio-pacb-stock-in-your-portfolio,2023-07-07 16:04:00,PacBio's (PACB) product development activities raise optimism about the stock.,BSX,0.213988,0.04064,Neutral
Reasons to Retain AMN Healthcare  ( AMN )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2117601/reasons-to-retain-amn-healthcare-amn-stock-in-your-portfolio,2023-07-06 15:21:00,Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.,BSX,0.211191,0.040223,Neutral
Peering Into Boston Scientific's Recent Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/07/33122026/peering-into-boston-scientifics-recent-short-interest,2023-07-05 19:46:16,"Boston Scientific's BSX short percent of float has fallen 29.07% since its last report. The company recently reported that it has 8.72 million shares sold short, which is 0.61% of all regular shares that are available for trading.",BSX,0.221819,0.083071,Neutral
DexCom's  ( DXCM )  G7 CGM System Gets Nod From Health Canada,https://www.zacks.com/stock/news/2117001/dexcoms-dxcm-g7-cgm-system-gets-nod-from-health-canada,2023-07-05 14:01:00,"DexCom's (DXCM) G7 CGM System's latest approval by Health Canada is expected to combine simplicity and power, thereby providing a better way to manage diabetes.",BSX,0.21258,0.040391,Neutral
LabCorp  ( LH )  Partners With Forge Biologics for Gene Therapies,https://www.zacks.com/stock/news/2117036/labcorp-lh-partners-with-forge-biologics-for-gene-therapies,2023-07-05 13:54:00,"LabCorp's (LH) latest partnership will significantly assist patients gain access to cutting-edge, potentially life-saving medication.",BSX,0.208017,0.03969,Neutral
3 Reasons to Retain NextGen  ( NXGN )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2116525/3-reasons-to-retain-nextgen-nxgn-stock-in-your-portfolio,2023-07-04 14:52:00,NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.,BSX,0.210274,0.040086,Neutral
Here's Why You Should Buy Exact Sciences  ( EXAS )  Stock Now,https://www.zacks.com/stock/news/2116561/heres-why-you-should-buy-exact-sciences-exas-stock-now,2023-07-04 14:40:00,Investors are optimistic about Exact Sciences (EXAS) on strong Cologuard growth and raised guidance.,BSX,0.211191,0.038475,Neutral
McKesson  ( MCK )  Hits 52-Week High: What's Driving the Stock?,https://www.zacks.com/stock/news/2116077/mckesson-mck-hits-52-week-high-whats-driving-the-stock,2023-07-03 15:38:00,Investors are optimistic about McKesson's (MCK) strength in its Biologics business.,BSX,0.218325,0.041288,Neutral
Integer Holdings  ( ITGR )  Hits 52-Week High: What's Aiding It?,https://www.zacks.com/stock/news/2116078/integer-holdings-itgr-hits-52-week-high-whats-aiding-it,2023-07-03 15:36:00,Investors are optimistic about Integer Holdings' (ITGR) solid foothold in the broader MedTech space.,BSX,0.213517,0.04057,Neutral
Acadia Healthcare  ( ACHC )  Inks JV to Better Serve New Hampshire,https://www.zacks.com/stock/news/2116136/acadia-healthcare-achc-inks-jv-to-better-serve-new-hampshire,2023-07-03 15:29:00,Acadia Healthcare (ACHC) enters into a JV with New Hampshire-based SolutionHealth to build a behavioral health facility and address the dire need for advanced behavioral health services across the state.,BSX,0.270373,0.164397,Somewhat-Bullish
Quest Diagnostics  ( DGX )  Presents New Data on Disease Testing,https://www.zacks.com/stock/news/2116092/quest-diagnostics-dgx-presents-new-data-on-disease-testing,2023-07-03 14:55:00,Quest Diagnostics (DGX) is dedicated to create cutting-edge laboratory tests to help assess patient risk for dementia and other degenerative diseases.,BSX,0.18856,0.036915,Neutral
Here's Why You Should Invest in Neogen  ( NEOG )  Stock Now,https://www.zacks.com/stock/news/2116022/heres-why-you-should-invest-in-neogen-neog-stock-now,2023-07-03 13:35:00,Investors are upbeat about Neogen (NEOG) owing to strong performance across its Animal Safety and Food Safety segments.,BSX,0.194242,0.03607,Neutral
"Heart Valve Devices Market to Cross USD 8.7 billion in 2031, expanding at a CAGR of 11.9%: TMR Report",https://www.benzinga.com/pressreleases/23/07/g33096509/heart-valve-devices-market-to-cross-usd-8-7-billion-in-2031-expanding-at-a-cagr-of-11-9-tmr-report,2023-07-03 13:30:00,"Wilmington, Delaware, United States, July 03, 2023 ( GLOBE NEWSWIRE ) -- In 2021, the global heart valve devices market was estimated to be worth US$ 8.7 billion. From 2022 to 2031, the global market is expected to increase at an 11.9% CAGR. The global market for heart valve devices is expected ...",BSX,0.077343,0.16437,Somewhat-Bullish
Medical Technologies Market size to grow at a CAGR of 8.3% from 2022 to 2027|Frequent product launches in IVDs to be a major driver - Technavio,https://www.prnewswire.com/news-releases/medical-technologies-market-size-to-grow-at-a-cagr-of-8-3-from-2022-to-2027frequent-product-launches-in-ivds-to-be-a-major-driver---technavio-301868814.html,2023-07-03 09:47:00,Medical Technologies Market size to grow at a CAGR of 8.3% from 2022 to 2027|Frequent product launches in IVDs to ... PR ...,BSX,0.033006,-0.131191,Neutral
AI helping remove Chinese goods made with Uyghur forced labor from corporate supply chains,https://www.foxbusiness.com/technology/ai-helping-remove-chinese-goods-made-with-uyghur-forced-labor-corporate-supply-chains,2023-07-01 20:05:53,is playing a role in helping companies and government agencies remove products from the supply chain that are suspected of being tainted by the use of Uyghur-forced labor in China.,BSX,0.033656,-0.013473,Neutral
Baxter's  ( BAX )  New Launch to Support Complex Critical Care Needs,https://www.zacks.com/stock/news/2115409/baxters-bax-new-launch-to-support-complex-critical-care-needs,2023-06-30 14:45:00,Baxter's (BAX) Progressa+ bed for the ICU is expected to enhance workflow and reduce strain on nursing resources.,BSX,0.244723,0.04523,Neutral
Thermo Fisher's  ( TMO )  New Launch to Advance Cancer Therapies,https://www.zacks.com/stock/news/2115391/thermo-fishers-tmo-new-launch-to-advance-cancer-therapies,2023-06-30 13:06:00,Thermo Fisher's (TMO) Gibco OncoPro Tumoroid Culture Medium Kit is intended to increase researchers' access to sophisticated cancer models.,BSX,0.189298,0.036986,Neutral
Glaukos'  ( GKOS )  New Tie-Up to Address Chronic Eye Disease,https://www.zacks.com/stock/news/2124006/glaukos-gkos-new-tie-up-to-address-chronic-eye-disease,2023-07-19 16:43:00,"Glaukos' (GKOS) new partnership is expected to advance next-generation wearable patient engagement and diagnostic technology, thereby making the detection of eye diseases more efficient.",BSX,0.222838,0.090816,Neutral
"Elevance Health  ( ELV )  Beats on Q2 Earnings, Ups '23 Profit View",https://www.zacks.com/stock/news/2123983/elevance-health-elv-beats-on-q2-earnings-ups-23-profit-view,2023-07-19 15:21:00,Elevance Health's (ELV) Q2 results benefit from an expanding customer base and solid pharmacy product revenues. Adjusted net income is expected to be more than $32.85 per share for 2023.,BSX,0.07104,0.083624,Neutral
Align Technology  ( ALGN )  to Post Q2 Earnings: What's in Store?,https://www.zacks.com/stock/news/2123527/align-technology-algn-to-post-q2-earnings-whats-in-store,2023-07-19 12:58:00,Align Technology's (ALGN) second-quarter 2023 results are likely to highlight sustained stability across its Clear Aligner business.,BSX,0.119038,0.052855,Neutral
Here's Why You Should Add BD  ( BDX )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2123156/heres-why-you-should-add-bd-bdx-stock-in-your-portfolio,2023-07-18 16:20:00,BD's (BDX) slew of product launches raises optimism about the stock.,BSX,0.217346,0.041102,Neutral
Masimo's  ( MASI )  Preliminary Q2 Revenues Dampened by Lower Sales,https://www.zacks.com/stock/news/2123143/masimos-masi-preliminary-q2-revenues-dampened-by-lower-sales,2023-07-18 16:07:00,"Masimo's (MASI) second-quarter 2023 results are likely to have been dampened by the postponement of orders and increased hospital labor costs, among others.",BSX,0.213517,0.133699,Neutral
What's in Store for Thermo Fisher  ( TMO )  in Q2 Earnings?,https://www.zacks.com/stock/news/2123161/whats-in-store-for-thermo-fisher-tmo-in-q2-earnings,2023-07-18 15:23:00,"Thermo Fisher (TMO) is likely to have generated growth in the second quarter, driven by a favorable business mix and new launches.",BSX,0.075161,0.075691,Neutral
Inogen  ( INGN )  Inks Buyout Agreement to Expand Product Portfolio,https://www.zacks.com/stock/news/2122318/inogen-ingn-inks-buyout-agreement-to-expand-product-portfolio,2023-07-17 16:46:00,Inogen's (INGN) latest acquisition is expected to leverage its commercial infrastructure and capabilities as well as potentially address a large growing bronchiectasis market.,BSX,0.207127,0.085764,Neutral
Intuitive Surgical  ( ISRG )  Hits 52-Week High: What's Aiding It?,https://www.zacks.com/stock/news/2122309/intuitive-surgical-isrg-hits-52-week-high-whats-aiding-it,2023-07-17 16:42:00,Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.,BSX,0.21686,0.087112,Neutral
Boston Scientific  ( BSX )  Gets FDA Nod for Vercise Software,https://www.zacks.com/stock/news/2122168/boston-scientific-bsx-gets-fda-nod-for-vercise-software,2023-07-17 14:35:00,Boston Scientific's (BSX) Vercise Neural Navigator 5 Software has an improved user interface that presents patient data in an easier-to-understand style and enables better therapy delivery.,BSX,0.256179,0.318535,Somewhat-Bullish
"Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical's Board of Directors - BioPlus Acquisition  ( NASDAQ:BIOS ) ",https://www.benzinga.com/pressreleases/23/07/g33246012/renown-cardiologist-and-professor-ian-t-meredith-md-to-join-avertix-medicals-board-of-directors,2023-07-17 12:00:10,Recently served as Boston Scientific Executive Vice President and Global Chief Medical Officer Professor Meredith brings to Avertix over 35 years of cardiology experience and commitment to advancing cardiac care,BSX,0.056011,0.045012,Neutral
They Lost Their Legs. Doctors and Health Care Giants Profited.,https://www.nytimes.com/2023/07/15/health/atherectomy-peripheral-artery-disease.html,2023-07-15 09:00:50,Medical device makers have bankrolled a cottage industry of doctors and clinics that perform artery-clearing procedures that can lead to amputations.,BSX,0.021031,0.085506,Neutral
"UnitedHealth Group  ( UNH )  Q2 Earnings Beat, Boosts '23 EPS View",https://www.zacks.com/stock/news/2121564/unitedhealth-group-unh-q2-earnings-beat-boosts-23-eps-view,2023-07-14 16:00:00,UnitedHealth Group's (UNH) Q2 results benefited on the back of solid contributions from the UnitedHealthcare and Optum segments. Management presently forecasts adjusted net EPS within $24.70-$25.00 for 2023.,BSX,0.078482,0.076026,Neutral
Inogen's  ( INGN )  Preliminary Q2 Revenues Dampened by Lower Sales,https://www.zacks.com/stock/news/2121411/inogens-ingn-preliminary-q2-revenues-dampened-by-lower-sales,2023-07-14 15:01:00,Inogen's (INGN) revenue growth in the second quarter is likely to have been hampered by lower revenues in its business-to-business and direct-to-consumer channels.,BSX,0.319933,0.186343,Somewhat-Bullish
Thermo Fisher  ( TMO )  Launches Diomni Enterprise Software,https://www.zacks.com/stock/news/2121468/thermo-fisher-tmo-launches-diomni-enterprise-software,2023-07-14 14:40:00,"Thermo Fisher's (TMO) Diomni Enterprise Software effortlessly connects each individual processing stage to a single, integrated platform.",BSX,0.233556,0.041674,Neutral
"AngioDynamics  ( ANGO )  Q4 Earnings Lag Estimates, Revenues Top",https://www.zacks.com/stock/news/2120780/angiodynamics-ango-q4-earnings-lag-estimates-revenues-top,2023-07-13 15:59:00,AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in fourth-quarter fiscal 2023.,BSX,0.141102,0.053697,Neutral
Here's Why You Should Retain Merit Medical  ( MMSI )  Stock for Now,https://www.zacks.com/stock/news/2120777/heres-why-you-should-retain-merit-medical-mmsi-stock-for-now,2023-07-13 15:56:00,Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.,BSX,0.20279,0.038973,Neutral
CVS Health  ( CVS )  Launches Caremark Cost Saver With a New Pact,https://www.zacks.com/stock/news/2120858/cvs-health-cvs-launches-caremark-cost-saver-with-a-new-pact,2023-07-13 15:42:00,CVS Health (CVS) is able to dynamically shop for the lowest price on its clients' behalf with the help of Caremark Cost Saver solution.,BSX,0.204936,0.037583,Neutral
VREX vs. BSX: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2120754/vrex-vs-bsx-which-stock-is-the-better-value-option,2023-07-13 15:40:13,Investors with an interest in Medical - Products stocks have likely encountered both VAREX IMAGING ( VREX Quick QuoteVREX - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer ...,BSX,0.616447,0.591744,Bullish
"Disposable Endoscope Market to grow by USD 1,523.59 million from 2022 to 2027| Ambu AS, Boston Scientific Corp., Coloplast Corp., and more to emerge as key players -Technavio.",https://www.prnewswire.com/news-releases/disposable-endoscope-market-to-grow-by-usd-1-523-59-million-from-2022-to-2027-ambu-as-boston-scientific-corp-coloplast-corp-and-more-to-emerge-as-key-players--technavio-301875856.html,2023-07-13 08:15:00,"Disposable Endoscope Market to grow by USD 1,523.59 million from 2022 to 2027| Ambu AS, Boston Scientific Corp ... PR ...",BSX,0.064362,0.065041,Neutral
Illumina's  ( ILMN )  Latest Launch to Boost Genomics Analysis,https://www.zacks.com/stock/news/2120109/illuminas-ilmn-latest-launch-to-boost-genomics-analysis,2023-07-12 16:18:00,"Illumina's (ILMN) DRAGEN v4.2 is expected to improve the identification of genetic disease causes, drug discovery and population genomics.",BSX,0.261818,0.047713,Neutral
Alcon  ( ALC )  Hits 52-Week High: What's Driving the Stock?,https://www.zacks.com/stock/news/2120134/alcon-alc-hits-52-week-high-whats-driving-the-stock,2023-07-12 15:41:00,"Investors are bullish about Alcon (ALC) owing to solid demand, strong commercial execution and pricing improvements across the Surgical and Vision Care franchises.",BSX,0.213048,0.03874,Neutral
DaVita  ( DVA )  Hits 52-Week High: What's Driving the Stock?,https://www.zacks.com/stock/news/2119343/davita-dva-hits-52-week-high-whats-driving-the-stock,2023-07-11 15:54:00,Investors are optimistic about DaVita's (DVA) strength in its kidney care.,BSX,0.223866,0.042076,Neutral
"Alcon  ( ALC )  Surgical End Market Grows, Vision Care Sales Rise",https://www.zacks.com/stock/news/2118730/alcon-alc-surgical-end-market-grows-vision-care-sales-rise,2023-07-10 15:17:00,"In Equipment, Alcon (ALC) continues to upgrade and expand its installed base with the CENTURION and LEGION devices.",BSX,0.229149,0.041044,Neutral
Here's Why Investors Should Hold Align Technology  ( ALGN )  Now,https://www.zacks.com/stock/news/2118775/heres-why-investors-should-hold-align-technology-algn-now,2023-07-10 15:07:00,Investors are optimistic about Align Technology's (ALGN) Invisalign portfolio expansion and strategic alliances.,BSX,0.198221,-0.009544,Neutral
Why You Should Add Humana  ( HUM )  Stock to Your Portfolio Now,https://www.zacks.com/stock/news/2118718/why-you-should-add-humana-hum-stock-to-your-portfolio-now,2023-07-10 14:59:00,Humana's (HUM) strength in Individual Medicare Advantage business and state-based contract wins are likely to be major tailwinds.,BSX,0.155451,0.101048,Neutral
Quest Diagnostics'  ( DGX )  New Pact to Get Home Fertility Test,https://www.zacks.com/stock/news/2118729/quest-diagnostics-dgx-new-pact-to-get-home-fertility-test,2023-07-10 14:15:00,The Proov Confirm home collection kit can be purchased now on Quest Diagnostics' questhealth.com for $29.,BSX,0.201105,0.038723,Neutral
Route 92 Medical Announces Appointment of Chris Hartman as Chief Commercial Officer,https://www.benzinga.com/pressreleases/23/07/g33165215/route-92-medical-announces-appointment-of-chris-hartman-as-chief-commercial-officer,2023-07-10 13:00:00,"SAN MATEO, Calif., July 10, 2023 ( GLOBE NEWSWIRE ) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Chris Hartman to the role of Chief Commercial Officer.",BSX,0.083833,0.051397,Neutral
BD  ( BDX )  Gears Up for Q3 Earnings: What's in the Offing?,https://www.zacks.com/stock/news/2129655/bd-bdx-gears-up-for-q3-earnings-whats-in-the-offing,2023-07-28 17:43:00,Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited Q3 sales.,BSX,0.097325,0.09598,Neutral
Acadia Healthcare  ( ACHC )  Q2 Earnings Beat on Higher Admissions,https://www.zacks.com/stock/news/2129653/acadia-healthcare-achc-q2-earnings-beat-on-higher-admissions,2023-07-28 16:42:00,Acadia Healthcare's (ACHC) Q2 results indicate improved patient days and revenue per patient day. Management expects 2023 adjusted EPS of $3.25-$3.50.,BSX,0.107495,0.088997,Neutral
Endoprosthesis Market size to grow by USD 18.24 billion from 2022 to 2027|Growth driven by increasing prevalence of ... - PR Newswire,https://www.prnewswire.com/news-releases/endoprosthesis-market-size-to-grow-by-usd-18-24-billion-from-2022-to-2027growth-driven-by-increasing-prevalence-of-orthopedic-diseases-and-associated-risk-factors---technavio-301886538.html,2023-07-28 02:00:00,Endoprosthesis Market size to grow by USD 18.24 billion from 2022 to 2027|Growth driven by increasing prevalence of ... PR ...,BSX,0.037446,0.039495,Neutral
"Molina  ( MOH )  Q2 Earnings Beat on High Premiums, '23 View Raised",https://www.zacks.com/stock/news/2128957/molina-moh-q2-earnings-beat-on-high-premiums-23-view-raised,2023-07-27 16:43:00,"Molina Healthcare's (MOH) second-quarter results are aided by increased membership, and Medicaid and Medicare strength.",BSX,0.162437,0.094561,Neutral
"Boston Scientific  ( BSX )  Q2 Earnings Beat, Margins Improve",https://www.zacks.com/stock/news/2128921/boston-scientific-bsx-q2-earnings-beat-margins-improve,2023-07-27 15:53:00,Boston Scientific's (BSX) organic and operational revenues at its respective core business segments and geographies rise in the second quarter.,BSX,0.290607,0.348556,Somewhat-Bullish
Boston Scientific Q2 Earnings Surpass Estimates - Here's How It Foresees FY23 - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/earnings/23/07/33418393/boston-scientific-q2-earnings-surpass-estimates-heres-how-it-foresees-fy23,2023-07-27 15:02:56,"Boston Scientific Corp BSX generated Q2 revenues of $3.59 billion, beating the Wall Street estimate of $3.50 billion. The sales increased 11% on a reported basis, 12% on an operational basis, and 11.6% on an organic basis, beating the management of approximately 6.5%-8.5% ( 7-9% organic ) .",BSX,0.769861,0.313025,Somewhat-Bullish
"Medical Giant Boston Scientific Reports 20% EPS Gain, Ups Guidance",https://www.investors.com/news/technology/bsx-stock-near-buy-point-boston-scientific-earnings-beat-medical-giant-raises-guidance/,2023-07-27 12:16:00,BSX Stock Near Buy Point: Boston Scientific Earnings Beat. Medical Giant Raises Guidance Investor's Business Daily ...,BSX,0.901057,0.465408,Bullish
Boston Scientific  ( BSX )  Q2 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2128595/boston-scientific-bsx-q2-earnings-and-revenues-beat-estimates,2023-07-27 11:55:09,"Boston Scientific (BSX) delivered earnings and revenue surprises of 8.16% and 2.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",BSX,0.397098,0.245519,Somewhat-Bullish
Boston Scientific lifts annual profit forecast on heart devices strength,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-lifts-annual-profit-forecast-heart-devices-strength-2023-07-27/,2023-07-27 11:55:00,"July 27 ( Reuters ) - Boston Scientific ( BSX.N ) raised its annual profit forecast for a second straight quarter on Thursday, banking on resilient demand for its cardiovascular devices as surgical procedure volumes pick up pace.",BSX,0.522333,0.402982,Bullish
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2023,https://www.prnewswire.com/news-releases/boston-scientific-announces-results-for-second-quarter-2023-301887271.html,2023-07-27 10:34:00,"MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation ( NYSE: BSX ) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational1 basis and 11.6 percent on an organic2 basis, all ...",BSX,0.241124,0.206947,Somewhat-Bullish
"Medical Device Stocks' Q2 Earnings on Jul 27: BSX, LH & IART",https://www.zacks.com/stock/news/2128010/medical-device-stocks-q2-earnings-on-jul-27-bsx-lh-iart,2023-07-26 15:04:00,"Medical Device companies' second-quarter results are likely to reflect a year-over-year decline. Let's see how BSX, LH and IART fare this time.",BSX,0.307924,0.452664,Bullish
5 Must-Buy Stocks Ahead of Q2 Earnings Tomorrow,https://www.zacks.com/stock/news/2127620/5-must-buy-stocks-ahead-of-q2-earnings-tomorrow,2023-07-26 11:46:00,"We have narrowed our search to five stocks that are set to declare second-quarter earnings results on Jul 27, before market open. These are: HON, BSX, AOS, SPGI, ATHM.",BSX,0.267315,0.254921,Somewhat-Bullish
"Product recalls threaten Medtronic's position in implantable cardioverter defibrillator market, says GlobalData",https://www.financialexpress.com/healthcare/medicaldevices/product-recalls-threaten-medtronics-position-in-implantable-cardioverter-defibrillator-market-says-globaldata/3186520/,2023-07-26 01:30:00,"Medtronic recently issued a recall for its nearly 350,000 implantable cardioverter defibrillator ( ICD ) devices, which include product lines such as Cobalt, Evera and Visia. These products are their most prominent devices and, in the past, have established Medtronic as the market leader, ...",BSX,0.222838,0.196745,Somewhat-Bullish
Will Growing Customer Base Aid Centene  ( CNC )  in Q2 Earnings?,https://www.zacks.com/stock/news/2127235/will-growing-customer-base-aid-centene-cnc-in-q2-earnings,2023-07-25 15:59:00,"Centene's (CNC) Q2 results are likely to reflect growing Medicaid and Marketplace membership, coupled with an improved HBR, partly offset by escalating medical expenses.",BSX,0.106541,0.051832,Neutral
Zimmer Biomet  ( ZBH )  Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release,https://www.zacks.com/stock/news/2126979/zimmer-biomet-zbh-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q2-release,2023-07-25 14:01:29,Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,BSX,0.173645,0.047247,Neutral
"Critical Limb Ischemia Treatment Market to Grow at an 8.03% CAGR from 2023 to 2031, reaching USD 3.49 billion: TMR Report",https://www.benzinga.com/pressreleases/23/07/g33349539/critical-limb-ischemia-treatment-market-to-grow-at-an-8-03-cagr-from-2023-to-2031-reaching-usd-3-4,2023-07-24 16:00:00,"Wilmington, Delaware, United States, July 24, 2023 ( GLOBE NEWSWIRE ) -- The global critical limb ischemia treatment market is anticipated to grow at 8.03 % CAGR from 2023 to 2031. A market valuation of US$ 3.49 billion by 2031.",BSX,0.037098,0.119485,Neutral
BD  ( BDX )  Receives FDA Nod to Address Critical Infusion Needs,https://www.zacks.com/stock/news/2126245/bd-bdx-receives-fda-nod-to-address-critical-infusion-needs,2023-07-24 15:26:00,The latest regulatory clearance for BD's (BDX) Alaris Infusion System is expected to improve healthcare system efficiency via better care coordination and utilization of actionable information.,BSX,0.18602,0.084785,Neutral
Reasons to Add HealthEquity  ( HQY )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2126244/reasons-to-add-healthequity-hqy-stock-to-your-portfolio,2023-07-24 15:24:00,HealthEquity's (HQY) strength in HSA raises optimism about the stock.,BSX,0.211652,0.13282,Neutral
How Is The Market Feeling About Boston Scientific? - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/07/33346840/how-is-the-market-feeling-about-boston-scientific,2023-07-24 14:00:24,"Boston Scientific's BSX short percent of float has fallen 3.28% since its last report. The company recently reported that it has 8.48 million shares sold short, which is 0.59% of all regular shares that are available for trading.",BSX,0.221819,0.083071,Neutral
Are Medical Stocks Lagging Boston Scientific  ( BSX )  This Year?,https://www.zacks.com/stock/news/2126079/are-medical-stocks-lagging-boston-scientific-bsx-this-year,2023-07-24 13:40:11,Here is how Boston Scientific (BSX) and DexCom (DXCM) have performed compared to their sector so far this year.,BSX,0.745397,0.45367,Bullish
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2125981/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings,2023-07-24 12:50:06,The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.,BSX,0.251032,0.269613,Somewhat-Bullish
What's in the Cards for Universal Health  ( UHS )  in Q2 Earnings?,https://www.zacks.com/stock/news/2125549/whats-in-the-cards-for-universal-health-uhs-in-q2-earnings,2023-07-21 16:03:00,"Universal Health's (UHS) Q2 results are likely to benefit from higher patient volumes at its acute care hospitals and behavioral health facilities, partly offset by increased physician expenses.",BSX,0.104455,0.136919,Neutral
"Boston Scientific Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/boston-scientific-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-07-21 07:00:00,"Boston Scientific ( BSX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Friday, with an increase from 79 to 82. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.",BSX,0.673107,0.520509,Bullish
Will Boston Scientific  ( BSX )  Beat Q2 Earnings Estimates?,https://www.zacks.com/stock/news/2124911/will-boston-scientific-bsx-beat-q2-earnings-estimates,2023-07-20 16:46:00,"Boston Scientific (BSX) is expected to have registered strong growth in EMEA within structural heart, including TAVR, WATCHMAN and other interventional cardiology therapies.",BSX,0.349329,0.426553,Bullish
Avantor's  ( AVTR )  New Expansion Plans to Boost Workflow,https://www.zacks.com/stock/news/2124825/avantors-avtr-new-expansion-plans-to-boost-workflow,2023-07-20 15:39:00,Avantor's (AVTR) latest expansion plans are likely to aid customers in creating customized workflow solutions.,BSX,0.232996,0.094085,Neutral
Boston Scientific  ( BSX )  Reports Next Week: Wall Street Expects Earnings Growth,https://www.zacks.com/stock/news/2124585/boston-scientific-bsx-reports-next-week-wall-street-expects-earnings-growth,2023-07-20 14:02:36,Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,BSX,0.297661,0.241319,Somewhat-Bullish
Boston Scientific Receives FDA Approval for the POLARx™ Cryoablation System,https://www.prnewswire.com/news-releases/boston-scientific-receives-fda-approval-for-the-polarx-cryoablation-system-301896170.html,2023-08-08 20:01:00,"MARLBOROUGH, Mass., Aug. 8, 2023 /PRNewswire/ -- Boston Scientific Corporation ( NYSE: BSX ) today announced it has received U.S. Food and Drug Administration ( FDA ) approval for the POLARx™ Cryoablation System.",BSX,0.196132,0.237096,Somewhat-Bullish
Here's Why You Should Invest in Medtronic  ( MDT )  Stock Now,https://www.zacks.com/stock/news/2133796/heres-why-you-should-invest-in-medtronic-mdt-stock-now,2023-08-08 15:21:00,Investors are optimistic about Medtronic (MDT) on strong growth prospects within the Neurosurgery portfolio and upbeat 2024 guidance.,BSX,0.040969,0.096299,Neutral
Stocks This Week: Hold Netflix And Sell Short Boston Scientific,https://www.forbes.com/sites/greatspeculations/2023/08/07/stocks-this-week-hold-netflix-and-sell-short-boston-scientific/,2023-08-07 10:00:00,"Over the near term, the indices are likely to move higher into the 14th. The autumn correction will not be hard on many stocks such as Netflix.",BSX,0.195814,-0.119058,Neutral
"Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges - Edwards Lifesciences  ( NYSE:EW ) , Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/news/23/08/33588733/barrons-weekend-stock-picks-paypal-nikola-and-icahn-enterprises-challenges,2023-08-05 21:13:49,"Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In ""Ozempic Is the Rage.",BSX,0.263942,-0.265792,Somewhat-Bearish
Medical imaging market size to grow by USD 12.87 billion from 2022 to 2027 | Increasing prevalence of chronic ... - PR Newswire,https://www.prnewswire.com/news-releases/medical-imaging-market-size-to-grow-by-usd-12-87-billion-from-2022-to-2027--increasing-prevalence-of-chronic-conditions-drives-growth---technavio-301893116.html,2023-08-04 16:00:00,Medical imaging market size to grow by USD 12.87 billion from 2022 to 2027 | Increasing prevalence of chronic ... PR ...,BSX,0.033562,0.145207,Neutral
Want to be a contrarian stock investor? This market pro shares his secrets.,https://www.marketwatch.com/story/want-to-be-a-contrarian-stock-investor-this-market-pro-shares-his-secrets-34c97e43,2023-08-04 11:20:00,These 3 tactics contribute to this contrarian-minded mutual fund's outperformance.,BSX,0.100729,0.063757,Neutral
Boston Scientific Sees RS Rating Climb To 72,https://www.investors.com/ibd-data-stories/boston-scientific-sees-rs-rating-climb-to-72/,2023-08-04 07:00:00,"Boston Scientific ( BSX ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, with an upgrade from 67 to 72. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",BSX,0.716023,0.556855,Bullish
Mobile health solutions market to grow at a CAGR of 27.09% from 2022 to 2027 | Increasing smartphone penetration will drive growth - Technavio,https://www.benzinga.com/pressreleases/23/08/n33534424/mobile-health-solutions-market-to-grow-at-a-cagr-of-27-09-from-2022-to-2027-increasing-smartphone-,2023-08-02 21:15:00,"NEW YORK, Aug. 2, 2023 /PRNewswire/ -- The mobile health solutions market size is estimated to grow by USD 256.69 billion from 2022 to 2027, at a CAGR of 27.09% according to Technavio. Download a Sample Report! Coverage: Parent market analysis. key drivers, major trends, and challenges.",BSX,0.086297,0.070871,Neutral
"Atherosclerosis Market to Witness Growth by 2032, Estimates DelveInsight | Leading Companies - CSL Behring, Novartis, Merck, Amgen, Ionis , BioMarin, AstraZeneca",https://www.prnewswire.com/news-releases/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight--leading-companies---csl-behring-novartis-merck-amgen-ionis--biomarin-astrazeneca-301891245.html,2023-08-02 21:01:00,"Atherosclerosis Market to Witness Growth by 2032, Estimates DelveInsight | Leading Companies - CSL Behring ... PR ...",BSX,0.028868,-0.085973,Neutral
"Privia Health Announces Changes to Board of Directors - Boston Scientific  ( NYSE:BSX ) , Cardinal Health  ( NYSE:CAH ) ",https://www.benzinga.com/pressreleases/23/07/g33469013/privia-health-announces-changes-to-board-of-directors,2023-07-31 13:00:00,"ARLINGTON, Va., July 31, 2023 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. PRVA today announced the election of David S. Wichmann and Pamela O. Kimmet to its Board of Directors, effective August 1, 2023.",BSX,0.096477,0.064094,Neutral
Nerve Repair and Regeneration Global Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/nerve-repair-and-regeneration-global-market-is-expected-to-showcase-a-significant-growth-at-a-cagr-of-9-by-2028--delveinsight-301903232.html,2023-08-17 21:01:00,Nerve Repair and Regeneration Global Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by ... PR ...,BSX,0.142847,0.09051,Neutral
Foresight Diagnostics Strengthens Leadership Team with Addition of Chief Business Officer John Truesdell,https://www.prnewswire.com/news-releases/foresight-diagnostics-strengthens-leadership-team-with-addition-of-chief-business-officer-john-truesdell-301901694.html,2023-08-17 11:00:00,"AURORA, Colo., Aug. 17, 2023 /PRNewswire/ -- Foresight Diagnostics, a leading provider of ultrasensitive cancer detection tests, today announced the appointment of John Truesdell as Chief Business Officer. John comes to Foresight most recently from SeQure Dx, where he served as Chief Business ...",BSX,0.072435,0.137025,Neutral
Boston Scientific  ( NYSE:BSX )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/08/17/boston-scientific-nysebsx-coverage-initiated-at-stocknews-com.html,2023-08-17 06:38:47,"Research analysts at StockNews.com started coverage on shares of Boston Scientific ( NYSE:BSX - Get Free Report ) in a research note issued on Thursday. The firm set a ""buy"" rating on the medical equipment provider's stock. Several other analysts have also recently weighed in on the company.",BSX,0.683539,0.445659,Bullish
"Intracardiac Echocardiography Market to Surpass USD 979.5 million by 2031, Expanding at a CAGR of 5.3%: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33877672/intracardiac-echocardiography-market-to-surpass-usd-979-5-million-by-2031-expanding-at-a-cagr-of-5,2023-08-16 15:16:53,"Wilmington, Delaware, United States, Aug. 16, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global intracardiac echocardiography market is projected to flourish at a CAGR of 5.3% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 979.5 million is ...",BSX,0.040899,0.0,Neutral
Here's Why You Should Invest in Edward Lifesciences  ( EW )  Now,https://www.zacks.com/stock/news/2136848/heres-why-you-should-invest-in-edward-lifesciences-ew-now,2023-08-16 12:41:00,Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of a solid foundation for innovative therapies.,BSX,0.049835,-0.066389,Neutral
Stock Upgrades: Penumbra Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-penumbra-shows-rising-relative-strength-4/,2023-08-16 07:00:00,"On Wednesday, Penumbra ( PEN ) received a positive adjustment to its Relative Strength ( RS ) Rating, from 73 to 81. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",BSX,0.329551,0.0,Neutral
Boston Scientific's  ( BSX )  POLARx System Gets FDA Approval,https://www.zacks.com/stock/news/2136460/boston-scientifics-bsx-polarx-system-gets-fda-approval,2023-08-15 13:38:00,Boston Scientific's (BSX) POLARx enables doctors to expand and modify the new POLARx catheter to match a patient's unique anatomy during an ablation treatment.,BSX,0.106305,0.165243,Somewhat-Bullish
Stocks Showing Improved Relative Strength: Penumbra,https://www.investors.com/ibd-data-stories/stocks-showing-improved-relative-strength-penumbra-3/,2023-08-15 07:00:00,"Penumbra ( PEN ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Tuesday, rising from 63 to 73. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.",BSX,0.306963,0.0,Neutral
LivaNova Shows Improved Relative Strength; Still Shy Of Benchmark,https://www.investors.com/ibd-data-stories/livanova-shows-improved-relative-strength-still-shy-of-benchmark/,2023-08-15 07:00:00,LivaNova Shows Improved Relative Strength. Still Shy Of Benchmark Investor's Business Daily ...,BSX,0.294093,0.0,Neutral
The Medical Aesthetics Market to grow at a CAGR of 8.6% from 2022 to 2027; Increasing global awareness about ... - PR Newswire,https://www.prnewswire.com/news-releases/the-medical-aesthetics-market-to-grow-at-a-cagr-of-8-6-from-2022-to-2027-increasing-global-awareness-about-medical-aesthetics-to-boost-market-growth---technavio-301898792.html,2023-08-14 09:00:00,The Medical Aesthetics Market to grow at a CAGR of 8.6% from 2022 to 2027. Increasing global awareness about ... PR ...,BSX,0.056674,0.0,Neutral
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33754935/boston-scientifics-farapulse-eyes-stronger-us-market-position-with-potential-fda-ap,2023-08-11 16:53:18,Boston Scientific Corp BSX will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation ( PFA ) system at the 2023 European Society of Cardiology Congress on 27 August. ADVENT is a randomized clinical trial comparing Farapulse PFA to thermal ablation.,BSX,0.60326,0.254131,Somewhat-Bullish
How Is The Market Feeling About Boston Scientific? - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/08/33677043/how-is-the-market-feeling-about-boston-scientific,2023-08-09 19:30:31,"Boston Scientific's BSX short percent of float has fallen 13.56% since its last report. The company recently reported that it has 7.36 million shares sold short, which is 0.51% of all regular shares that are available for trading.",BSX,0.221819,0.083071,Neutral
The Spinal Implants and Surgical Devices Market size to grow at a CAGR of 5.3% from 2022 to 2027; Technological ... - PR Newswire,https://www.prnewswire.com/news-releases/the-spinal-implants-and-surgical-devices-market-size-to-grow-at-a-cagr-of-5-3-from-2022-to-2027-technological-advancements-are-a-major-trend---technavio-301895596.html,2023-08-09 07:00:00,The Spinal Implants and Surgical Devices Market size to grow at a CAGR of 5.3% from 2022 to 2027. Technological ... PR ...,BSX,0.042346,0.103516,Neutral
"Stocks making the biggest moves midday: RPT Realty, Mister Car Wash, Boston Scientific, 3M and more",https://www.cnbc.com/2023/08/28/stocks-making-the-biggest-moves-midday-rpt-mcw-bsx-mmm.html,2023-08-28 16:51:17,These are the stocks posting the largest moves in midday trading.,BSX,0.16117,0.029789,Neutral
Boston Scientific Jumps On Positive Surprise On Farapulse For AFIB Ablation - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/23/08/34072014/boston-scientific-jumps-on-positive-surprise-on-farapulse-for-afib-ablation,2023-08-28 15:43:38,"Signal ( s ) to enter, add, reduce, exit, hold or change. Boston Scientific BSX stock is jumping 6.25% to $53.92 as of this writing on a positive surprise from ADVENT study. Farapulse Pulsed Field Ablation is a system in which electric fields selectively ablate heart tissue in patients with ...",BSX,0.629492,0.551124,Bullish
Stock Market Starts Fresh Week On A High Note; 3M Stock Lifts The Dow,https://www.investors.com/market-trend/stock-market-today/stock-market-starts-fresh-week-on-a-high-note-3m-stock-lifts-the-dow/,2023-08-28 14:49:00,Stock Market Starts Fresh Week On A High Note. 3M Stock Lifts The ... Investor's Business Daily ...,BSX,0.121037,0.046409,Neutral
"Jabil, Boston Scientific, Hersha Hospitality Trust And Other Big Stocks Moving Higher On Monday - Aehr Test Systems  ( NASDAQ:AEHR ) , Applied Optoelectronics  ( NASDAQ:AAOI ) ",https://www.benzinga.com/news/23/08/34070133/jabil-boston-scientific-hersha-hospitality-trust-and-other-big-stocks-moving-higher-on-monday,2023-08-28 14:44:43,"U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Monday. Here are some big stocks recording gains in today's session. Hersha Hospitality Trust HT shares gained 56.5% to $9.82 after it announced a merger with KSL Capital Partners LLC, an investor in travel and leisure ...",BSX,0.337811,0.286615,Somewhat-Bullish
Boston Scientific Surges As It Looks To Enter A Nearly $8 Billion Market,https://www.investors.com/news/technology/bsx-stock-surges-as-it-looks-to-enter-a-nearly-8-billion-market/,2023-08-28 14:09:00,Boston Scientific Surges As It Looks To Enter A Nearly $8 Billion ... Investor's Business Daily ...,BSX,0.682689,-0.132441,Neutral
"German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals - Bayer  ( OTC:BAYRY ) , Bayer  ( OTC:BAYZF ) ",https://www.benzinga.com/general/biotech/23/08/34066835/german-pharma-firm-bayers-new-parkinsons-treatment-shows-promise-what-the-phase-1-trial-reveals,2023-08-28 14:02:46,"Boston Scientific Corporation BSX released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation ( PFA ) System, a nonthermal treatment in which electric fields selectively ablate ( remove body tissue surgically ) heart tissue in patients with atrial fibrillation ...",BSX,0.299478,0.214396,Somewhat-Bullish
Why Is Boston Scientific Stock Trading Higher Today? - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/08/34067516/why-is-boston-scientific-stock-trading-higher-today,2023-08-28 13:59:05,"Boston Scientific Corporation BSX released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation ( PFA ) System, a nonthermal treatment in which electric fields selectively ablate ( remove body tissue surgically ) heart tissue in patients with atrial fibrillation ...",BSX,0.306963,0.218544,Somewhat-Bullish
ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints,https://markets.businessinsider.com/news/stocks/advent-study-of-the-farapulse-pulsed-field-ablation-system-meets-primary-efficacy-and-safety-endpoints-1032584042,2023-08-27 10:44:01,Findings presented at ESC Congress 2023 and simultaneously published in The New England Journal of Medicine,BSX,0.21803,0.201785,Somewhat-Bullish
ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints,https://www.prnewswire.com/news-releases/advent-study-of-the-farapulse-pulsed-field-ablation-system-meets-primary-efficacy-and-safety-endpoints-301910636.html,2023-08-27 10:13:00,Findings presented at ESC Congress 2023 and simultaneously published in The New England Journal of Medicine,BSX,0.179254,0.174506,Somewhat-Bullish
StockNews.com Downgrades Boston Scientific  ( NYSE:BSX )  to Hold,https://www.defenseworld.net/2023/08/25/stocknews-com-downgrades-boston-scientific-nysebsx-to-hold.html,2023-08-25 05:26:52,"Boston Scientific ( NYSE:BSX - Get Free Report ) was downgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued to investors on Friday. Other research analysts have also issued research reports about the stock.",BSX,0.800944,0.47642,Bullish
Peripheral Artery Disease Global Market to Surpass USD 54 Billion Mark by 2027 | DelveInsight,https://www.prnewswire.com/news-releases/peripheral-artery-disease-global-market-to-surpass-usd-54-billion-mark-by-2027--delveinsight-301908812.html,2023-08-24 21:01:00,The global peripheral artery disease market is expanding rapidly due to reasons such as the growing geriatric population and the rising prevalence of peripheral artery disease and arteriosclerosis worldwide.,BSX,0.053569,0.002,Neutral
Boston Scientific  ( BSX )  Expands Globally Amid FX Concerns,https://www.zacks.com/stock/news/2140289/boston-scientific-bsx-expands-globally-amid-fx-concerns,2023-08-24 14:40:00,Boston Scientific's (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and pulmonary treatment options.,BSX,0.580245,0.471609,Bullish
Which Is A Better Buy - Boston Scientific Stock Or Abbott?,https://www.forbes.com/sites/greatspeculations/2023/08/24/which-is-a-better-buy--boston-scientific-stock-or-abbott/,2023-08-24 13:00:35,"Sharpe is a measure of return per unit of risk, and high-performance portfolios can provide the best of both worlds.",BSX,0.791298,0.303416,Somewhat-Bullish
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year,https://www.investors.com/news/technology/boston-scientific-reaches-80-plus-relative-strength-rating-benchmark/,2023-08-23 21:32:00,Boston Scientific Stock Rises. Profit Pops 56% Investor's Business Daily ...,BSX,0.822,0.300046,Somewhat-Bullish
"Target, Pinterest And 2 Other Stocks Insiders Are Selling - Boston Scientific  ( NYSE:BSX ) , Pinterest  ( NYSE:PINS ) ",https://www.benzinga.com/news/23/08/34003746/target-pinterest-and-2-other-stocks-insiders-are-selling,2023-08-23 13:12:23,"The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",BSX,0.402618,-0.153612,Somewhat-Bearish
Boston Scientific Reaches 80-Plus Relative Strength Rating Benchmark,https://www.investors.com/ibd-data-stories/boston-scientific-reaches-80-plus-relative-strength-rating-benchmark/,2023-08-23 07:00:00,Boston Scientific Reaches 80-Plus Relative Strength Rating ... Investor's Business Daily ...,BSX,0.804025,0.495065,Bullish
Medtronic raises forecast as demand for heart devices powers upbeat results,https://www.reuters.com/business/healthcare-pharmaceuticals/medtronic-raises-annual-forecast-demand-medical-procedures-picks-up-2023-08-22/,2023-08-22 11:53:00,"Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",BSX,0.132368,0.0,Neutral
Pain Management Devices Market size to grow by USD 2.70 billion from 2022 to 2027 | Technological advances in ... - PR Newswire,https://www.prnewswire.com/news-releases/pain-management-devices-market-size-to-grow-by-usd-2-70-billion-from-2022-to-2027--technological-advances-in-ablation-devices-are-major-trends---technavio-301904152.html,2023-08-19 04:15:00,Pain Management Devices Market size to grow by USD 2.70 billion from 2022 to 2027 | Technological advances in ... PR ...,BSX,0.048425,-0.103848,Neutral
Boston Scientific  ( BSX )  WATCHMAN FLX Pro Gets FDA Approval,https://www.zacks.com/stock/news/2146187/boston-scientific-bsx-watchman-flx-pro-gets-fda-approval,2023-09-07 15:16:00,"Boston Scientific's (BSX) latest device features a polymer coating, visualization markers and a broader size matrix to treat a wider range of patients.",BSX,0.208914,0.280816,Somewhat-Bullish
Stock Upgrades: LivaNova Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-livanova-shows-rising-relative-strength-3/,2023-09-07 07:00:00,"When considering what names to put on your watch list, look for stocks with an 80 or higher RS Rating. LivaNova ( LIVN ) just cleared that benchmark with an upgrade from 80 to 83. As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.",BSX,0.358152,0.0,Neutral
Stocks Showing Rising Market Leadership: Penumbra Earns 84 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-rising-market-leadership-penumbra-earns-84-rs-rating/,2023-09-07 07:00:00,Stocks Showing Rising Market Leadership: Penumbra Earns 84 RS ... Investor's Business Daily ...,BSX,0.345674,0.0,Neutral
A Look Into Boston Scientific Inc's Price Over Earnings - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/09/34287525/a-look-into-boston-scientific-incs-price-over-earnings,2023-09-06 17:00:16,"In the current session, the stock is trading at $53.55, after a 0.47% increase. Over the past month, Boston Scientific Inc. BSX stock increased by 4.88%, and in the past year, by 25.38%.",BSX,0.532941,0.435468,Bullish
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2145006/heres-why-you-should-retain-boston-scientific-bsx-now,2023-09-05 15:59:00,Investors are optimistic about Boston Scientific (BSX) on growth in the legacy business and upbeat guidance.,BSX,0.25142,0.326973,Somewhat-Bullish
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick,https://www.zacks.com/stock/news/2144855/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick,2023-09-05 13:50:07,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",BSX,0.493128,0.285811,Somewhat-Bullish
"10x Genomics Clears Technical Benchmark, Hitting 90-Plus RS Rating",https://www.investors.com/ibd-data-stories/10x-genomics-clears-technical-benchmark-hitting-90-plus-rs-rating/,2023-09-05 07:00:00,"On Tuesday, 10x Genomics ( TXG ) got an upgrade to its Relative Strength ( RS ) Rating, from 87 to 91. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",BSX,0.355588,0.146337,Neutral
"U.S. Implantable Medical Devices Market to Expand at a 9.5% CAGR from 2023 to 2028, Reaching a Value of US$ 48.3 billion Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/09/g34211012/u-s-implantable-medical-devices-market-to-expand-at-a-9-5-cagr-from-2023-to-2028-reaching-a-value-,2023-09-04 14:30:00,"Wilmington, Delaware, United States, Sept. 04, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The U.S. implantable medical devices market is slated to reach US$ 30.7 billion by 2023. From 2023 to 2028, the industry is forecast to expand at a 9.5% CAGR to reach US$ 48.3 billion.",BSX,0.036091,0.0,Neutral
Absorbable Sutures Market size to grow by USD 622.72 million from 2022 to 2027 | The number of surgical procedures ... - PR Newswire,https://www.prnewswire.com/news-releases/absorbable-sutures-market-size-to-grow-by-usd-622-72-million-from-2022-to-2027--the-number-of-surgical-procedures-globally-drives-market-growth---technavio-301916016.html,2023-09-04 11:00:00,Absorbable Sutures Market size to grow by USD 622.72 million from 2022 to 2027 | The number of surgical procedures ... PR ...,BSX,0.05387,0.0,Neutral
Boston Scientific  ( NYSE:BSX )  Downgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/09/02/boston-scientific-nysebsx-downgraded-by-stocknews-com-to-hold.html,2023-09-02 07:32:43,"Boston Scientific ( NYSE:BSX - Get Free Report ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a report issued on Saturday.",BSX,0.773419,0.418909,Bullish
Boston Scientific's  ( BSX )  FARAPULSE System Study Data Positive,https://www.zacks.com/stock/news/2143849/boston-scientifics-bsx-farapulse-system-study-data-positive,2023-09-01 14:54:00,Boston Scientific's (BSX) FARAPULSE PFA System's performance in the trial is an encouraging sign of the potential utilization of the device in the United States.,BSX,0.252987,0.260749,Somewhat-Bullish
Looking Into Boston Scientific's Recent Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/08/34150633/looking-into-boston-scientifics-recent-short-interest,2023-08-31 16:15:15,"Boston Scientific's BSX short percent of float has risen 5.26% since its last report. The company recently reported that it has 8.72 million shares sold short, which is 0.6% of all regular shares that are available for trading.",BSX,0.221819,0.155473,Somewhat-Bullish
The Coronary Atherectomy Devices Market Is Expected To Grow At A Rate Of More Than 8% With The Rise In Cardiovascular Diseases - By The Business Research Company,https://www.prnewswire.com/news-releases/the-coronary-atherectomy-devices-market-is-expected-to-grow-at-a-rate-of-more-than-8-with-the-rise-in-cardiovascular-diseases--by-the-business-research-company-301914925.html,2023-08-31 15:40:00,The Coronary Atherectomy Devices Market Is Expected To Grow At A Rate Of More Than 8% With The Rise In ... PR ...,BSX,0.064797,0.162278,Somewhat-Bullish
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS,https://www.globenewswire.com/news-release/2023/08/31/2735263/0/en/GLUCOTRACK-ANNOUNCES-THE-APPOINTMENT-OF-ERIN-CARTER-TO-BOARD-OF-DIRECTORS.html,2023-08-31 12:30:00,"Rutherford, NJ, Aug. 31, 2023 ( GLOBE NEWSWIRE ) -- Glucotrack, Inc. ( Nasdaq: GCTK ) ( ""Glucotrack"" or the ""Company"" ) , a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has appointed Erin Carter to its Board ...",BSX,0.097062,0.052963,Neutral
"$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today - Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/news/earnings/23/08/34120296/1000-invested-in-this-stock-10-years-ago-would-be-worth-5-000-today,2023-08-30 16:30:23,"Boston Scientific BSX has outperformed the market over the past 10 years by 6.92% on an annualized basis producing an average annual return of 17.54%. Currently, Boston Scientific has a market capitalization of $80.31 billion.",BSX,0.980595,0.386944,Bullish
"If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now",https://www.zacks.com/stock/news/2142300/if-you-invested-1000-in-boston-scientific-a-decade-ago-this-is-how-much-itd-be-worth-now,2023-08-30 12:30:04,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",BSX,0.529659,0.323985,Somewhat-Bullish
Laparoscopy Devices Market is Projected to Hit USD 16.4 Billion at a Healthy CAGR of 6.5% by 2030 - Report by Transparency Market Research,https://www.benzinga.com/pressreleases/23/08/g34108095/laparoscopy-devices-market-is-projected-to-hit-usd-16-4-billion-at-a-healthy-cagr-of-6-5-by-2030-r,2023-08-30 07:42:36,"Wilmington, Delaware, United States, Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- The global laparoscopy devices market is projected to flourish at a CAGR of 6.5% from 2020 to 2030. As per the report published by TMR, a valuation of US$ 16.4 billion is anticipated for the market in 2031.",BSX,0.0428,-0.171195,Somewhat-Bearish
PBH vs. BSX: Which Stock Should Value Investors Buy Now?,https://www.zacks.com/stock/news/2141994/pbh-vs-bsx-which-stock-should-value-investors-buy-now,2023-08-29 15:40:06,PBH vs. BSX: Which Stock Is the Better Value Option?,BSX,0.694939,0.633749,Bullish
"Company News for Aug 29, 2023",https://www.zacks.com/stock/news/2141830/company-news-for-aug-29-2023,2023-08-29 13:35:00,Companies in The News Are: ...,BSX,0.546745,0.333902,Somewhat-Bullish
"Quiet Streak, Scary Inflation Monster, SentinelOne Watch, Fed SVB Fallout, China",https://realmoney.thestreet.com/markets/quiet-streak-scary-inflation-monster-sentinelone-watch-fed-svb-fallout-china-16132034,2023-08-29 11:53:17,"The S&P 500 and Nasdaq Composite have both now suffered three-week losing streaks. Both have also hit stiff resistance at their respective 50-day simple moving averages. However, on the bright side, our two most important equity indexes have now also put together back-to-back ""up"" days. Don't ...",BSX,0.049939,0.238671,Somewhat-Bullish
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/earnings/23/09/34589624/100-invested-in-this-stock-10-years-ago-would-be-worth-400-today,2023-09-14 17:30:20,"Boston Scientific BSX has outperformed the market over the past 10 years by 6.04% on an annualized basis producing an average annual return of 16.08%. Currently, Boston Scientific has a market capitalization of $77.56 billion.",BSX,0.980595,0.386944,Bullish
PBH vs. BSX: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2149023/pbh-vs-bsx-which-stock-is-the-better-value-option,2023-09-14 15:40:07,Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare ( PBH Quick QuotePBH - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two companies is the best option for those looking for undervalued stocks?,BSX,0.690822,0.561548,Bullish
"Percutaneous Coronary Intervention Guidance Devices Market Revenue to Cross USD 23.5 billion by 2031, Expanding at a 6.1% CAGR: TMR Report",https://www.benzinga.com/pressreleases/23/09/g34578437/percutaneous-coronary-intervention-guidance-devices-market-revenue-to-cross-usd-23-5-billion-by-20,2023-09-14 12:30:00,"Wilmington, Delaware, United States, Sept. 14, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The percutaneous coronary intervention guidance devices market was estimated to have acquired US$ 12.2 billion in 2021.",BSX,0.04076,0.0,Neutral
Is Boston Scientific A Better Pick Over Altria Stock?,https://www.forbes.com/sites/greatspeculations/2023/09/14/is-boston-scientific-a-better-pick-over-altria-stock/,2023-09-14 11:00:40,"We believe that Boston Scientific stock (NYSE: BSX) is a better pick over Altria stock (NYSE: MO), given its better prospects.",BSX,0.769014,0.353297,Bullish
Stocks Showing Market Leadership: Neogen Earns 91 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-market-leadership-neogen-earns-91-rs-rating/,2023-09-14 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Neogen ( NEOG ) , which saw a positive improvement to its Relative Strength ( RS ) Rating on Thursday, with an increase from 86 to 91.",BSX,0.2872,0.123807,Neutral
Innovations and Opportunities in European Healthcare Technologies,https://investingnews.com/innovations-and-opportunities-in-european-healthcare-technologies/,2023-09-14 04:19:26,These advanced European technologies are often only distributed and implemented exclusively within the European Union. The good news is that it doesn't need to stay this way.,BSX,0.021718,0.131751,Neutral
Price Over Earnings Overview: Boston Scientific - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/09/34539553/price-over-earnings-overview-boston-scientific,2023-09-13 14:45:21,"In the current market session, Boston Scientific Inc. BSX stock price is at $53.24, after a 0.34% decrease. However, over the past month, the company's stock spiked by 3.47%, and in the past year, by 26.17%.",BSX,0.434142,0.301415,Somewhat-Bullish
Coronary Stents Market worth $13.87 Billion by 2025 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/09/g34536532/coronary-stents-market-worth-13-87-billion-by-2025-exclusive-report-by-the-insight-partners,2023-09-13 13:23:47,"Pune, India, Sept. 13, 2023 ( GLOBE NEWSWIRE ) -- Coronary stents are a kind of little mesh metal tubes that are developed for providing support to the weakened arteries within the heart.",BSX,0.035502,-0.015663,Neutral
"10x Genomics Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/10x-genomics-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-09-13 07:00:00,"On Wednesday, 10x Genomics ( TXG ) hit an important performance benchmark, with its Relative Strength ( RS ) Rating moving into the 80-plus percentile with an upgrade to 84, a rise from 77 the day before. X When looking for the best stocks to buy and watch, keep a close on eye on relative ...",BSX,0.340915,0.0,Neutral
Integer Holdings Shows Market Leadership With Jump To 82 RS Rating,https://www.investors.com/ibd-data-stories/integer-holdings-shows-market-leadership-with-jump-to-82-rs-rating/,2023-09-12 07:00:00,Integer Holdings Shows Market Leadership With Jump To 82 RS ... Investor's Business Daily ...,BSX,0.380012,0.0,Neutral
Neogen Shows Rising Price Performance With Jump To 82 RS Rating,https://www.investors.com/ibd-data-stories/neogen-shows-rising-price-performance-with-jump-to-82-rs-rating/,2023-09-11 07:00:00,"Neogen ( NEOG ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Monday, rising from 79 to 82. X As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.",BSX,0.320974,0.0,Neutral
"Jim Cramer Says 'Entertainment Stocks Are So Hated': Here's One That's 'Not Expensive Anymore' - Boston Scientific  ( NYSE:BSX ) , Devon Energy  ( NYSE:DVN ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/09/34939031/jim-cramer-says-entertainment-stocks-are-so-hated-heres-one-thats-not-expensive-anymore,2023-09-27 12:53:41,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Devon Energy Corporation's DVN stock is ""low enough, it had a bad quarter, it's being punished endlessly, that's wrong."" When asked about TransMedics Group, Inc.",BSX,0.448842,-0.0725,Neutral
Weill Cornell Medicine and MEDX Xelerator Sign Xplore Program Agreement,https://www.benzinga.com/pressreleases/23/09/n34943024/weill-cornell-medicine-and-medx-xelerator-sign-xplore-program-agreement,2023-09-27 11:00:00,"NEW YORK and OR YEHUDA, Israel, Sept. 27, 2023 /PRNewswire/ -- Weill Cornell Medicine Enterprise Innovation and MEDX Xelerator have signed a venture creation agreement.",BSX,0.096283,0.230603,Somewhat-Bullish
"Endoscopy Procedures Market Size worth $53.19 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/09/g34912197/endoscopy-procedures-market-size-worth-53-19-billion-globally-by-2030-exclusive-report-by-the-insi,2023-09-26 14:35:28,"Pune, India, Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- Endoscopy is a minimally invasive procedure used to examine a person's digestive tract through the mouth, anus, or in small incisions. The procedure uses an endoscope, a flexible tube with a light and camera attached.",BSX,0.032825,0.143827,Neutral
Is Boston Scientific  ( BSX )  Outperforming Other Medical Stocks This Year?,https://www.zacks.com/stock/news/2155422/is-boston-scientific-bsx-outperforming-other-medical-stocks-this-year,2023-09-26 13:40:09,Here is how Boston Scientific (BSX) and Conmed (CNMD) have performed compared to their sector so far this year.,BSX,0.771935,0.390483,Bullish
Exclusive: Edwards Lifesciences targeted in EU antitrust raid last week - sources,https://www.reuters.com/business/healthcare-pharmaceuticals/edwards-lifesciences-targeted-eu-antitrust-raid-sept-19-sources-2023-09-26/,2023-09-26 11:52:00,Exclusive: Edwards Lifesciences targeted in EU antitrust raid on Sept 19 - sources ...,BSX,0.114682,0.0,Neutral
"Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... - PR Newswire",https://www.prnewswire.com/news-releases/electrophysiology-catheters-market-size-to-grow-by-usd-2-24-billion-from-2022-2027-abbott-laboratories-acutus-medical-inc-and-johnson-and-johnson-are-some-of-the-major-companies-in-the-market---technavio-301936344.html,2023-09-25 21:15:00,"Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... PR ...",BSX,0.063933,0.070037,Neutral
"Leading Companies Like Medtronic, Abbott Laboratories, and Boston Scientific Corp. Spearhead Innovation in the Neuroprosthetics Market Amid Technological Advancements and Regulatory Support",https://www.prnewswire.com/news-releases/leading-companies-like-medtronic-abbott-laboratories-and-boston-scientific-corp-spearhead-innovation-in-the-neuroprosthetics-market-amid-technological-advancements-and-regulatory-support-301937588.html,2023-09-25 16:30:00,"Leading Companies Like Medtronic, Abbott Laboratories, and Boston Scientific Corp. Spearhead Innovation in the ... PR ...",BSX,0.071145,0.13405,Neutral
"The Zacks Analyst Blog Highlights Amazon.com, Boeing, Regeneron, Boston Scientific and Waste Management",https://www.zacks.com/stock/news/2154908/the-zacks-analyst-blog-highlights-amazoncom-boeing-regeneron-boston-scientific-and-waste-management,2023-09-25 13:07:00,"Amazon.com, Boeing, Regeneron, Boston Scientific and Waste Management are part of the Zacks top Analyst Blog.",BSX,0.146469,0.037354,Neutral
Ziptek LLC Makes Strides in Medtech at the New York Venture Forum - PR Newswire,https://www.prnewswire.com/news-releases/ziptek-llc-makes-strides-in-medtech-at-the-new-york-venture-forum-301937446.html,2023-09-25 12:35:00,Ziptek LLC Makes Strides in Medtech at the New York Venture Forum PR ...,BSX,0.088799,0.18148,Somewhat-Bullish
"HP, Amazon And 2 Other Stocks Insiders Are Selling - Best Buy Co  ( NYSE:BBY ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/09/34861824/hp-amazon-and-2-other-stocks-insiders-are-selling,2023-09-25 12:31:55,"The Nasdaq 100 closed slightly higher on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",BSX,0.167904,0.167783,Somewhat-Bullish
Boston Scientific  ( BSX )  Set to Acquire Relievant Medsystems,https://www.zacks.com/stock/news/2154695/boston-scientific-bsx-set-to-acquire-relievant-medsystems,2023-09-25 12:31:00,Boston Scientific's (BSX) new M&A deal is likely to broaden the Neuromodulation business portfolio.,BSX,0.316439,0.237923,Somewhat-Bullish
"Laparoscopic Devices Market to grow by USD 4.39 billion from 2022-2027, North America to account for 36% of market ... - PR Newswire",https://www.prnewswire.com/news-releases/laparoscopic-devices-market-to-grow-by-usd-4-39-billion-from-2022-2027--north-america-to-account-for-36-of-market-growth---technavio-301935797.html,2023-09-24 10:35:00,"Laparoscopic Devices Market to grow by USD 4.39 billion from 2022-2027, North America to account for 36% of market ... PR ...",BSX,0.108466,0.110819,Neutral
"Zoom Video, eBay And 2 Other Stocks Insiders Are Selling - eBay  ( NASDAQ:EBAY ) , Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/news/23/09/34820722/zoom-video-ebay-and-2-other-stocks-insiders-are-selling,2023-09-22 11:46:53,"The Nasdaq 100 closed lower by around 275 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",BSX,0.443626,0.083093,Neutral
Boston Scientific's 'Next Level' Long-Term Plans: Why 2 Analysts Boost Price Targets - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/large-cap/23/09/34797693/boston-scientifics-next-level-long-term-plans-why-2-analysts-boost-price-targets,2023-09-21 16:52:35,"Boston Scientific Corporation BSX CEO Mike Mahoney set the theme at the company's 2023 Investor Day event as ""next level,' stating that his goal was to make Boston Scientific a ""compelling"" and ""fantastic place to be 10 years from now.""",BSX,0.641573,0.533437,Bullish
Jim Cramer's top 10 things to watch in the stock market Thursday,https://www.cnbc.com/2023/09/21/jim-cramers-top-10-things-to-watch-in-the-stock-market-thursday.html,2023-09-21 13:02:23,"Investors are digesting the latest update from the Federal Reserve Wednesday, including the likelihood of leaving rates higher for longer.",BSX,0.123844,0.0,Neutral
"CrowdStrike Holdings To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Thursday - Atlas Lithium  ( NASDAQ:ATLX ) , Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/news/23/09/34789056/crowdstrike-holdings-to-rally-over-31-here-are-10-other-analyst-forecasts-for-thursday,2023-09-21 11:48:00,"Needham increased the price target for CrowdStrike Holdings, Inc. CRWD from $200 to $215. Needham analyst Alex Henderson maintained a Buy rating. CrowdStrike shares fell 1% to close at $163.89 on Wednesday. Raymond James raised FedEx Corporation FDX price target from $270 to $279.",BSX,0.285526,0.404728,Bullish
Boston Scientific Reaches 80-Plus Relative Strength Rating Benchmark,https://www.investors.com/ibd-data-stories/boston-scientific-reaches-80-plus-relative-strength-rating-benchmark-2/,2023-09-21 07:00:00,Boston Scientific Reaches 80-Plus Relative Strength Rating ... Investor's Business Daily ...,BSX,0.642555,0.022299,Neutral
Stock Market Falls Apart In Final Hour; Pinterest Bucks The Trend,https://www.investors.com/market-trend/stock-market-today/stock-market-skittish-after-fed-leaves-rates-pinterest-stock-rallies/,2023-09-20 20:34:00,Stock Market Falls Apart In Final Hour. Pinterest Bucks The Trend Investor's Business Daily ...,BSX,0.101154,0.142061,Neutral
Atrion Corporation Announces Election of New Director - Atrion  ( NASDAQ:ATRI ) ,https://www.benzinga.com/pressreleases/23/09/g34773341/atrion-corporation-announces-election-of-new-director,2023-09-20 20:29:46,"ALLEN, Texas, Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- Atrion Corporation ATRI announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies.",BSX,0.388879,0.060136,Neutral
Atrion Corporation Announces Election of New Director,https://www.globenewswire.com/news-release/2023/09/20/2746868/0/en/Atrion-Corporation-Announces-Election-of-New-Director.html,2023-09-20 20:29:00,"ALLEN, Texas, Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- Atrion Corporation ( NASDAQ: ATRI ) announced the election today of Jeannette Bankes as a director, effective immediately.",BSX,0.414559,0.062976,Neutral
"Medtech Giant Briefly Hits A Buy Zone, But Investor Day Hype Cools",https://www.investors.com/news/technology/bsx-stock-briefly-hits-buy-zone-but-investor-day-hype-cools/,2023-09-20 14:37:00,"Boston Scientific ( BSX ) kicked off its Investor Day on Wednesday, a day after announcing the acquisition of pain expert Relievant Medsystems, and BSX stock launched briefly into a buy zone.",BSX,0.860547,0.165202,Somewhat-Bullish
3 Best Janus Mutual Funds to Invest In,https://www.zacks.com/stock/news/2152914/3-best-janus-mutual-funds-to-invest-in,2023-09-20 10:52:00,"Invest in Janus mutual funds such as JANEX, JNGLX and JDPAX, which have demonstrated a track record of delivering impressive returns.",BSX,0.065506,0.067072,Neutral
6 Healthcare Stocks Analysts Still Like,https://www.barrons.com/articles/healthcare-stocks-analysts-like-8b0f4dd2,2023-09-20 07:00:00,"This has been an epically bad year for the healthcare sector, but there are still a few stocks out there that Wall Street analysts like. Some of them are even more beaten down than the rest of the industry. The S&P 500 Health Care sector index is down 3% this year, vastly behind the S&P 500, ...",BSX,0.16171,0.059347,Neutral
Boston Scientific to buy chronic back pain therapy maker Relievant,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-pay-850-mln-upfront-buy-relievant-medsystems-2023-09-19/,2023-09-19 13:48:00,Boston Scientific to buy chronic back pain therapy maker ...,BSX,0.716023,0.114223,Neutral
OXOS Medical taps medtech transformational leader Jeff Brown as COO,https://www.benzinga.com/pressreleases/23/09/g34729402/oxos-medical-taps-medtech-transformational-leader-jeff-brown-as-coo,2023-09-19 13:30:43,"ATLANTA, Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- OXOS Medical®, a leader in the portable x-ray solutions market, today announced that it has appointed Jeff Brown as the company's new Chief Operations Officer.",BSX,0.090474,0.064221,Neutral
Impulse Dynamics Announces Leadership Changes,https://www.benzinga.com/pressreleases/23/09/g34722638/impulse-dynamics-announces-leadership-changes,2023-09-19 11:17:08,"MARLTON, N.J., Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership appointments, including Jason Spees to Chief Executive Officer, Shlomi Nachman to Chairman of the ...",BSX,0.023395,0.015525,Neutral
"Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.",https://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-relievant-medsystems-inc-301931674.html,2023-09-19 11:00:00,Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain,BSX,0.250386,0.110688,Neutral
ONWARD® Reports 2023 Half Year Results and Business Update,https://www.globenewswire.com/news-release/2023/09/19/2745268/0/en/ONWARD-Reports-2023-Half-Year-Results-and-Business-Update.html,2023-09-19 04:30:00,"Eindhoven, Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7 ( 1 ) OF THE EUROPEAN MARKET ABUSE REGULATION ...",BSX,0.020096,0.108051,Neutral
Looking Into Boston Scientific's Recent Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/09/34702522/looking-into-boston-scientifics-recent-short-interest,2023-09-18 20:45:27,"Boston Scientific's BSX short percent of float has risen 40.0% since its last report. The company recently reported that it has 12.22 million shares sold short, which is 0.84% of all regular shares that are available for trading.",BSX,0.221819,0.155473,Somewhat-Bullish
"Investors should stick to the 'late cycle playbook' and buy these sectors, says Morgan Stanley's Mike Wilson",https://www.marketwatch.com/story/investors-should-stick-to-the-late-cycle-playbook-and-buy-these-sectors-says-morgan-stanleys-mike-wilson-1ddc1cf7,2023-09-18 14:53:00,"The market is likely to trade in a ""late cycle"" manner and investors would be put their dollars to work accordingly, says Morgan Stanley's top U.S. equity srategist.",BSX,0.154455,0.191824,Somewhat-Bullish
Acute Pancreatitis Market worth $8.82 Billion by 2030 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/09/g34689335/acute-pancreatitis-market-worth-8-82-billion-by-2030-exclusive-report-by-the-insight-partners,2023-09-18 13:10:10,"Pune, India, Sept. 18, 2023 ( GLOBE NEWSWIRE ) -- Acute pancreatitis is a condition characterized by the inflammation of pancreas over a short period. It is a common disease and a leading cause of hospitalization among gastrointestinal disorders in the US population.",BSX,0.031864,0.096895,Neutral
"Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology - PR Newswire",https://www.prnewswire.com/apac/news-releases/field-medical-inc-announces-oversubscribed-seed-round-to-advance-next-generation-cardiac-ablation-technology-301929888.html,2023-09-18 10:00:00,"Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology PR ...",BSX,0.060236,0.031028,Neutral
"Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology - PR Newswire",https://www.prnewswire.com/news-releases/field-medical-inc-announces-oversubscribed-seed-round-to-advance-next-generation-cardiac-ablation-technology-301929850.html,2023-09-18 10:00:00,"Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology PR ...",BSX,0.060236,0.031028,Neutral
Weight Management Devices Market to grow by USD 4.57 billion between 2022 - 2027 | Growth Driven by Growing ... - PR Newswire,https://www.prnewswire.com/news-releases/weight-management-devices-market-to-grow-by-usd-4-57-billion-between-2022---2027--growth-driven-by-growing-obese-population---technavio-301929563.html,2023-09-18 03:15:00,Weight Management Devices Market to grow by USD 4.57 billion between 2022 - 2027 | Growth Driven by Growing ... PR ...,BSX,0.047559,0.159676,Somewhat-Bullish
Enteral Feeding Devices Market to grow by USD 1.36 billion from 2022-2027 | North America to account for 46% of ... - PR Newswire,https://www.prnewswire.com/news-releases/enteral-feeding-devices-market-to-grow-by-usd-1-36-billion-from-2022-2027--north-america-to-account-for-46-of-market-growth---technavio-301929515.html,2023-09-18 02:35:00,Enteral Feeding Devices Market to grow by USD 1.36 billion from 2022-2027 | North America to account for 46% of ... PR ...,BSX,0.049835,0.0,Neutral
"Integer Holdings Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/integer-holdings-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-10-06 07:00:00,"Integer Holdings Clears Technical Benchmark, Hitting 80-Plus RS ... Investor's Business Daily ...",BSX,0.301315,0.0,Neutral
AngioDynamics  ( ANGO )  Q1 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2160876/angiodynamics-ango-q1-earnings-and-revenues-top-estimates,2023-10-05 14:45:00,AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in first-quarter fiscal 2024.,BSX,0.140485,0.018666,Neutral
How Is The Market Feeling About Boston Scientific? - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/10/35093700/how-is-the-market-feeling-about-boston-scientific,2023-10-04 16:45:18,"Boston Scientific's BSX short percent of float has fallen 3.57% since its last report. The company recently reported that it has 11.88 million shares sold short, which is 0.81% of all regular shares that are available for trading.",BSX,0.221819,0.083071,Neutral
PBH or BSX: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2160171/pbh-or-bsx-which-is-the-better-value-stock-right-now,2023-10-04 15:40:11,PBH vs. BSX: Which Stock Is the Better Value Option?,BSX,0.690822,0.587075,Bullish
"Medical Supplies Market Size is Projected to Hit USD 185.21 Billion, at a 4.5% CAGR by 2028 | Brandessence Market Research",https://www.prnewswire.com/news-releases/medical-supplies-market-size-is-projected-to-hit-usd-185-21-billion-at-a-4-5-cagr-by-2028--brandessence-market-research-301947208.html,2023-10-04 15:15:00,"Medical Supplies Market Size is Projected to Hit USD 185.21 Billion, at a 4.5% CAGR by 2028 | Brandessence Market ... PR ...",BSX,0.067536,-0.16357,Somewhat-Bearish
Business Leaders Speak Out for Mental Health Equity at Work,https://www.benzinga.com/pressreleases/23/10/g35071749/business-leaders-speak-out-for-mental-health-equity-at-work,2023-10-03 19:33:29,"LOS ANGELES, Oct. 03, 2023 ( GLOBE NEWSWIRE ) -- In anticipation of World Mental Health Day on October 10, the Health Action Alliance ( HAA ) is thrilled to announce its second annual Mental Health Equity at Work Summit.",BSX,0.039483,0.15002,Somewhat-Bullish
"Exact Sciences  ( EXAS )  Aided by Innovation, Strategic Buyouts",https://www.zacks.com/stock/news/2159316/exact-sciences-exas-aided-by-innovation-strategic-buyouts,2023-10-03 15:11:00,Exact Sciences (EXAS) is planning several key milestones to bring six innovative cancer diagnostics from its pipeline to patients in need.,BSX,0.136888,0.080135,Neutral
3 Healthcare Stocks to Keep an Eye On,https://www.fool.com/investing/2023/10/03/3-healthcare-stocks-to-keep-an-eye-on/,2023-10-03 13:45:00,These three lesser-known healthcare companies have strong growth potential.,BSX,0.040078,0.0,Neutral
Cardiovascular Crisis Meets Cutting-Edge Solutions: Insights from the Peripheral Vascular Stents Market Report,https://www.prnewswire.com/news-releases/cardiovascular-crisis-meets-cutting-edge-solutions-insights-from-the-peripheral-vascular-stents-market-report-301943239.html,2023-09-30 02:15:00,"DUBLIN, Sept. 29, 2023 /PRNewswire/ -- The ""Peripheral Vascular Stents Market Size, Share & Trends Analysis Report, 2023 - 2030"" has been added to ResearchAndMarkets.com's offering.",BSX,0.073321,0.0,Neutral
From Managing Chronic Diseases to Monitoring Nutrition: Patient-Centric Apps are the Next Big Thing in Healthcare,https://www.prnewswire.com/news-releases/from-managing-chronic-diseases-to-monitoring-nutrition-patient-centric-apps-are-the-next-big-thing-in-healthcare-301943201.html,2023-09-29 23:15:00,"DUBLIN, Sept. 29, 2023 /PRNewswire/ -- The ""Patient Centric Healthcare App Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028"" report has been added to ResearchAndMarkets.com's offering.",BSX,0.073098,0.099734,Neutral
Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now,https://www.zacks.com/stock/news/2157159/heres-why-you-should-retain-medtronic-mdt-stock-for-now,2023-09-28 13:49:00,Investors are optimistic about Medtronic (MDT) on strong global expansion.,BSX,0.049221,0.085209,Neutral
"STERIS'  ( STE )  Improved Volume, New Buyouts Drive Growth",https://www.zacks.com/stock/news/2167341/steris-ste-improved-volume-new-buyouts-drive-growth,2023-10-17 15:17:00,"On the capital equipment side for STERIS (STE), the easing of supply-chain issues and reduced lead times are boosting shipments.",BSX,0.060694,0.074052,Neutral
Bariatric Surgeries Market Worth $27.64 Billion by 2030 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/10/g35287685/bariatric-surgeries-market-worth-27-64-billion-by-2030-exclusive-report-by-the-insight-partners,2023-10-17 13:20:22,"Pune, India, Oct. 17, 2023 ( GLOBE NEWSWIRE ) -- The basic principle of bariatric surgery is restricting food intake and reducing food absorption in the intestines and stomach. Bariatric surgery is done when exercise and diet fail to reduce weight or when a patient has serious health problems ...",BSX,0.032338,-0.001927,Neutral
Boston Scientific Stock Sees IBD RS Rating Improve To 74,https://www.investors.com/research/boston-scientific-stock-sees-ibd-rs-rating-improve-to-74/,2023-10-16 18:41:00,"On Monday, Boston Scientific ( BSX ) stock got an upgrade to its Relative Strength ( RS ) Rating, from 69 to 74. As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",BSX,0.791422,0.524787,Bullish
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/10/35274009/1000-invested-in-boston-scientific-15-years-ago-would-be-worth-this-much-today,2023-10-16 18:30:26,"Boston Scientific BSX has outperformed the market over the past 15 years by 1.84% on an annualized basis producing an average annual return of 12.48%. Currently, Boston Scientific has a market capitalization of $72.51 billion.",BSX,0.980595,0.386944,Bullish
Boston Scientific's  ( BSX )  Wavewriter Alpha SCS Gets FDA's Nod,https://www.zacks.com/stock/news/2166297/boston-scientifics-bsx-wavewriter-alpha-scs-gets-fdas-nod,2023-10-16 12:28:00,Boston Scientific (BSX) receives the FDA's nod for an expanded indication of Wavewriter SCS Systems.,BSX,0.271777,0.143114,Neutral
Should You Pick MGM Resorts Over Boston Scientific Stock For Better Returns?,https://www.forbes.com/sites/greatspeculations/2023/10/16/should-you-pick-mgm-resorts-over-boston-scientific-stock-for-better-returns/,2023-10-16 11:00:00,"Given its better prospects, we believe MGM Resorts stock (NYSE: MGM) is a better pick than Boston Scientific stock (NYSE: BSX).",BSX,0.681079,0.405568,Bullish
Boston Scientific Sees IBD RS Rating Improve To 74,https://www.investors.com/ibd-data-stories/boston-scientific-sees-ibd-rs-rating-improve-to-74/,2023-10-16 07:00:00,"On Monday, Boston Scientific ( BSX ) got an upgrade to its Relative Strength ( RS ) Rating, from 69 to 74. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",BSX,0.841282,0.587894,Bullish
"Shanghai mayor vows to attract more foreign firms like Tesla, Boston Scientific",https://www.scmp.com/business/china-business/article/3238024/shanghai-mayor-vows-attract-even-more-foreign-business-after-tesla-and-boston-scientific-factories,2023-10-15 13:30:21,Mayor Gong Zheng said more landmark deals are in the works as Shanghai tries to burnish its image as an international investment magnet.,BSX,0.129168,0.0,Neutral
QuidelOrtho  ( QDEL )  Reports Solid Preliminary Q3 Revenues,https://www.zacks.com/stock/news/2165627/quidelortho-qdel-reports-solid-preliminary-q3-revenues,2023-10-13 14:11:00,QuidelOrtho's (QDEL) revenue growth in the third quarter is likely to have been boosted by continued strength in its non-respiratory product sales.,BSX,0.220809,-0.02928,Neutral
Boston Scientific Unusual Options Activity For October 12 - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/markets/options/23/10/35226851/boston-scientific-unusual-options-activity-for-october-12,2023-10-12 18:03:25,"Someone with a lot of money to spend has taken a bearish stance on Boston Scientific BSX. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",BSX,0.790605,0.130513,Neutral
"Walgreens Boots  ( WBA )  Q4 Earnings Miss Estimates, Margins Down",https://www.zacks.com/stock/news/2165064/walgreens-boots-wba-q4-earnings-miss-estimates-margins-down,2023-10-12 15:07:00,Walgreens Boots (WBA) Q4 retail revenues are impacted by macroeconomic-driven consumer pressure and lower COVID-19 OTC test kit sales.,BSX,0.152258,0.020882,Neutral
Is Boston Scientific  ( BSX )  Stock Outpacing Its Medical Peers This Year?,https://www.zacks.com/stock/news/2164855/is-boston-scientific-bsx-stock-outpacing-its-medical-peers-this-year,2023-10-12 13:40:08,"Here is how Boston Scientific (BSX) and Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) have performed compared to their sector so far this year.",BSX,0.704675,0.369655,Bullish
5 Medical Product Stocks to Buy Amid Industry Recovery,https://www.zacks.com/commentary/2164682/5-medical-product-stocks-to-buy-amid-industry-recovery,2023-10-12 12:14:00,"Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, BSX, ZBH, PODD and HAE are well-poised to gain from the favorable factors.",BSX,0.083614,0.027292,Neutral
Healthcare Education Solutions Market size to grow by USD 5.30 billion from 2022 to 2027 | Market is fragmented due ... - PR Newswire,https://www.prnewswire.com/news-releases/healthcare-education-solutions-market-size-to-grow-by-usd-5-30-billion-from-2022-to-2027--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-3m-co-bbraun-se-and-becton-dickinson-and-co-and-many-more-301952875.html,2023-10-11 23:15:00,Healthcare Education Solutions Market size to grow by USD 5.30 billion from 2022 to 2027 | Market is fragmented due ... PR ...,BSX,0.070725,0.086725,Neutral
"Neogen's  ( NEOG )  Q1 Earnings Miss Estimates, Margins Rise",https://www.zacks.com/stock/news/2164501/neogens-neog-q1-earnings-miss-estimates-margins-rise,2023-10-11 16:43:00,"Neogen's (NEOG) Q1 Animal Safety business experiences continued destocking, with channel inventory levels reaching multi-year lows.",BSX,0.179788,0.024882,Neutral
Here's Why You Should Invest in Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2164426/heres-why-you-should-invest-in-boston-scientific-bsx-now,2023-10-11 14:47:00,Investors are optimistic about Boston Scientific (BSX) on consistent growth and upbeat guidance.,BSX,0.293506,0.164302,Somewhat-Bullish
Urology Devices Market to grow by USD 14.10 billion from 2022-2027 | North America to account for 37% of market ... - PR Newswire,https://www.prnewswire.com/news-releases/urology-devices-market-to-grow-by-usd-14-10-billion-from-2022-2027--north-america-to-account-for-37-of-market-growth---technavio-301949805.html,2023-10-09 08:15:00,Urology Devices Market to grow by USD 14.10 billion from 2022-2027 | North America to account for 37% of market ... PR ...,BSX,0.103331,0.16353,Somewhat-Bullish
Altana using AI to map and analyze global supply chain with launch of next-gen Atlas,https://www.foxbusiness.com/technology/altana-using-ai-map-analyze-global-supply-chain-with-launch-next-gen-atlas,2023-10-08 10:24:36,"startup Altana launched its next-generation Atlas this week which provides a dynamic map of the global supply chain for businesses, governments and logistics firms looking to monitor the supply chain. New York-based Altana has worked with U.S.",BSX,0.044634,0.012887,Neutral
"Integer Holdings  ( ITGR )  Q3 Earnings Top Estimates, FY23 View Up",https://www.zacks.com/stock/news/2173867/integer-holdings-itgr-q3-earnings-top-estimates-fy23-view-up,2023-10-27 15:35:00,"Integer Holdings' (ITGR) third-quarter results reflect robust Medical Sales, along with strength in the majority of the product lines.",BSX,0.145583,-0.006376,Neutral
"Merit Medical  ( MMSI )  Q3 Earnings Top Estimates, FY23 View Revised",https://www.zacks.com/stock/news/2173855/merit-medical-mmsi-q3-earnings-top-estimates-fy23-view-revised,2023-10-27 15:16:00,Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the third quarter.,BSX,0.138066,-0.006185,Neutral
Sanofi Crashes 16% As Third Quarter Comes In Light Ahead Of Spinoff,https://www.investors.com/news/technology/sanofi-stock-sanofi-earnings-q3-2023/,2023-10-27 13:03:00,"Sanofi Stock Crashes 16% On Earnings Miss, Announces ... Investor's Business Daily ...",BSX,0.200688,0.0,Neutral
Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of 14.94% | Infinium Global Research,https://www.prnewswire.com/news-releases/global-medical-robotics-market-is-forecast-to-reach-a-value-of-usd-28-77-billion-by-2030-with-a-growing-cagr-of-14-94--infinium-global-research-301970015.html,2023-10-27 10:03:00,Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of ... PR ...,BSX,0.038101,0.066226,Neutral
Analysis: Healthcare companies counter investor worries over Wegovy effect,https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-companies-counter-investor-worries-over-wegovy-effect-2023-10-27/,2023-10-27 05:00:20,"A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing Rights",BSX,0.049221,0.052759,Neutral
"Dexcom Shrugs Off Pressure From Weight-Loss Drugs, Boosts 2023 Outlook",https://www.investors.com/news/technology/dxcm-stock-dexcom-earnings-q3-2023/,2023-10-26 20:18:00,DXCM Stock Pops 10% After Besting Forecasts And Boosting Its ... Investor's Business Daily ...,BSX,0.233556,0.0,Neutral
"Medical Devices Provider Boston Scientific Cardiovascular Segment Sees Traction In Q3, Company Adjusts Annual Outlook - Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/news/earnings/23/10/35440234/medical-devices-provider-boston-scientific-cardiovascular-segment-sees-traction-in-q3-company-adjus,2023-10-26 16:26:56,"Boston Scientific Corp BSX generated Q3 revenues of $3.53 billion, beating the Wall Street estimate of $3.48 billion. The sales increased 11.2% on a reported basis, 11.1% on an operational basis, and 10.2% on an organic basis, beating the management of approximately 8.5% - 10.5% ( 7% - 9% organic ...",BSX,0.760593,0.465123,Bullish
"Boston Scientific  ( BSX )  Q3 Earnings Beat, Gross Margin Dips",https://www.zacks.com/stock/news/2173045/boston-scientific-bsx-q3-earnings-beat-gross-margin-dips,2023-10-26 16:06:00,Boston Scientific's (BSX) organic and operational revenues at its respective core business segments and geographies rise in the third quarter.,BSX,0.278109,0.249297,Somewhat-Bullish
Boston Scientific lifts earnings forecast on solid demand for heart devices,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-beats-quarterly-profit-estimates-strength-heart-devices-unit-2023-10-26/,2023-10-26 15:13:00,"Oct 26 ( Reuters ) - Boston Scientific ( BSX.N ) raised its annual profit forecast on Thursday, banking on strong demand for heart devices including its stroke prevention product, Watchman, and a recovery in demand for elective surgeries.",BSX,0.468029,0.247615,Somewhat-Bullish
Medtech Giant Ekes Out A Narrow Third-Quarter Win,https://www.investors.com/news/technology/bsx-stock-boston-scientific-q3-2023/,2023-10-26 13:12:00,BSX Stock Edges Higher After Eking Out A Third-Quarter Beat Investor's Business Daily ...,BSX,0.860826,0.345775,Somewhat-Bullish
Boston Scientific  ( BSX )  Tops Q3 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2172412/boston-scientific-bsx-tops-q3-earnings-and-revenue-estimates,2023-10-26 11:50:13,"Boston Scientific (BSX) delivered earnings and revenue surprises of 4.17% and 1.77%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",BSX,0.397098,0.245519,Somewhat-Bullish
"Pain Management Devices Market Share Worth $8.38 Billion, Globally, by 2027 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35436375/pain-management-devices-market-share-worth-8-38-billion-globally-by-2027-exclusive-report-by-the-i,2023-10-26 11:47:02,"Pune, India, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Chronic or acute pain due to diseases like cancer, diabetes, arthritis and others can be reduced or controlled through pain management therapy.",BSX,0.037387,-0.020852,Neutral
"Why Nasdaq, S&P 500 Futures Are Sliding Today - Alphabet  ( NASDAQ:GOOGL ) , Mattel  ( NASDAQ:MAT ) , Ford Motor  ( NYSE:F ) , Merck & Co  ( NYSE:MRK ) ",https://www.benzinga.com/markets/equities/23/10/35436214/nasdaq-futures-plunge-as-meta-warns-of-q4-softness-gdp-data-amazon-earnings-on-investors-radar-a,2023-10-26 11:38:30,"A somber mood looms over Wall Street, stirred by lackluster earnings reports and relentless bond yield increases. Stock futures dipped early Thursday, with Meta Platforms, Inc.'s META impressive results failing to satisfy investors.",BSX,0.066877,0.0,Neutral
"Morning Bid: Haunted by 5% ahead of ECB, GDP and Amazon",https://www.reuters.com/markets/us/global-markets-view-usa-2023-10-26/,2023-10-26 10:01:00,"Traders work on the floor at the New York Stock Exchange ( NYSE ) in New York City, U.S., October 23, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights A look at the day ahead in U.S. and global markets from Mike Dolan",BSX,0.051551,0.105477,Neutral
Nasdaq futures slide as megacaps drag; economic data in focus,https://www.reuters.com/markets/us/nasdaq-futures-slide-megacaps-drag-economic-data-focus-2023-10-26/,2023-10-26 09:48:00,Nasdaq futures slide as megacaps drag. economic data in focus ...,BSX,0.092569,0.0,Neutral
Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the ... - PR Newswire,https://www.prnewswire.com/news-releases/boston-scientific-agent-drug-coated-balloon-demonstrates-superiority-to-uncoated-balloon-angioplasty-in-the-agent-ide-trial-301967754.html,2023-10-25 18:29:00,Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the ... PR ...,BSX,0.169875,0.207589,Somewhat-Bullish
"NextGen  ( NXGN )  Q2 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2171946/nextgen-nxgn-q2-earnings-top-estimates-margins-down,2023-10-25 16:33:00,NextGen's (NXGN) second-quarter fiscal 2024 results reflect strength in its Recurring revenues.,BSX,0.178459,0.021796,Neutral
Boston Scientific may be shielded from weight-loss drugs hit by procedure recovery,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-may-be-shielded-weight-loss-drugs-hit-by-procedure-recovery-2023-10-25/,2023-10-25 14:18:00,Oct 25 ( Reuters ) - Boston Scientific's ( BSX.N ) quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could take a hit from the surging popularity of weight-loss drugs.,BSX,0.491255,0.200107,Somewhat-Bullish
"Medical Device Stocks' Q3 Earnings Due on Oct 26: BSX, BIO & More",https://www.zacks.com/stock/news/2171766/medical-device-stocks-q3-earnings-due-on-oct-26-bsx-bio-more,2023-10-25 14:08:00,"Medical Device companies' third-quarter results are likely to reflect a year-over-year decline. Let's see how BSX, BIO, EW and LH fare this time.",BSX,0.207317,0.158056,Somewhat-Bullish
Shockwave Medical  ( SWAV )  Announces IVL Studies' Positive Results,https://www.zacks.com/stock/news/2170737/shockwave-medical-swav-announces-ivl-studies-positive-results,2023-10-24 13:15:00,Shockwave Medical's (SWAV) latest announcement of two new publications validates the utility of IVL in complex nodular and eccentric calcium.,BSX,0.224903,0.292571,Somewhat-Bullish
"mHealth Market Size to Hit $410.39 Billion, Globally, by 2028 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35389192/mhealth-market-size-to-hit-410-39-billion-globally-by-2028-exclusive-report-by-the-insight-partner,2023-10-24 10:23:48,"Pune, India, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- Mobile health ( mHealth ) is a technique that includes the use of mobile commination devices, such as mobile phones, tablets, PDAs ( personal digital assistants ) and other wireless devices for distributing health services and information. mHealth ...",BSX,0.064276,0.140473,Neutral
Medical equipment maintenance market size to increase by USD 39.28 billion | The product innovation and advances ... - PR Newswire,https://www.prnewswire.com/news-releases/medical-equipment-maintenance-market-size-to-increase-by-usd-39-28-billion--the-product-innovation-and-advances-leading-to-portfolio-extension-and-product-premiumization-drives-the-market-growth--technavio-301965110.html,2023-10-24 02:30:00,Medical equipment maintenance market size to increase by USD 39.28 billion | The product innovation and advances ... PR ...,BSX,0.059636,-0.068996,Neutral
Shanghai economic demand seen driven by US rate cuts in 2024: govt adviser,https://www.scmp.com/business/china-business/article/3238919/shanghais-economy-under-pressure-weak-property-and-stock-markets-home-banks-external-demand-drivers,2023-10-23 23:00:16,"Shanghai's economy, dealt a double blow by China's troubled property sector and the nation's tumbling stock market this year, could see better days in 2024 when the US is widely expected to lower interest rates, a government economic adviser said ...",BSX,0.062434,0.022077,Neutral
Greater MSP region wins designation as U.S. Tech Hub for medical technology,https://www.benzinga.com/pressreleases/23/10/g35385285/greater-msp-region-wins-designation-as-u-s-tech-hub-for-medical-technology,2023-10-23 22:07:41,"MINNEAPOLIS and SAINT PAUL, Minn., Oct. 23, 2023 ( GLOBE NEWSWIRE ) -- The Greater MSP region was designated as one of the leading technology hubs in the U.S. through a closely watched national competition run by the U.S. Department of Commerce.",BSX,0.042122,0.068115,Neutral
OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE,https://www.newswire.ca/news-releases/opsens-announces-the-positive-clinical-results-from-the-safe-tavi-study-with-savvywire-in-europe-863949107.html,2023-10-23 17:22:00,OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN ... Canada ...,BSX,0.051663,0.228971,Somewhat-Bullish
What's in Store for Boston Scientific  ( BSX )  in Q3 Earnings?,https://www.zacks.com/stock/news/2170104/whats-in-store-for-boston-scientific-bsx-in-q3-earnings,2023-10-23 10:02:00,"With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.",BSX,0.3038,0.384982,Bullish
"Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? - Alphabet  ( NASDAQ:GOOGL ) , Logitech International  ( NASDAQ:LOGI ) , Archer-Daniels Midland  ( NYSE:ADM ) , Novartis  ( NYSE:NVS ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35367409/amazon-alphabet-meta-intel-q3-earnings-this-week-will-mega-caps-shatter-forecasts-a,2023-10-23 07:15:17,"After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-declining trend.",BSX,0.104228,0.0,Neutral
"Stock Market Outlook Clouded With Amazon, Microsoft, Meta, Alphabet Set To Report",https://www.investors.com/research/investing-action-plan/middle-east-house-leadership-cloud-stock-market-outlook-with-amazon-microsoft-meta-and-alphabet-to-report/,2023-10-20 22:22:00,"Stock Market Outlook Clouded With Amazon, Microsoft, Meta ... Investor's Business Daily ...",BSX,0.030661,0.086828,Neutral
Transcatheter Aortic Valve Replacement Market size to grow by USD 2.34 billion from 2022-2027| 4C Medical ... - PR Newswire,https://www.prnewswire.com/news-releases/transcatheter-aortic-valve-replacement-market-size-to-grow-by-usd-2-34-billion-from-2022-2027-4c-medical-technologies-inc-abbott-laboratories-anteris-technologies-ltd-are-among-the-major-companies-in-the-market---technavio-301962355.html,2023-10-20 21:15:00,Transcatheter Aortic Valve Replacement Market size to grow by USD 2.34 billion from 2022-2027| 4C Medical ... PR ...,BSX,0.063091,0.063017,Neutral
 ( BSX )  - Analyzing Boston Scientific's Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/10/35354314/bsx-analyzing-boston-scientifics-short-interest,2023-10-20 16:30:24,"Boston Scientific's BSX short percent of float has fallen 3.57% since its last report. The company recently reported that it has 11.88 million shares sold short, which is 0.81% of all regular shares that are available for trading.",BSX,0.221819,0.083071,Neutral
"The Zacks Analyst Blog Highlights Visa, AbbVie, BHP Group, Caterpillar and Boston Scientific",https://www.zacks.com/stock/news/2169342/the-zacks-analyst-blog-highlights-visa-abbvie-bhp-group-caterpillar-and-boston-scientific,2023-10-20 09:20:00,"Visa, AbbVie, BHP Group, Caterpillar and Boston Scientific are included in this Analyst Blog.",BSX,0.149656,0.041626,Neutral
"Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens",https://www.prnewswire.com/apac/news-releases/striving-together-for-a-thriving-industry-international-biopharma-industry-week-shanghai-2023-opens-301962953.html,2023-10-20 07:29:00,"SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- On October 16th, the inaugural ceremony of the 2023 International Biopharma Industry Week Shanghai ( IBIWS 2023 ) unfolded at the Zhangjiang Science Hall in Shanghai.",BSX,0.019364,0.190474,Somewhat-Bullish
Stocks Flashing Renewed Technical Strength: Boston Scientific,https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-boston-scientific/,2023-10-19 07:00:00,"When putting together your watch list, look for stocks with an 80 or higher RS Rating. Boston Scientific ( BSX ) is one stock that just reached the mark, now earning a score of 81. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",BSX,0.689185,0.0924,Neutral
"HTR Recognizes RXNT as a ""True Trailblazer"" Among Top 100 Health Tech Companies of 2023",https://www.prnewswire.com/news-releases/htr-recognizes-rxnt-as-a-true-trailblazer-among-top-100-health-tech-companies-of-2023-301961225.html,2023-10-18 20:18:00,"ANNAPOLIS, Md., Oct. 18, 2023 /PRNewswire/ -- , an enduring pioneer in the ambulatory healthcare technology space, today announced that it has been recognized as one of the ""Top 100 Healthcare Technology Companies of 2023"" by the .",BSX,0.090816,0.142504,Neutral
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/11/35600394/heres-how-much-1000-invested-in-boston-scientific-10-years-ago-would-be-worth-today,2023-11-03 19:30:21,"Boston Scientific BSX has outperformed the market over the past 10 years by 6.7% on an annualized basis producing an average annual return of 16.26%. Currently, Boston Scientific has a market capitalization of $77.59 billion.",BSX,0.980595,0.386944,Bullish
Alcon Trying To Close In On Key Technical Measure,https://www.investors.com/ibd-data-stories/alcon-trying-to-close-in-on-key-technical-measure/,2023-11-03 08:00:00,"In a welcome move, Alcon ( ALC ) saw its Relative Strength Rating rise from 67 to 72 on Friday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's unique rating tracks share price performance with a 1 ( worst ) to 99 ( best ) ...",BSX,0.316846,0.0,Neutral
Medical Product Stocks' Q3 Earnings Due on Nov 1: SYK & More,https://www.zacks.com/stock/news/2176140/medical-product-stocks-q3-earnings-due-on-nov-1-syk-more,2023-11-01 11:46:00,"Third-quarter results of Medical Product companies are likely to reflect a year-over-year decline. Let's see how SYK, COR, BAX, FMS and XRAY fare this time around.",BSX,0.02799,0.113136,Neutral
"Stryker Corp Clears Key Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/stryker-corp-clears-key-benchmark-hitting-80-plus-rs-rating-2/,2023-11-01 08:00:00,"When building your watch list, focus on stocks with an 80 or higher RS Rating. Stryker Corp ( SYK ) now meets that criteria, with a jump from 74 to 83 Wednesday. X When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength.",BSX,0.327366,0.0,Neutral
Inari Medical Sees Relative Strength Rating Climb To 79,https://www.investors.com/ibd-data-stories/inari-medical-sees-relative-strength-rating-climb-to-79/,2023-11-01 08:00:00,"Inari Medical ( NARI ) saw a positive improvement to its Relative Strength ( RS ) Rating on Wednesday, rising from 62 to 79. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",BSX,0.310843,0.0,Neutral
"PacBio  ( PACB )  Tops on Q3 Earnings, Raises FY23 Revenue View",https://www.zacks.com/stock/news/2175683/pacbio-pacb-tops-on-q3-earnings-raises-fy23-revenue-view,2023-10-31 15:35:00,"PacBio (PACB) witnesses strong revenue growth in the third quarter, partly aided by customers' continued product transition to the Revio system.",BSX,0.162255,-0.006828,Neutral
"Ecolab  ( ECL )  Q3 Earnings Surpass Estimates, Margins Rise",https://www.zacks.com/stock/news/2175651/ecolab-ecl-q3-earnings-surpass-estimates-margins-rise,2023-10-31 15:07:00,Ecolab's (ECL) robust performance across all segments drives its third-quarter sales despite business challenges.,BSX,0.172713,-0.007127,Neutral
"Hysteroscopy Procedures Market to Exceed USD 9 billion by 2032, Expanding at a CAGR of 8.4%: TMR Report",https://www.benzinga.com/pressreleases/23/10/g35496749/hysteroscopy-procedures-market-to-exceed-usd-9-billion-by-2032-expanding-at-a-cagr-of-8-4-tmr-repo,2023-10-30 17:30:00,"Wilmington, Delaware, United States, Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global hysteroscopy procedures market is projected to flourish at a CAGR of 8.4% from 2022 to 2032. As per the report published by TMR, a valuation of US$ billion is anticipated for ...",BSX,0.047654,0.0,Neutral
"Avantor  ( AVTR )  Q3 Earnings In-Line With Estimates, Revenues Top",https://www.zacks.com/stock/news/2174744/avantor-avtr-q3-earnings-in-line-with-estimates-revenues-top,2023-10-30 16:24:00,"Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft third-quarter performance.",BSX,0.154703,-0.006619,Neutral
"Revvity  ( RVTY )  Misses on Q3 Earnings, Lowers '23 EPS View",https://www.zacks.com/stock/news/2174778/revvity-rvty-misses-on-q3-earnings-lowers-23-eps-view,2023-10-30 15:55:00,Revvity's (RVTY) third-quarter results reflect the impact of increased market uncertainty. The company's earnings and sales miss their respective estimates.,BSX,0.251032,0.140683,Neutral
Are Medical Stocks Lagging Boston Scientific  ( BSX )  This Year?,https://www.zacks.com/stock/news/2174450/are-medical-stocks-lagging-boston-scientific-bsx-this-year,2023-10-30 13:40:07,Here is how Boston Scientific (BSX) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.,BSX,0.717937,0.308164,Somewhat-Bullish
Stryker Corp Trying To Close In On Key Technical Benchmark,https://www.investors.com/ibd-data-stories/stryker-corp-trying-to-close-in-on-key-technical-benchmark/,2023-10-30 08:00:00,"On Monday, Stryker Corp ( SYK ) earned an upgrade to its Relative Strength ( RS ) Rating, from 67 to 73. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",BSX,0.320974,0.0,Neutral
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/11/35832579/1000-invested-in-boston-scientific-15-years-ago-would-be-worth-this-much-today,2023-11-16 17:00:14,"Boston Scientific BSX has outperformed the market over the past 15 years by 3.43% on an annualized basis producing an average annual return of 15.65%. Currently, Boston Scientific has a market capitalization of $79.67 billion.",BSX,0.980595,0.386944,Bullish
CONMED Getting Closer To Key Technical Measure,https://www.investors.com/ibd-data-stories/conmed-getting-closer-to-key-technical-measure/,2023-11-16 08:00:00,"CONMED ( CNMD ) saw a positive improvement to its Relative Strength ( RS ) Rating on Thursday, rising from 65 to 74. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",BSX,0.327366,0.0,Neutral
Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming,https://www.investors.com/news/technology/stocks-with-rising-relative-price-strength-stryker-corp/,2023-11-15 12:00:00,Stryker Stock Elevated To Top Tier Rating. Fresh Base Forming Investor's Business Daily ...,BSX,0.174587,0.0,Neutral
Here's Why You Should Retain Penumbra  ( PEN )  Stock for Now,https://www.zacks.com/stock/news/2184063/heres-why-you-should-retain-penumbra-pen-stock-for-now,2023-11-14 15:19:00,Investors are optimistic about Penumbra (PEN) on strong vascular and neuro businesses growth and upbeat guidance.,BSX,0.048327,0.061822,Neutral
Boston Scientific  ( BSX )  Just Reclaimed the 50-Day Moving Average,https://www.zacks.com/stock/news/2183966/boston-scientific-bsx-just-reclaimed-the-50-day-moving-average,2023-11-14 14:30:02,Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?,BSX,0.882468,0.627169,Bullish
Stocks With Rising Relative Price Strength: Stryker Corp,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-price-strength-stryker-corp/,2023-11-14 08:00:00,"On Tuesday, Stryker Corp ( SYK ) got an upgrade to its Relative Strength ( RS ) Rating, from 78 to 84. X As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.",BSX,0.366061,0.0,Neutral
Stocks Showing Rising Market Leadership: Glaukos Earns 84 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-rising-market-leadership-glaukos-earns-84-rs-rating/,2023-11-14 08:00:00,Stocks Showing Rising Market Leadership: Glaukos Earns 84 RS ... Investor's Business Daily ...,BSX,0.345674,0.0,Neutral
PBH vs. BSX: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2183456/pbh-vs-bsx-which-stock-is-the-better-value-option,2023-11-13 16:40:11,Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare ( PBH Quick QuotePBH - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find ...,BSX,0.666827,0.546514,Bullish
Dermatology Devices Market is Expected to Reach $11.3 billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/11/g35745699/dermatology-devices-market-is-expected-to-reach-11-3-billion-marketsandmarkets,2023-11-13 12:30:00,"Chicago, Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Dermatology Devices market in terms of revenue was estimated to be worth $6.2 billion in 2022 and is poised to reach $11.3 billion by 2027, growing at a CAGR of 12.7% from 2022 to 2027 according to a latest report published by MarketsandMarkets™.",BSX,0.143415,0.208235,Somewhat-Bullish
Peripheral Vascular Diagnostic Systems Market to grow by USD 178.07 million from 2023-2028; North America to ... - PR Newswire,https://www.prnewswire.com/news-releases/peripheral-vascular-diagnostic-systems-market-to-grow-by-usd-178-07-million-from-2023-2028-north-america-to-account-for-39-of-market-growth---technavio-301984286.html,2023-11-10 23:35:00,Peripheral Vascular Diagnostic Systems Market to grow by USD 178.07 million from 2023-2028. North America to ... PR ...,BSX,0.058472,0.0,Neutral
Looking Into Boston Scientific's Recent Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/11/35733559/looking-into-boston-scientifics-recent-short-interest,2023-11-10 20:30:25,"Boston Scientific's BSX short percent of float has fallen 31.52% since its last report. The company recently reported that it has 9.14 million shares sold short, which is 0.63% of all regular shares that are available for trading.",BSX,0.221819,0.083071,Neutral
Smart Wearable Healthcare Devices Market to grow by USD 24.22 billion from 2023 to 2028; North America to account ... - PR Newswire,https://www.prnewswire.com/news-releases/smart-wearable-healthcare-devices-market-to-grow-by-usd-24-22-billion-from-2023-to-2028-north-america-to-account-for-34-of-market-growth--technavio-301984301.html,2023-11-10 19:45:00,Smart Wearable Healthcare Devices Market to grow by USD 24.22 billion from 2023 to 2028. North America to account ... PR ...,BSX,0.065506,0.0,Neutral
"If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now",https://www.zacks.com/stock/news/2182213/if-you-invested-1000-in-boston-scientific-a-decade-ago-this-is-how-much-itd-be-worth-now,2023-11-10 13:30:04,"Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",BSX,0.536866,0.414638,Bullish
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2181886/heres-why-you-should-retain-boston-scientific-bsx-now,2023-11-09 18:18:00,"Investors are optimistic about Boston Scientific (BSX), led by growing demand for WATCHMAN FLX devices and upbeat guidance.",BSX,0.242406,0.218316,Somewhat-Bullish
Corporate America weighs business impact of new weight-loss drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/corporate-america-weighs-business-impact-new-weight-loss-drugs-2023-11-08/,2023-11-08 18:19:00,"[1/3] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",BSX,0.054114,-0.009037,Neutral
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research,https://www.benzinga.com/pressreleases/23/11/g35672998/truveta-announces-availability-of-millions-of-echocardiogram-reports-to-advance-cardiovascular-res,2023-11-08 14:00:00,"BELLEVUE, Wash., Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- Today Truveta announced the availability of more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports from more than 1.7 million de-identified patients, making it the market leader in real-world data to ...",BSX,0.053035,0.103006,Neutral
Zimmer Biomet beats quarterly profit estimates on knee procedure strength,https://www.reuters.com/business/healthcare-pharmaceuticals/zimmer-biomet-beats-quarterly-profit-estimates-knee-procedure-strength-2023-11-07/,2023-11-07 12:20:00,"The logo of medical implants maker Zimmer Biomet is seen at a plant in Winterthur, Switzerland, November 16, 2018. Picture taken November 16, 2018. REUTERS/Moritz Hager/File Photo Acquire Licensing Rights",BSX,0.175859,0.153021,Somewhat-Bullish
"Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... - PR Newswire",https://www.prnewswire.com/news-releases/mobile-health-solutions-market-to-grow-at-a-usd-256-69-billion-from-2022-to-2027--abbott-laboratories-airstrip-technologies-inc-apple-inc-and-more-among-the-key-companies-in-the-market---technavio-301978707.html,2023-11-07 01:15:00,"Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... PR ...",BSX,0.058047,0.143994,Neutral
Could Ozempic Harm These 3 Medical Device Stocks?,https://www.fool.com/investing/2023/11/25/could-ozempic-harm-these-3-medical-device-stocks/,2023-11-25 11:58:00,The drug is on track to cause massive competitive shifts in the healthcare sector.,BSX,0.152821,0.034841,Neutral
ENT Laser Devices Market to grow by USD 119.6 million from 2022 to 2027; North America to account for 40% of ... - PR Newswire,https://www.prnewswire.com/news-releases/ent-laser-devices-market-to-grow-by-usd-119-6-million-from-2022-to-2027-north-america-to-account-for-40-of-market-growth---technavio-301996118.html,2023-11-23 08:35:00,ENT Laser Devices Market to grow by USD 119.6 million from 2022 to 2027. North America to account for 40% of ... PR ...,BSX,0.071357,0.0,Neutral
A Look Into Boston Scientific Inc's Price Over Earnings - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/11/35919095/a-look-into-boston-scientific-incs-price-over-earnings,2023-11-22 16:00:15,"In the current session, the stock is trading at $55.67, after a 0.64% spike. Over the past month, Boston Scientific Inc. BSX stock increased by 11.37%, and in the past year, by 26.10%.",BSX,0.532941,0.290372,Somewhat-Bullish
"Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities - Microbot Medical  ( NASDAQ:MBOT ) ",https://www.benzinga.com/pressreleases/23/11/g35895211/microbot-medical-appoints-seasoned-medical-expert-dr-juan-diaz-cartelle-as-its-new-chief-medical-o,2023-11-21 14:12:03,"BRAINTREE, Mass., Nov. 21, 2023 ( GLOBE NEWSWIRE ) -- Microbot Medical Inc. MBOT, developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced the appointment of Dr. Juan Diaz-Cartelle as its new Chief Medical Officer ( CMO ) , effective December 1, 2023.",BSX,0.043108,0.092409,Neutral
"Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities",https://www.globenewswire.com/news-release/2023/11/21/2784122/0/en/Microbot-Medical-Appoints-Seasoned-Medical-Expert-Dr-Juan-Diaz-Cartelle-as-its-New-Chief-Medical-Officer-in-Anticipation-of-Its-Clinical-Regulatory-and-Commercial-Activities.html,2023-11-21 14:12:00,The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase. The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation ...,BSX,0.043738,0.093543,Neutral
Boston Scientific  ( BSX )  Closes the Relievant Medsystems Buyout,https://www.zacks.com/stock/news/2187043/boston-scientific-bsx-closes-the-relievant-medsystems-buyout,2023-11-21 11:56:00,Boston Scientific (BSX) expands the neuromodulation portfolio with the acquisition of Relievant Medsystems.,BSX,0.287762,-0.215979,Somewhat-Bearish
Atherectomy Systems Market to Hit USD 1.1 billion by 2031 | Says Transparency Market Research Inc.,https://www.benzinga.com/pressreleases/23/11/g35888060/atherectomy-systems-market-to-hit-usd-1-1-billion-by-2031-says-transparency-market-research-inc,2023-11-21 08:30:00,"Wilmington, Delaware, United States, Nov. 21, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global atherectomy systems market stood at US$ 650 million in 2022, and the global market is projected to reach US$ 1.1 billion in 2031.",BSX,0.040691,0.219219,Somewhat-Bullish
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities,https://www.prnewswire.com/news-releases/novavax-makes-changes-to-executive-leadership-team-to-enhance-focus-on-delivery-of-strategic-priorities-301991645.html,2023-11-17 12:15:00,• New organizational structure for executive leadership team designed to facilitate a leaner and more focused approach to annual execution of business plans • to join as Chief Legal Officer and Corporate Secretary,BSX,0.03468,0.079721,Neutral
IBD Rating Upgrades: Lantheus Holdings Shows Improved Technical Strength,https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-lantheus-holdings-shows-improved-technical-strength/,2023-11-17 08:00:00,IBD Rating Upgrades: Lantheus Holdings Shows Improved ... Investor's Business Daily ...,BSX,0.345674,0.0,Neutral
"Healthcare education solutions market recorded 8.25% growth between 2021 and 2022 | 3M Corp, B. Braun SE ... - PR Newswire",https://www.prnewswire.com/news-releases/healthcare-education-solutions-market-recorded-8-25-growth-between-2021-and-2022--3m-corp-b-braun-se-becton-dickinson-and-co-and-more-among-the-key-companies-in-the-market--technavio-302006885.html,2023-12-06 02:35:00,"Healthcare education solutions market recorded 8.25% growth between 2021 and 2022 | 3M Corp, B. Braun SE ... PR ...",BSX,0.066414,0.032078,Neutral
"Boston Scientific  ( BSX )  Gains From Global Expansion, FX Woe Ails",https://www.zacks.com/stock/news/2193448/boston-scientific-bsx-gains-from-global-expansion-fx-woe-ails,2023-12-05 13:30:00,Boston Scientific's (BSX) Endoscopy business within MedSurg benefits from strong worldwide demand for its broad range of GI and pulmonary treatment options.,BSX,0.538177,0.476395,Bullish
"If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You'd Have Now",https://www.zacks.com/stock/news/2192075/if-you-invested-1000-in-boston-scientific-10-years-ago-this-is-how-much-youd-have-now,2023-12-01 13:30:05,Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,BSX,0.536866,0.397674,Bullish
Peering Into Boston Scientific's Recent Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/11/36010935/peering-into-boston-scientifics-recent-short-interest,2023-11-29 20:30:17,"Boston Scientific's BSX short percent of float has risen 28.57% since its last report. The company recently reported that it has 11.85 million shares sold short, which is 0.81% of all regular shares that are available for trading.",BSX,0.221819,0.155473,Somewhat-Bullish
PBH or BSX: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2191032/pbh-or-bsx-which-is-the-better-value-stock-right-now,2023-11-29 16:40:10,PBH vs. BSX: Which Stock Is the Better Value Option?,BSX,0.616447,0.5846,Bullish
"Dermatology Lasers Market to grow by USD 729.65 million from 2023-2028, North America to account for 39% of ... - PR Newswire",https://www.prnewswire.com/news-releases/dermatology-lasers-market-to-grow-by-usd-729-65-million-from-2023-2028--north-america-to-account-for-39-of-market-growth---technavio-302016307.html,2023-12-15 22:15:00,"Dermatology Lasers Market to grow by USD 729.65 million from 2023-2028, North America to account for 39% of ... PR ...",BSX,0.063258,0.17018,Somewhat-Bullish
"This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch - Enovis  ( NYSE:ENOV ) , Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36262735/this-analyst-selects-enovis-as-top-pick-for-2024-spotlight-on-empowr-revision-launc,2023-12-15 19:38:41,"Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation ENOV, raising the price target to $70 from $62. The analyst selected ENOV as his top pick for 2024 and added it to the Needham Conviction List, replacing Boston Scientific Corporation BSX.",BSX,0.268294,0.161877,Somewhat-Bullish
PBH or BSX: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2198847/pbh-or-bsx-which-is-the-better-value-stock-right-now,2023-12-15 16:40:11,PBH vs. BSX: Which Stock Is the Better Value Option?,BSX,0.743396,0.588676,Bullish
Boston Scientific  ( BSX )  Hits 52-Week High: What's Aiding It?,https://www.zacks.com/stock/news/2197938/boston-scientific-bsx-hits-52-week-high-whats-aiding-it,2023-12-14 14:16:00,Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment.,BSX,0.269181,0.297479,Somewhat-Bullish
"Shock Wave Therapy Devices Market Size to Exceed USD 158.5 million by 2031, with a Robust CAGR of 5.2 %| States Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/23/12/g36236264/shock-wave-therapy-devices-market-size-to-exceed-usd-158-5-million-by-2031-with-a-robust-cagr-of-5,2023-12-14 13:45:14,"Wilmington, Delaware, United States, Dec. 14, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global shock wave therapy devices market was projected to attain US$ 101.3 million in 2022.",BSX,0.038162,0.0,Neutral
Billionaire Ken Griffin's Citadel Returned a Whopping $7 Billion to Investors -- These Are 3 of Its Biggest Holdings,https://www.fool.com/investing/2023/12/14/billionaire-ken-griffins-citadel-returned-a-whoppi/,2023-12-14 10:51:00,These two stocks and one ETF helped the billionaire's hedge fund make a boatload of money in 2023.,BSX,0.387875,0.151066,Somewhat-Bullish
"Boston Scientific Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/boston-scientific-clears-technical-benchmark-hitting-80-plus-rs-rating-2/,2023-12-13 08:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Boston Scientific ( BSX ) , which had its Relative Strength ( RS ) Rating upgraded from 76 to 81 Wednesday.",BSX,0.592095,0.572743,Bullish
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/12/36179132/100-invested-in-this-stock-10-years-ago-would-be-worth-500-today,2023-12-11 16:00:22,"Boston Scientific BSX has outperformed the market over the past 10 years by 7.1% on an annualized basis producing an average annual return of 17.03%. Currently, Boston Scientific has a market capitalization of $80.76 billion.",BSX,0.980595,0.386944,Bullish
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2195111/heres-why-you-should-retain-boston-scientific-bsx-now,2023-12-07 20:14:00,Investors are optimistic about Boston Scientific (BSX) on strong worldwide demand for its GI and pulmonary treatment options and traction in Europe for its next-generation WATCHMAN FLX.,BSX,0.426225,0.484124,Bullish
Perrigo  ( PRGO )  Up 2% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2194904/perrigo-prgo-up-2-since-last-earnings-report-can-it-continue,2023-12-07 16:31:08,Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,BSX,0.235823,0.063278,Neutral
Edwards Lifesciences to spin off critical care unit to focus on heart devices,https://www.reuters.com/business/healthcare-pharmaceuticals/edwards-lifesciences-spin-off-critical-care-unit-focus-heart-devices-2023-12-07/,2023-12-07 16:18:00,Dec 7 ( Reuters ) - Edwards Lifesciences ( EW.N ) said on Thursday it would spin off its critical care unit at the end of 2024 to concentrate on its larger heart devices business.,BSX,0.146916,0.099675,Neutral
"Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion Return - Microsoft  ( NASDAQ:MSFT ) , Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/general/23/12/36365068/show-me-the-money-inside-ken-griffins-citadels-jaw-dropping-7-billion-return,2023-12-22 16:14:29,"Citadel Founder and CEO Ken Griffin is one of the most successful investors of all time, managing over $62 billion in assets. He is also the founder of Citadel Securities, the largest market-making firm for the New York Stock Exchange and one of the largest designated market makers in the world.",BSX,0.259267,0.308742,Somewhat-Bullish
"Tumor Ablation Market Size to Reach USD 2.3 Billion, at a 6.9% CAGR By 2031 - Transparency Market Research Inc.",https://www.benzinga.com/pressreleases/23/12/g36357854/tumor-ablation-market-size-to-reach-usd-2-3-billion-at-a-6-9-cagr-by-2031-transparency-market-rese,2023-12-22 10:00:00,"Wilmington, Delaware, United States, Dec. 22, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global tumor ablation market was projected to attain US$ 1.3 billion in 2022. It is anticipated to garner a 6.9% CAGR from 2023 to 2031 and by 2031, the market is likely to attain US$ ...",BSX,0.04076,0.0,Neutral
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/23/12/36350088/100-invested-in-this-stock-10-years-ago-would-be-worth-500-today,2023-12-21 19:00:27,"Boston Scientific BSX has outperformed the market over the past 10 years by 6.46% on an annualized basis producing an average annual return of 16.3%. Currently, Boston Scientific has a market capitalization of $80.68 billion.",BSX,0.980595,0.386944,Bullish
 ( BSX )  - Analyzing Boston Scientific's Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/short-sellers/23/12/36302963/bsx-analyzing-boston-scientifics-short-interest,2023-12-19 14:00:14,"Boston Scientific's BSX short percent of float has fallen 22.22% since its last report. The company recently reported that it has 9.24 million shares sold short, which is 0.63% of all regular shares that are available for trading.",BSX,0.221819,0.083071,Neutral
Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm,https://www.newswire.ca/news-releases/clarivate-reveals-stronger-outlook-for-pulsed-field-ablation-market-and-potential-for-device-to-revolutionize-treatment-paradigm-827827379.html,2023-12-19 07:00:00,Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize ... Canada ...,BSX,0.042346,0.250001,Somewhat-Bullish
Boston Scientific  ( NYSE:BSX )  Raised to Buy at StockNews.com,https://www.defenseworld.net/2023/12/17/boston-scientific-nysebsx-raised-to-buy-at-stocknews-com.html,2023-12-17 06:56:44,StockNews.com upgraded shares of Boston Scientific ( NYSE:BSX - Free Report ) from a hold rating to a buy rating in a report published on Friday. BSX has been the subject of several other reports. Robert W.,BSX,0.782378,0.453132,Bullish
Boston Scientific  ( NYSE:BSX )  Rating Increased to Buy at StockNews.com,https://www.defenseworld.net/2023/12/17/boston-scientific-nysebsx-rating-increased-to-buy-at-stocknews-com.html,2023-12-17 06:56:43,"Boston Scientific ( NYSE:BSX - Get Free Report ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued to investors on Friday.",BSX,0.729277,0.458636,Bullish
Boston Scientific  ( BSX )  Rides on Global Growth Amid Macro Woes,https://www.zacks.com/stock/news/2206372/boston-scientific-bsx-rides-on-global-growth-amid-macro-woes,2024-01-05 15:39:00,"Within APAC, Boston Scientific (BSX) is registering strong growth in Japan and China.",BSX,0.468029,0.509515,Bullish
"Ultrasound Equipment Market is to grow by USD 2.98 billion from 2023 to 2028, North America to account for 36% of ... - PR Newswire",https://www.prnewswire.com/news-releases/ultrasound-equipment-market-is-to-grow-by-usd-2-98-billion-from-2023-to-2028--north-america-to-account-for-36-of-market-growth--technavio-302026161.html,2024-01-05 01:00:00,"Ultrasound Equipment Market is to grow by USD 2.98 billion from 2023 to 2028, North America to account for 36% of ... PR ...",BSX,0.125134,0.122308,Neutral
Here's How Much You'd Have If You Invested $1000 in Boston Scientific a Decade Ago,https://www.zacks.com/stock/news/2205533/heres-how-much-youd-have-if-you-invested-1000-in-boston-scientific-a-decade-ago,2024-01-04 13:30:05,Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,BSX,0.535653,0.394347,Bullish
Endoscopy Ultrasound Market to reach USD 1.8 billion and thriving at a CAGR of 5.6% by 2031: TMR Report,https://www.benzinga.com/pressreleases/24/01/g36485832/endoscopy-ultrasound-market-to-reach-usd-1-8-billion-and-thriving-at-a-cagr-of-5-6-by-2031-tmr-rep,2024-01-04 11:00:00,"Wilmington, Delaware, United States, Jan. 04, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global endoscopy ultrasound market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.",BSX,0.035714,0.371208,Bullish
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/24/01/36475618/heres-how-much-you-would-have-made-owning-boston-scientific-stock-in-the-last-15-years,2024-01-03 18:30:21,"Boston Scientific BSX has outperformed the market over the past 15 years by 2.72% on an annualized basis producing an average annual return of 14.29%. Currently, Boston Scientific has a market capitalization of $84.72 billion.",BSX,0.980595,0.386944,Bullish
Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now,https://www.zacks.com/stock/news/2204570/heres-why-you-should-retain-medtronic-mdt-stock-for-now,2024-01-02 17:10:00,Investors are optimistic about Medtronic's (MDT) expansion in global markets and stable solvency position.,BSX,0.04823,0.097986,Neutral
Boston Scientific  ( BSX )  Initiates AVANT GUARD Clinical Trial,https://www.zacks.com/stock/news/2204314/boston-scientific-bsx-initiates-avant-guard-clinical-trial,2024-01-02 12:18:00,Boston Scientific's (BSX) AVANT GUARD clinical trial is set to evaluate the FARAPULSE PFA System as the first-line treatment for persistent AF.,BSX,0.315397,0.264255,Somewhat-Bullish
PBH vs. BSX: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2204175/pbh-vs-bsx-which-stock-is-the-better-value-option,2024-01-01 16:40:09,Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare ( PBH Quick QuotePBH - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks presents investors with the better value opportunity right now?,BSX,0.690822,0.579536,Bullish
Stock Market Turns Sour; Ride-Sharing Stocks Take A Hit,https://www.investors.com/market-trend/stock-market-today/stock-market-turns-sour-ride-sharing-stocks-take-a-hit/,2023-12-29 18:48:00,Stock Market Turns Sour. Ride-Sharing Stocks Take A Hit Investor's Business Daily ...,BSX,0.224903,0.384491,Bullish
These Two Stocks Rocked 2023 And Reach New Highs,https://www.investors.com/stock-lists/new-highs/tjx-stock-and-bsx-stock-rocked-2023-and-are-reaching-new-highs/,2023-12-29 18:41:00,TJX Stock and BSX Stock Rocked 2023 And Are Reaching New Highs Investor's Business Daily ...,BSX,0.640873,0.505093,Bullish
Why Medical Devices Behemoth Boston Scientific  ( BSX )  Shares Are Rising Friday - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/general/biotech/23/12/36423627/why-medical-devices-behemoth-boston-scientific-shares-are-rising-friday,2023-12-29 11:57:06,Boston Scientific Corporation BSX said it expects FARAPULSE Pulsed Field Ablation ( PFA ) System to get FDA approval in the first quarter of 2024.,BSX,0.521465,0.36492,Bullish
Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation,https://www.prnewswire.com/news-releases/boston-scientific-initiates-avant-guard-clinical-trial-to-evaluate-farapulse-pulsed-field-ablation-system-as-first-line-treatment-for-persistent-atrial-fibrillation-302023445.html,2023-12-28 21:00:00,Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as ... PR ...,BSX,0.200411,0.208072,Somewhat-Bullish
"Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky",https://www.marketwatch.com/story/heres-a-solid-contrarian-idea-for-2024-according-to-btigs-krinsky-32a86261,2023-12-28 11:34:00,Investors should consider this list of healthcare stocks for ...,BSX,0.081414,0.0,Neutral
"Angiography Catheters Market Predicted to Hit US$ 2.7 Billion in 2033, Riding on a Strong 6.5% CAGR | According to Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36625759/angiography-catheters-market-predicted-to-hit-us-2-7-billion-in-2033-riding-on-a-strong-6-5-cagr-a,2024-01-14 21:30:00,"New York, Jan. 15, 2024 ( GLOBE NEWSWIRE ) -- Over the past seven years, from 2015 to 2022, the global market has witnessed a significant average annual growth rate of 6.2%.Cardiology has undergone a transformation, revolutionizing disease management through more precise diagnostics and ...",BSX,0.021562,0.0,Neutral
"ALERT: The M&A Class Action Firm Continues Investigating the Merger - GRCL, KRTX, AXNX, HA",https://www.prnewswire.com/news-releases/alert-the-ma-class-action-firm-continues-investigating-the-merger--grcl-krtx-axnx-ha-302033973.html,2024-01-13 01:20:00,"NEW YORK, Jan. 12, 2024 /PRNewswire/ -- , founder and managing partner of the class action firm ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, ...",BSX,0.073773,0.134952,Neutral
"Market Rebounds As Nvidia Leads; Bitcoin ETFs, Tesla Fall: Weekly Review",https://www.investors.com/news/stock-market-rally-rebounds-nvidia-tesla-jpmorgan-bitcoin-etfs-in-focus/,2024-01-12 19:13:00,"Market Rebounds As Nvidia Leads. Bitcoin ETFs, Tesla Fall: Weekly Review Investor's Business Daily ...",BSX,0.045612,-0.022883,Neutral
"Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling - Robinhood Markets  ( NASDAQ:HOOD ) , Axonics  ( NASDAQ:AXNX ) ",https://www.benzinga.com/news/24/01/36591821/robinhood-palo-alto-networks-and-2-other-stocks-insiders-are-selling,2024-01-11 12:46:44,"The Nasdaq 100 closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",BSX,0.08183,0.0,Neutral
"Epilepsy Treatment Market Anticipates Reaching a Valuation of $14.7 Billion by 2033, Propelled by a Robust CAGR of 7.7%, according to projections by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36588618/epilepsy-treatment-market-anticipates-reaching-a-valuation-of-14-7-billion-by-2033-propelled-by-a-,2024-01-11 07:00:00,"New York, Jan. 11, 2024 ( GLOBE NEWSWIRE ) -- The global epilepsy treatment market revolves around the management and treatment of epilepsy, a neurological disorder characterized by recurrent seizures.",BSX,0.026241,0.0,Neutral
"Mechanical Thrombectomy Devices Market Size to be Worth USD 1.8 billion by 2031, Grow at CAGR of 6.4%| Report by Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36576038/mechanical-thrombectomy-devices-market-size-to-be-worth-usd-1-8-billion-by-2031-grow-at-cagr-of-6-,2024-01-10 14:01:36,"Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The mechanical thrombectomy devices industry was valued at US$ 1.1 billion in 2022. Between 2023 and 2031, the market is expected to expand at a CAGR of 6.4%, resulting in revenues ...",BSX,0.036812,0.0,Neutral
Biliary Stent Market to Cross USD 666.5 million at a CAGR of 5.2 % by 2031: Transparency Market Research Report,https://www.benzinga.com/pressreleases/24/01/g36571195/biliary-stent-market-to-cross-usd-666-5-million-at-a-cagr-of-5-2-by-2031-transparency-market-resea,2024-01-10 07:44:12,"Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global biliary stent market is estimated to flourish at a CAGR of 5.2% from 2023 to 2031.",BSX,0.179254,0.216235,Somewhat-Bullish
"ALERT: Juan Monteverde Encourages the Shareholders of AXNX, BVH, GRCL, CVLY to Take Action",https://www.benzinga.com/pressreleases/24/01/g36567556/alert-juan-monteverde-encourages-the-shareholders-of-axnx-bvh-grcl-cvly-to-take-action,2024-01-09 22:31:18,"NEW YORK, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and headquartered ...",BSX,0.064797,0.126667,Neutral
Boston Scientific  ( NYSE:BSX )  Downgraded by StockNews.com to Hold,https://www.defenseworld.net/2024/01/09/boston-scientific-nysebsx-downgraded-by-stocknews-com-to-hold.html,2024-01-09 08:16:46,StockNews.com cut shares of Boston Scientific ( NYSE:BSX - Free Report ) from a buy rating to a hold rating in a research report released on Monday morning.,BSX,0.776667,0.421916,Bullish
"Hysteroscopes Market Size to Exceed USD 446.6 million By 2031, with a Robust CAGR of 5.8%| States Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36550526/hysteroscopes-market-size-to-exceed-usd-446-6-million-by-2031-with-a-robust-cagr-of-5-8-states-tra,2024-01-09 08:02:36,"Wilmington, Delaware, United States, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The hysteroscopes market was worth US$ 267.7 million in 2022. From 2023 to 2031, the market is expected to expand at a CAGR of 5.8%, with a total market value of US$ 446.6 million by 2031.",BSX,0.037098,0.0,Neutral
"SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX, EAR - Ambrx Biopharma  ( NASDAQ:AMAM ) , Axonics  ( NASDAQ:AXNX ) ",https://www.benzinga.com/pressreleases/24/01/g36548462/shareholder-rights-investigation-halper-sadeh-llc-investigates-harp-amam-axnx-ear,2024-01-09 01:21:35,"NEW YORK, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Harpoon Therapeutics, Inc.",BSX,0.141726,0.095681,Neutral
Why Axonics Stock Soared Today,https://www.fool.com/investing/2024/01/08/why-axonics-stock-soared-today/,2024-01-09 00:38:18,The medical device maker agreed to be acquired by Boston Scientific.,BSX,0.772194,0.551739,Bullish
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc.  ( Nasdaq - AMAM ) , Gracell Biotechnologies Inc.  ( Nasdaq - GRCL ) , Axonics, Inc.  ( Nasdaq - AXNX ) , Harpoon Therapeutics, Inc.  ( Nasdaq - HARP ) ",https://www.benzinga.com/pressreleases/24/01/g36547175/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ambrx-biophar,2024-01-08 22:31:37,"BALA CYNWYD, Pa., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",BSX,0.233556,0.235274,Somewhat-Bullish
Tech sector powers stock market higher with the Nasdaq jumping 2%,https://markets.businessinsider.com/news/stocks/stock-market-news-today-tech-sector-nasdaq-surge-ces-conference-2024-1,2024-01-08 21:05:00,Stock Market News Today: Tech Sector Powers Markets Higher With 2% Gain - Markets Insider ...,BSX,0.100308,0.057295,Neutral
FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology,https://www.prnewswire.com/news-releases/fda-approves-medtronic-percept-rc-neurostimulator-with-exclusive-brainsense-technology-302028785.html,2024-01-08 17:38:00,"Rechargeable neurostimulator joins the Medtronic Percept™ family - the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc ( NYSE:MDT ) , a global leader in healthcare technology, today announced ...",BSX,0.063091,-0.038006,Neutral
How To Buy Hot And Promising - But Uncertain - Biotech Stocks,https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/xbi-etf-how-to-buy-hot-and-promising-but-uncertain-biotech-stocks/,2024-01-08 17:34:00,"A mix of choppy or nonexistent earnings alongside the promise of game-changing breakthroughs make biotech stocks a challenge for investors. The SPDR S&P Biotech ETF ( XBI ) , now on the IBD Leaderboard watchlist, offers an alternative to betting on a single biotech name.",BSX,0.166169,0.200529,Somewhat-Bullish
"Stock Market Mixed To Start New Week; Boeing Sees More Pain, Nvidia Hits A High",https://www.investors.com/market-trend/stock-market-today/stock-market-starts-week-mostly-higher-boeing-sees-more-pain-as-nvidia-hits-new-high/,2024-01-08 15:52:00,"Stock Market Mixed To Start New Week. Boeing Sees More Pain, Nvidia Hits A High Investor's Business Daily ...",BSX,0.170075,0.37368,Bullish
"Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today? - Boston Scientific  ( NYSE:BSX ) , Axonics  ( NASDAQ:AXNX ) ",https://www.benzinga.com/news/earnings/24/01/36534875/why-is-bladder-disorder-focused-axonics-stock-trading-higher-today,2024-01-08 15:10:49,"Boston Scientific Corporation BSX has agreed to acquire Axonics Inc AXNX for $71 in cash per share, representing an enterprise value of approximately $3.4 billion and an equity value of approximately $3.7 billion.",BSX,0.663719,0.58984,Bullish
"Health Care Company Boston Scientific Announces Acquisition of Axonics - Boston Scientific  ( NYSE:BSX ) , Axonics  ( NASDAQ:AXNX ) ",https://www.benzinga.com/m-a/24/01/36535903/health-care-company-boston-scientific-announces-acquisition-of-axonics,2024-01-08 15:10:21,"Boston Scientific BSX has announced an acquisition of Axonics AXNX that is expected to be completed 2024-H1. Under the terms of the agreement, Boston Scientific has agreed to give Axonics $3.70 billion in cash in exchange for AXNX stock.",BSX,0.481177,-0.160979,Somewhat-Bearish
Jim Cramer's top 10 things to watch in the stock market Monday,https://www.cnbc.com/2024/01/08/jim-cramers-top-10-things-to-watch-in-the-stock-market-monday.html,2024-01-08 14:23:57,Wall Street looks to bounce back after first down week in the past 10.,BSX,0.068502,0.046261,Neutral
Two Biotechs Roughly Double After Snagging Splashy Takeover Deals,https://www.investors.com/news/technology/amam-stock-harp-stock-catapult-after-snagging-jnj-merck-buyouts/,2024-01-08 14:19:00,"AMAM Stock, HARP Stock Catapult After Snagging J&J, Merck Buyouts Investor's Business Daily ...",BSX,0.529185,0.18163,Somewhat-Bullish
AXNX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Axonics to Boston Scientific - Axonics  ( NASDAQ:AXNX ) ,https://www.benzinga.com/pressreleases/24/01/g36533299/axnx-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-axonics-to-boston-sc,2024-01-08 13:47:04,"MONSEY, N.Y., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the $71.00 per share in cash pursuant to which Axonics, Inc. AXNX ( ""Axonics"" ) has agreed to be sold to Boston Scientific Corporation ( ""Boston Scientific"" ) .",BSX,0.377142,0.309996,Somewhat-Bullish
Boston Scientific to Acquire Axonics For About $3.7 Billion,https://www.wsj.com/health/boston-scientific-to-acquire-axonics-for-about-3-7-bln-7d990bc2,2024-01-08 12:58:00,Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion.,BSX,0.987581,0.541795,Bullish
Boston Scientific to Acquire Axonics For About $3.7 Billion,https://www.wsj.com/business/energy-oil/boston-scientific-to-acquire-axonics-for-about-3-7-bln-7d990bc2,2024-01-08 12:58:00,Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion.,BSX,0.987581,0.541795,Bullish
Telehealth & Telemedicine Market is Expected to Reach $285.7 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/24/01/g36530941/telehealth-telemedicine-market-is-expected-to-reach-285-7-billion-marketsandmarkets,2024-01-08 12:30:00,"Chicago, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Telehealth & Telemedicine market in terms of revenue was estimated to be worth $120.4 Billion in 2023 and is poised to reach $285.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028 according to a latest report published by ...",BSX,0.045569,-0.016622,Neutral
"Boston Scientific Announces Agreement to Acquire Axonics, Inc.",https://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-axonics-inc-302027843.html,2024-01-08 12:00:00,Acquisition to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction,BSX,0.290033,0.26656,Somewhat-Bullish
Urinary Catheters Market size to grow by USD 2.44 billion from 2023 to 2028| Growing demand for antimicrobial-coated urinary catheters to drive the market growth - Technavio,https://www.benzinga.com/pressreleases/24/01/g36520388/urinary-catheters-market-size-to-grow-by-usd-2-44-billion-from-2023-to-2028-growing-demand-for-ant,2024-01-06 00:12:00,"New York, Jan. 05, 2024 ( GLOBE NEWSWIRE ) -- The Urinary Catheters Market size is projected to increase by USD 2.44 billion between 2023 and 2028, and register a CAGR of 7.63%, according to Technavio's latest market research report estimates.",BSX,0.04583,0.093551,Neutral
"SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VIA, FGH, AXNX - FG Group Holdings  ( AMEX:FGH ) , Axonics  ( NASDAQ:AXNX ) ",https://www.benzinga.com/pressreleases/24/01/g36778344/shareholder-notice-halper-sadeh-llc-investigates-via-fgh-axnx,2024-01-25 13:07:24,"NEW YORK, Jan. 25, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Via Renewables, Inc.",BSX,0.122894,0.089116,Neutral
"Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight",https://www.prnewswire.com/news-releases/drug-eluting-balloons-global-market-is-expected-to-expand-at-a-healthy-growth-rate-of-8-by-2028-predicts-delveinsight-302042856.html,2024-01-24 22:01:00,"Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts ... PR ...",BSX,0.051943,0.048943,Neutral
Boston Scientific  ( NYSE:BSX )  Cut to Hold at StockNews.com,https://www.defenseworld.net/2024/01/24/boston-scientific-nysebsx-cut-to-hold-at-stocknews-com.html,2024-01-24 06:34:44,"Boston Scientific ( NYSE:BSX - Get Free Report ) was downgraded by investment analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a note issued to investors on Wednesday. BSX has been the subject of a number of other reports.",BSX,0.721785,0.460168,Bullish
"Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight",https://www.prnewswire.com/news-releases/implantable-drug-delivery-devices-global-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2028-assesses-delveinsight-302041477.html,2024-01-23 22:31:00,Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028 ... PR ...,BSX,0.027103,0.088505,Neutral
"Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst - Inari Medical  ( NASDAQ:NARI ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36745475/arterial-device-focused-inari-medical-likely-acquisition-target-shares-are-attracti,2024-01-23 19:56:52,"Needham initiated coverage on Inari Medical Inc NARI, noting it as a leader in the very large and underpenetrated market for venous thrombectomy. Inari Medical projects an annual patient population of 280,000 with pulmonary embolism ( PE ) in the U.S., equating to a total available market ( TAM ) ...",BSX,0.213048,0.0,Neutral
Looking Into Boston Scientific's Recent Short Interest - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/insights/short-sellers/24/01/36741285/looking-into-boston-scientifics-recent-short-interest,2024-01-23 16:15:21,"Boston Scientific's BSX short percent of float has fallen 20.0% since its last report. The company recently reported that it has 9.35 million shares sold short, which is 0.64% of all regular shares that are available for trading.",BSX,0.221819,0.083071,Neutral
3 Medical Instruments Stocks to Buy as Industry Trends Improve,https://www.zacks.com/commentary/2214112/3-medical-instruments-stocks-to-buy-as-industry-trends-improve,2024-01-23 15:13:00,"The Zacks Medical - Instruments industry is gaining from the rising demand for digital health offers. However, inflation and staffing shortages continue to disrupt growth. HOLX, MASI and VCYT appear well-poised to brave the challenges.",BSX,0.027795,-0.005666,Neutral
Shanghai fails to achieve 5.5 per cent economic growth target for 2023,https://www.scmp.com/business/china-business/article/3249475/shanghai-failed-achieve-55-cent-economic-growth-target-2023-amid-complex-and-severe-external,2024-01-23 08:00:06,"The city's GDP expanded 5 per cent last year as the global economy turned out to be weaker than expected, Mayor Gong Zheng told an annual session of the Shanghai People's Congress on Tuesday.",BSX,0.067158,0.072583,Neutral
"Rehabilitation Equipment Global Market to Showcase Growth at a CAGR of ~5% by 2028, Examines DelveInsight",https://www.prnewswire.com/news-releases/rehabilitation-equipment-global-market-to-showcase-growth-at-a-cagr-of-5-by-2028-examines-delveinsight-302040512.html,2024-01-22 22:31:00,"The increasing demand for rehabilitation equipment is driven by several factors, including a growing number of accidents, injuries, and falls.",BSX,0.05333,0.004985,Neutral
Brain Implants Market Set for Remarkable Growth: Projected to Reach $8.77 Billion by 2028 As Per The Business Research Company's Brain Implants Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36719319/brain-implants-market-set-for-remarkable-growth-projected-to-reach-8-77-billion-by-2028-as-per-the,2024-01-22 16:30:00,"LONDON, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Brain Implants Global Market Report 2024, the global brain implants market has been experiencing rapid growth in recent years and is poised for significant expansion in the coming years.",BSX,0.054236,0.121772,Neutral
3Daughters Successfully Closes Over $2 million in First Tranche of Seed Financing Round,https://www.benzinga.com/pressreleases/24/01/g36714301/3daughters-successfully-closes-over-2-million-in-first-tranche-of-seed-financing-round,2024-01-22 13:00:56,"MANSFIELD, Mass., Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- 3Daughters, a clinical development company fueling evolutionary healthcare for women, announces closing of the first tranche in excess of $2 million in a Seed Round.",BSX,0.049019,0.197042,Somewhat-Bullish
Interventional Pulmonology Market to Reach a Revenue of US$ 1.9 Billion by 2033 End | According to Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36712582/interventional-pulmonology-market-to-reach-a-revenue-of-us-1-9-billion-by-2033-end-according-to-pe,2024-01-22 11:21:00,"New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: In 2022, the interventional pulmonology market generated a global revenue of US$ 1.2 billion, and it is projected to experience a steady growth with a Compound Annual Growth Rate ( CAGR ) of 4.2%.",BSX,0.03878,0.0,Neutral
"Intravenous Infusion Pump Market to Hit USD 13.2 Billion by 2032, says Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36712525/intravenous-infusion-pump-market-to-hit-usd-13-2-billion-by-2032-says-persistence-market-research,2024-01-22 11:15:00,"New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: Newly-released Intravenous Infusion Pumps market analysis report by Persistence Market Research shows that global sales of the Intravenous Infusion Pumps Market in 2021 were held at US$ 5.6 Bn. With a CAGR of 9% during 2022 ...",BSX,0.042196,-0.033591,Neutral
"The Zacks Analyst Blog Highlights Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific",https://www.zacks.com/stock/news/2213232/the-zacks-analyst-blog-highlights-microsoft-procter-gamble-astrazeneca-general-electric-and-boston-scientific,2024-01-22 10:56:00,"Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific are included in this Analyst Blog.",BSX,0.151539,0.041941,Neutral
"ALERT: The M&A Class Action Firm Continues Investigating the Merger - GRCL, AXNX, HARP, CVLY",https://www.benzinga.com/pressreleases/24/01/g36704957/alert-the-m-a-class-action-firm-continues-investigating-the-merger-grcl-axnx-harp-cvly,2024-01-20 01:00:00,"NEW YORK, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and headquartered ...",BSX,0.065506,0.126754,Neutral
Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/liquid-biopsy-in-cancer-diagnostics-global-market-is-likely-to-increase-at-a-massive-growth-rate-of-17-by-2028--delveinsight-302039144.html,2024-01-19 22:01:00,Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 ... PR ...,BSX,0.021143,0.024956,Neutral
United States FDA Medical Device Recalls rend and Impact Analysis Report 2023: Product Innovation will Reduce Medical Device Recalls,https://www.prnewswire.com/news-releases/united-states-fda-medical-device-recalls-rend-and-impact-analysis-report-2023-product-innovation-will-reduce-medical-device-recalls-302039330.html,2024-01-19 16:45:00,United States FDA Medical Device Recalls rend and Impact Analysis Report 2023: Product Innovation will Reduce ... PR ...,BSX,0.068502,0.134506,Neutral
Endoscopes Market Size & Share to Surpass US$ 27.3 Billion by 2033 | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36696436/endoscopes-market-size-share-to-surpass-us-27-3-billion-by-2033-persistence-market-research,2024-01-19 15:10:00,"New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: Worldwide revenue from the endoscope market was about US$ 13.9 Billion in 2022, with the global market estimated to surge ahead at a CAGR of 6.3% to reach a valuation of US$ 27.3 Billion by the end of 2033.",BSX,0.018023,0.0,Neutral
"Cardiac Sutures Market Estimated to Reach USD 2.3 billion, Advancing at a CAGR of 6.8% by 2031: Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36680030/cardiac-sutures-market-estimated-to-reach-usd-2-3-billion-advancing-at-a-cagr-of-6-8-by-2031-trans,2024-01-18 15:30:00,"Wilmington, Delaware, United States, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global cardiac sutures market is estimated to flourish at a CAGR of 6.8% from 2023 to 2031.",BSX,0.036532,0.0,Neutral
4 Fidelity Mutual Funds to Buy as the Market Ebbs and Flows,https://www.zacks.com/stock/news/2211852/4-fidelity-mutual-funds-to-buy-as-the-market-ebbs-and-flows,2024-01-18 10:36:00,"Invest in Fidelity mutual funds like FPHAX, FCAKX, FDTIX and FDSCX for high returns alongside risk reduction in the current environment.",BSX,0.045396,0.126219,Neutral
PBH or BSX: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2211577/pbh-or-bsx-which-is-the-better-value-stock-right-now,2024-01-17 16:40:11,PBH vs. BSX: Which Stock Is the Better Value Option?,BSX,0.751437,0.553576,Bullish
What's in Store for Boston Scientific  ( BSX )  in Q4 Earnings?,https://www.zacks.com/stock/news/2211533/whats-in-store-for-boston-scientific-bsx-in-q4-earnings,2024-01-17 15:40:00,"Boston Scientific (BSX) is expected to have witnessed strong growth of the WATCHMAN franchise in the fourth quarter, given the FDA approval of WATCHMAN FLX Pro in September.",BSX,0.313484,0.39371,Bullish
Bioabsorbable Stents Market to Attain a Valuation of USD 560.1 million by 2031: Transparency Market Research Study,https://www.benzinga.com/pressreleases/24/01/g36660532/bioabsorbable-stents-market-to-attain-a-valuation-of-usd-560-1-million-by-2031-transparency-market,2024-01-17 14:30:00,"Wilmington, Delaware, United States, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The bioabsorbable stents market stood at US$ 375.5 million in 2022. A CAGR of 6.4% is projected from 2023 to 2031, reaching more than US$ 560.1 million during the forecast period.",BSX,0.036532,-0.110458,Neutral
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2024/01/17/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html,2024-01-17 14:19:13,"Stock futures were lower Wednesday, as 10-year Treasury yield rose back above 4%.",BSX,0.060388,0.095001,Neutral
"Palo Alto Networks, Nvidia, And 2 Other Stocks Insiders Are Selling - Jabil  ( NYSE:JBL ) , Boston Scientific  ( NYSE:BSX ) ",https://www.benzinga.com/news/24/01/36656584/palo-alto-networks-nvidia-and-2-other-stocks-insiders-are-selling,2024-01-17 11:44:01,"The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",BSX,0.439026,0.2108,Somewhat-Bullish
"SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates FGH, AXNX, AMAM, HARP - Ambrx Biopharma  ( NASDAQ:AMAM ) , Axonics  ( NASDAQ:AXNX ) ",https://www.benzinga.com/pressreleases/24/01/g36653978/shareholder-rights-investigation-halper-sadeh-llc-investigates-fgh-axnx-amam-harp,2024-01-17 05:00:00,"NEW YORK, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: FG Group Holdings Inc.",BSX,0.12546,0.089947,Neutral
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc.  ( Nasdaq - AMAM ) , Gracell Biotechnologies Inc.  ( Nasdaq - GRCL ) , Axonics, Inc.  ( Nasdaq - AXNX ) , Harpoon Therapeutics, Inc.  ( Nasdaq - HARP ) ",https://www.benzinga.com/pressreleases/24/01/g36638641/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ambrx-biophar,2024-01-16 13:05:00,"BALA CYNWYD, Pa., Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",BSX,0.233556,0.235274,Somewhat-Bullish
Spinal Implants and Surgical Devices Market Projected USD 4.24 Billion Growth between 2024 and 2028: Market to ... - PR Newswire,https://www.prnewswire.com/news-releases/spinal-implants-and-surgical-devices-market-projected-usd-4-24-billion-growth-between-2024-and-2028-market-to-focus-on-open-surgeries-and-minimally-invasive-surgeries---technavio-302051530.html,2024-02-02 17:20:00,Spinal Implants and Surgical Devices Market Projected USD 4.24 Billion Growth between 2024 and 2028: Market to ... PR ...,BSX,0.080728,0.104868,Neutral
"Stocks Handle Huge Earnings, Fed, Jobs Report: Weekly Review",https://www.investors.com/news/stock-market-handles-huge-earnings-week-fed-powell-jobs-report-weekly-review/,2024-02-02 17:15:00,"Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review Investor's Business Daily ...",BSX,0.049835,0.161989,Somewhat-Bullish
PBH vs. BSX: Which Stock Should Value Investors Buy Now?,https://www.zacks.com/stock/news/2220412/pbh-vs-bsx-which-stock-should-value-investors-buy-now,2024-02-02 16:40:12,PBH vs. BSX: Which Stock Is the Better Value Option?,BSX,0.680677,0.56132,Bullish
Boston Scientific  ( NYSE:BSX )  Upgraded to Buy at StockNews.com,https://www.defenseworld.net/2024/02/02/boston-scientific-nysebsx-upgraded-to-buy-at-stocknews-com.html,2024-02-02 15:45:00,StockNews.com upgraded shares of Boston Scientific ( NYSE:BSX - Free Report ) from a hold rating to a buy rating in a report released on Thursday morning.,BSX,0.725561,0.488268,Bullish
Neuromodulation Market Worth $11.0 Billion | MarketsandMarkets™.,https://www.prnewswire.com/news-releases/neuromodulation-market-worth-11-0-billion--marketsandmarkets-302051831.html,2024-02-02 15:30:00,"CHICAGO, Feb. 2, 2024 /PRNewswire/ -- Neuromodulation Market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR of 12.0% from 2023 to 2028 according to a new report by MarketsandMarkets™.",BSX,0.040416,0.0,Neutral
Boston Scientific's  ( BSX )  FARAPULSE PFA System Gets FDA Nod,https://www.zacks.com/stock/news/2220088/boston-scientifics-bsx-farapulse-pfa-system-gets-fda-nod,2024-02-02 13:09:00,Boston Scientific (BSX) secures FDA approval for the FARAPULSE PFA system.,BSX,0.311406,0.234082,Somewhat-Bullish
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/insights/news/24/02/36898182/heres-how-much-you-would-have-made-owning-boston-scientific-stock-in-the-last-10-years,2024-02-01 21:00:23,"Boston Scientific BSX has outperformed the market over the past 10 years by 6.83% on an annualized basis producing an average annual return of 17.63%. Currently, Boston Scientific has a market capitalization of $94.85 billion.",BSX,0.980595,0.386944,Bullish
Stryker Stock Sees Relative Strength Rating Jump To 84,https://www.investors.com/news/stryker-stock-sees-relative-strength-rating-jump-to-84/,2024-02-01 20:03:00,"The Relative Strength ( RS ) Rating for Stryker ( SYK ) stock jumped into a new percentile Thursday, with a rise from 76 to 84. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",BSX,0.334008,0.0,Neutral
"AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Boston Scientific  ( NYSE:BSX ) , Cigna Group  ( NYSE:CI ) ",https://www.benzinga.com/news/24/02/36886194/at-t-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday,2024-02-01 12:48:20,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised the price target for Boston Scientific Corporation BSX from $60 to $71.",BSX,0.242084,0.216608,Somewhat-Bullish
Stryker Stock Sees Relative Strength Rating Jump To 84,https://www.investors.com/news/stryker-stock-sees-relative-strength-rating-jump-to-84/,2024-02-01 08:00:00,Stocks To Watch: Stryker Sees Relative Strength Rating Jump To 84 Investor's Business Daily ...,BSX,0.334008,0.0,Neutral
Medical-device makers' stocks jump as procedures keep going strong,https://www.marketwatch.com/story/medical-device-makers-stocks-jump-as-procedures-keep-going-strong-87c98cbe,2024-01-31 17:48:00,"Shares of Stryker, Boston Scientific and other medical technology companies jumped Wednesday as healthy demand for medical procedures brightened investors' outlook on the device makers.",BSX,0.321673,0.331876,Somewhat-Bullish
"Boston Scientific  ( BSX )  Q4 Earnings Top, Operating Margin Falls",https://www.zacks.com/stock/news/2218938/boston-scientific-bsx-q4-earnings-top-operating-margin-falls,2024-01-31 16:55:00,Boston Scientific (BSX) sees an increase in organic and operational revenues in its core business segments and geographies in the reported quarter.,BSX,0.283167,0.17507,Somewhat-Bullish
Why Medical Devices Giant Boston Scientific Shares Are Rising Today Why Medical Devices Giant Boston Scientific  ( BSX )  Shares Are Rising Today - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/news/earnings/24/01/36867277/why-medical-devices-giant-boston-scientific-shares-are-rising-today,2024-01-31 14:27:31,"The company generated fourth-quarter revenues of $3.725 billion, beating the Wall Street estimate of $3.59 billion. Sales soared 14.9% on a reported basis, 14.5% on an operational basis, and 13.6% on an organic basis.",BSX,0.573213,0.146394,Neutral
Medtech Stock Surges On Its 'Impressive' First-Quarter Outlook,https://www.investors.com/news/technology/bsx-stock-boston-scientific-earnings-q4-2023/,2024-01-31 14:18:00,BSX Stock Surges After Boston Scientific Provides 'Impressive' First-Quarter Guidance Investor's Business Daily ...,BSX,0.756655,0.306105,Somewhat-Bullish
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer,https://www.globenewswire.com/news-release/2024/01/31/2821051/0/en/CVRx-Announces-Appointment-of-Kevin-Hykes-as-President-and-Chief-Executive-Officer.html,2024-01-31 13:00:00,"MINNEAPOLIS, Jan. 31, 2024 ( GLOBE NEWSWIRE ) -- CVRx, Inc. ( NASDAQ: CVRX ) ( ""CVRx"" ) , a commercial-stage medical device company, announced today the appointment of Kevin Hykes as the Company's new President and Chief Executive Officer, effective February 12.",BSX,0.051999,0.043705,Neutral
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer - CVRx  ( NASDAQ:CVRX ) ,https://www.benzinga.com/pressreleases/24/01/g36864586/cvrx-announces-appointment-of-kevin-hykes-as-president-and-chief-executive-officer,2024-01-31 13:00:00,"Appointment effective February 12 following Nadim Yared's retirement Hykes currently serves as Augmedics' President and CEO, and has served on CVRx's Board of Directors since 2022 MINNEAPOLIS, Jan. 31, 2024 ( GLOBE NEWSWIRE ) -- CVRx, Inc.",BSX,0.048523,0.042441,Neutral
"Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts",https://www.investors.com/news/technology/stryker-boston-scientific-score-earnings-beats-extend-breakouts/,2024-01-31 12:59:00,"Two leading medical products brands, Stryker ( SYK ) and Boston Scientific ( BSX ) , jumped in early trade Wednesday following quarterly reports. Stryker, which also received a pair of analyst price target hikes, ended Tuesday in a buy range after a Jan. 10 breakout.",BSX,0.53784,0.291856,Somewhat-Bullish
"Why Nasdaq Futures Are Diving Today - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/01/36864420/nasdaq-futures-plummet-as-alphabet-amd-disappointments-sour-sentiment-spotlight-shifts-to-fed-state,2024-01-31 12:47:00,"Disappointing tech tidings appear to be weighing down on the market, with the Nasdaq futures diving in early trading on Wednesday while the Dow futures were barely holding up. Earnings from the likes of Advanced Micro Devices, Inc. AMD, Microsoft Corp. MSFT, and Alphabet, Inc.",BSX,0.086556,-0.051341,Neutral
Boston Scientific's stock jumps 3% after earnings beat and upbeat guidance,https://www.marketwatch.com/story/boston-scientifics-stock-jumps-5-8-after-earnings-beat-and-upbeat-guidance-1b1bb7a2,2024-01-31 11:42:00,Medtech company's earnings beat estimates in the latest quarter as sales rose 14.9%.,BSX,0.504646,0.27267,Somewhat-Bullish
Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System,https://www.prnewswire.com/news-releases/boston-scientific-receives-fda-approval-for-farapulse-pulsed-field-ablation-system-302048807.html,2024-01-31 11:25:00,"Strong clinical evidence base, largest volume of real-world use reinforce safety, efficacy and efficiency advantages of the system MARLBOROUGH, Mass., Jan. 31, 2024 /PRNewswire/ -- Boston Scientific Corporation ( NYSE: BSX ) announced it has received U.S.",BSX,0.217694,0.16988,Somewhat-Bullish
Stryker  ( SYK )  Surpasses Q4 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2218249/stryker-syk-surpasses-q4-earnings-and-revenue-estimates,2024-01-30 22:15:05,"Stryker (SYK) delivered earnings and revenue surprises of 5.81% and 3.81%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",BSX,0.140076,0.0,Neutral
"Medical Products Q4 Earnings Due on Jan 31: BSX, TMO & ALGN",https://www.zacks.com/stock/news/2217861/medical-products-q4-earnings-due-on-jan-31-bsx-tmo-algn,2024-01-30 14:31:00,"Medical Products companies' fourth-quarter results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO and ALGN fare this time.",BSX,0.249288,0.188067,Somewhat-Bullish
enGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary,https://www.newswire.ca/news-releases/engene-appoints-lee-giguere-as-chief-legal-officer-and-corporate-secretary-810535443.html,2024-01-30 12:00:00,"Experienced biotech executive brings public company expertise in legal, corporate governance, and compliance to support enGene during late-stage clinical development and anticipated future commercial launch of its lead program EG-70",BSX,0.038655,0.116169,Neutral
"Cardiac Resynchronization Therapy System Market to Witness 4.9% CAGR, Projected to Reach USD 6.9 billion by 2031: Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36820877/cardiac-resynchronization-therapy-system-market-to-witness-4-9-cagr-projected-to-reach-usd-6-9-bil,2024-01-29 11:15:31,"Wilmington, Delaware, United States, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global cardiac resynchronization therapy system market is estimated to sluggishly surge at a CAGR of 4.9% from 2023 to 2031.",BSX,0.129866,0.268491,Somewhat-Bullish
"Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? - SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/01/36820476/tech-titans-microsoft-apple-lead-magnificent-seven-earnings-wave-this-week-can-mega-caps-ignite-mar,2024-01-29 10:51:00,"The past week's earnings were bordering on the negative, impacting trader sentiment, and the focus now shifts to the unfolding week that would see the release of a slew of tech earnings reports. The Week That Was: Tesla, Inc. TSLA, Intel, Inc. INTC, and Texas Instruments, Inc.",BSX,0.086713,-0.075054,Neutral
Shanghai offers financing and land-use support to foreign investors,https://www.scmp.com/business/china-business/article/3250008/shanghai-offers-financing-and-land-use-support-foreign-investors-city-commits-meet-5-cent-economic,2024-01-27 08:19:32,Shanghai Mayor Gong Zheng said the policy initiative to support more foreign direct investments would buttress the city's economic recovery efforts in 2024.,BSX,0.059194,0.06199,Neutral
"AXONICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX",https://www.prnewswire.com/news-releases/axonics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-axonics-inc---axnx-302046077.html,2024-01-27 04:18:00,"AXONICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC ... PR ...",BSX,0.451494,0.195991,Somewhat-Bullish
Boston Scientific  ( BSX )  Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates,https://www.zacks.com/stock/news/2216417/boston-scientific-bsx-q4-earnings-preview-what-you-should-know-beyond-the-headline-estimates,2024-01-26 14:15:26,"Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Boston Scientific (BSX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.",BSX,0.329112,0.19917,Somewhat-Bullish
